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Abstract
Shikimate kinase (SK; EC 2.7.1.71), an enzyme that catalyses the specific 
phosphorylation of the 3-hydroxyl group of shikimate using ATP as the phosphoryi donor, 
was chosen as a representative example of a subclass of a/{3 proteins with which to 
examine the unfolding, stability and mechanism of protein folding.
The equilibrium unfolding of the enzyme was monitored for SK in the absence and in the 
presence of shikimate and using both guanidinium chloride (GdmCI) and urea as 
denaturing agents. The changes in secondary and tertiary structure, monitored by far UV, 
circular dichroism (CD) and fluorescence respectively, could be fitted for both dénaturants 
to a 2-state model giving an estimate of 17 kJ/mol as the stability of the folded state. The 
marked loss of activity and decrease in shikimate binding observed at low concentrations 
of GdmCI were found to be largely due to ionic strength effects associated with 
perturbation of the shikimate binding site.
The effects of different salts (NaCI, KCI, CaClg, MgCl2 , NaF, NaBr, NaNOs and Na2S0 4 ) 
on the structure, activity, binding, and stability of SK have been investigated. The inclusion 
of salts leads to a marked stabilisation against unfolding of the enzyme by urea. Although 
the salts listed above have only small effects on far-UV CD and fluorescence spectra, 
NaCI and Na2 S0 4  were found to lead to a tightening of the structure of the enzyme as 
shown by the effect on the near-UV CD spectrum. All the salts studied have an effect on 
catalytic activity, which in general appears to be correlated with changes in ionic strength.
The refolding of SK after chemical dénaturation using both urea and GdmCI has been 
studied in detail. This was performed using measurements of CD, fluorescence, activity, 
8-anilino-1-naphthalene sulphonate (ANS) fluorescence, and employing both manual 
mixing and rapid reaction techniques. From these studies an outline pathway for the 
folding process has been formulated in which at least three intermediates are involved. 
The pathway described could act as a model for other members of the NMP kinase family 
of enzymes and the relevance of the results to the folding of other a/p domain proteins is 
discussed.
The unfolding of the enzyme by 4M urea could be prevented by inclusion of 1M NaCI or 
0.33M Na2 S0 4 , and the addition of these concentrations of salts to enzyme unfolded by 
4M urea led to a slow but nearly complete regain of overall native secondary and tertiary 
structure, as Judged by the regain of native-like CD and fluorescence. However, the 
refolded enzyme differs from the native form in terms of the degree of fluorescence 
quenching by iodide ions which suggests that the single Trp has only partially regained the 
positively charged environment provided by neighbouring Arg side chains and in terms of
the relatively weak binding of shikimate that can be observed by fluorescence quenching. 
While no binding of nucleotide could be detected directly there is some evidence for 
synergism in substrate binding which suggests that nucleotide may bind to some extent. 
However, the refolded enzyme does not possess detectable catalytic activity. During the 
refolding process brought about by addition of salt in the presence of 4M urea no change 
in the fluorescence of the probe ANS was observed, indicating that either an intermediate 
formed by hydrophobic collapse is unlikely to be significantly populated or that the 
concentration of the chaotropic agent used for dénaturation displaces the dye by shear 
competition. The results point to both specific and general effects of salts on SK and are 
discussed in the light of the structural information available on the enzyme.
Additional experiments to investigate the effect of the residual ionic strength on the 
process of refolding after a dénaturant jump were undertaken. In general the presence of 
NaCI and Na2 S0 4  lead to an increase in the refolding rate, while NaF seems to impair the 
efficiency of refolding.
Preliminary experiments to investigate the protection by substrates against inactivation of 
SK by the lysine-specific reagent pyridoxal-5’-phosphate (PLP) were carried out. The 
inclusion of shikimate, either alone or with ADP, does not appear to give any degree of 
protection against inactivation. The difference in the protection achieved in the presence 
of ADP or ATP points to the role of Lys 15 in the coordination of the y-phosphate of ATP 
and that this interaction is necessary to achieve the conformational change in the 
enzyme required for catalysis.
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Chapter 1: Introduction
1.1 Protein Folding
1.1.1 The protein folding problem and its applications
1.1.1.1 The protein folding problem
A protein molecule is composed of a polypeptide sequence that meets both thermodynamic 
and kinetic folding requirements; it possesses a unique native state that is stable under 
physiological conditions, and it is able to find that state in a reasonable time (Levinthal, 
1968). Understanding the mechanism by which proteins acquire this structure is known as 
“the protein folding problem” and the solution of this problem will require a detailed 
knowledge of the sequence of conformational events that leads from the ensemble of 
denatured states to the native protein. It is possible to divide this problem into a number of 
related questions: what is the physical basis of the stability of the folded protein 
conformation; what processes determine that a protein adopts its native conformation; what 
are the rules that link the amino acid sequence to the three-dimensional structure of a 
protein. If the three-dimensional structure of a protein can be predicted from its amino acid 
sequence (often referred as cracking the second half of the genetic code), this would provide 
the "missing link” in the flow of information between a gene sequence and the 3D structure of 
a protein (Creighton, 1990; 1994). Protein folding is no longer a purely academic research 
topic, as is illustrated by both biotechnological applications and by clinical consequences.
1.1.1.2 Folding: industrial implications
Transcription and translation of a recombinant gene do not always lead to the accumulation 
of a folded fully active protein. Instead, recombinant gene expression may lead to the 
production of protein in an inactive insoluble form known as an inclusion body, an extremely 
dense structure, different from amorphous precipitated protein. Inclusion bodies bear some 
similarities to true protein crystals in that, although not apparently ordered, they tend to be 
monocomponent and of extremely high packing density (Thatcher and Hitchcock, 1994). 
The reason for the formation of the inclusion bodies is probably associated with the 
particular environment in which the foreign protein accumulates, which can be quite 
different from the natural situation. In order to make a useful product this insoluble protein 
has first to be solubilized and then refolded artificially (Lilie et al., 1998). Despite the 
possible disadvantages associated with the solubilization of inclusion bodies and in vitro 
renaturation, there are also advantages to their use as starting materials. In contrast to 
soluble products, the isolation steps for inclusion bodies are relatively simple and result in a 
concentrated and relatively pure protein. For this reason many studies have dealt with the
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improvement of the refolding yield of recombinant proteins produced by overexpression in 
Escherichia coli. Most commonly, aggregates are solubilized in a strong chaotrope, such as 
8M guanidinium chloride (GdmCI), which results in nearly complete unfolding of the protein 
molecules. Once soluble and unfolded, the proteins are first diluted with additional GdmCI 
solution and then refolded by removing the chaotrope by dialysis or additional dilution (De 
Bernardez Clark, 1998). The refolding step, however, is difficult and depends strongly on 
renaturing conditions. A number of variations have been proposed to the standard 
procedure (De Bernardez Clark, 2001). Some of these utilise standard chromatographic 
procedure (Batas et a!., 1999), others use high pressure in place of high concentrations of 
chaotrope agent (St. John et a/., 1999; Randolph et a!., Int. Appl. WO 00/02 901, 2001).
In the cases of proteins that do not refold using conventional methods, the use of mini­
chaperones immobilized on agarose gel has been proposed (Altamirano et a!., 1997).
In many cases, folding has been achieved by manipulation with additives, such as salts, 
polyethylene glycol (PEG) or micelle-forming surfactants (Cleland and Wang, 1990; 
Wetlaufer and Xle, 1995). Since the efficiency of protein folding is largely determined by the 
rates of folding, unfolding and aggregation, it is important to know the influence of additives 
on these rate constants in order to obtain high folding yields (section 1.1.3.2). Refolding of 
denatured proteins is now recognised as a discrete and pivotal unit operation in the 
production of several products of industrial importance such as interferon beta 1-b 
(Betaferon® Sobering), interleukin 2 (Proleukin® - Cetus (Chiron)) (Dorin et ai., 1998; U.S. 
patent 4,748,234) and the tissue plasminogen activator (Repilysin® - Roche) (De Bernardez 
Clark, 2001).
1.1.1.3 Folding: clinical consequences and biological role of folding intermediates.
Because the aqueous environment (pH, temperature, ionic strength, presence of chaotropic 
agents) strongly influences the conformation adopted by the polypeptide, it is an 
unanswered question which conformational changes proteins may experience upon 
migrating from one compartment to another of the cell. It is believed that folding and 
unfolding play an important role in the mechanisms and control of a broad spectrum of 
cellular processes, failures of which can lead to cellular malfunctions and to disease.
In particular it was demonstrated that compact folding intermediates (Christensen and Pain,
1994) (section 1.1.2 and 1.1.3) play an important role in processes such as: the recognition 
of proteins by chaperones (Martin et al., 1991; Hendrick and HartI, 1993); the interaction 
and penetration of proteins into membranes (Bychkova et al., 1988; van der Goot et al., 
1991; Banuelos and Muga, 1995); the specificity of DNA-binding proteins (Hornby et al.,
1994); protein transport (Lindsay and Glover, 1992) and virus and phage caspid assembly 
processes (Kirkitadze et al., 1998; Tume and Thomas, 1997). In addition, some evidence
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indicates that certain mutations could be connected with incomplete protein folding, blocking 
it at the stages of compact intermediates (Lascu et a i, 1997), and this could lead to 
mislocation of proteins in a cell and may provoke genetic diseases (Bychkova and Ptitsyn,
1995). Misfolding of proteins does not need to involve mutations, but can be triggered by a 
variety of factors, such as protein overexpression, temperature, oxidative stress and 
activation of various signalling pathways linked to protein folding and quality control 
machinery. In the last few years, a variety of diseases have been shown to arise from 
protein misfolding. This group of diseases correlated with protein misfolding are now 
grouped together under the name of “protein conformational disorders” (PCDs) (Soto, 
2001); some of these are reported in Table 1.1.
Protein Involved Disease
(3-Amyloid Alzheimer’s disease
a-SynudeIn Parkinson disease
Amylln Diabetes Type 2
Superoxide dismutase Amyotrophic lateral sclerosis
(32-Microgiobulin Haemodialysis-related amyloidosis
CFTR protein Cystic fibrosis
Hemoglobin Sickle ceil anemia
Huntingtin Huntington disease
PrP Creutzfeldt-Jakob disease
and related disorders
Table 1.1: List of some Protein Conformational Disorders and the protein involved 
(Soto, 2001)
A common feature of most conformational diseases is the conversion of the soluble proteins 
into insoluble tertiary and quaternary structures with extensive (3-sheet content (Kaytor and 
Warren, 1999). The conformational change can contribute to pathology through a variety of 
inter-related mechanisms that include loss of function of the misfolded protein, gain of a 
toxic activity or damage triggered by the accumulation of the misfolded form inside or 
outside cells. The latter can interfere with the normal cell function by a variety of possible 
mechanisms including apoptosis (Sanders and Nagy, 2000). The ability to form fibrils in 
vitro is not limited to the disease-associated proteins (Glenner et al., 1974; Guijarro et al., 
1988; Chiti et al., 1999b; Fandrich et al., 2001): this has led to the idea that aggregation can
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be viewed as a general property of polypeptide chains. In fact, as already mentioned, a 
common feature of these diseases is the formation of a (3-sheet core which involves 
interactions between the atoms of main-chain amino acids that occur in all proteins (Ellis 
and Pinheiro, 2002).
The prion diseases provide an interesting example of the connection between protein 
folding and neurodegenerative disease (Cohen, 1999). It is believed that the prion protein 
(PrP), from a benign cellular conformation (PrP^) (bound to the external surface of the 
plasma membrane by a glycosylphosphatidylinositol (GPI)-anchor), is transformed to a 
neurotoxic form (PrP®'^ ) that self-propagates by recruiting and inducing the conformational 
change in additional PrP'  ^molecules (Prusiner, 1997; Dagget, 1998; Westaway ef a/., 1998). 
This hypothesis, known as the “protein-only” hypothesis, is supported by strong 
experimental evidence (Prusiner, 1998; Aguzzi and Weismann, 1997; Saborio ef a/., 2001). 
The molecular details of the replication process are not completely known, and a large 
number of studies have been carried out both on the recombinant protein in solution and in 
a membrane environment. PrP displays intrinsic plasticity in its conformations (Hope et ai, 
1996; Kelly, 1998): it is thought that portions of the PrP*^  may posses a relatively open 
conformation which makes it susceptible to conversion into PrP®'^  under appropriate 
conditions (Baskakov et a i, 2002; Zhang et a i, 1997).
Since sub-cellular compartmentalisation implies different chemical environments and the 
PrP*^  conformation depends on the phase composition, it is possible that this protein is able 
to assume various conformations in different cell compartments (Kelly, 1998; Pergami et ai,
1999). The hypothesis was advanced that, while the funnel model (section 1.1.2,2) 
generally considers the end point of folding a unique, native state, corresponding to the 
global free-energy minimum of the system, the inclusion of possible multiple conformers at 
the bottom of the energy funnel would be more appropriate (Ma et a i, 1999; Ferreira et a i,
2001). The membrane environment plays an important role in determining the conformation 
of the prion protein (Morillas ef ai, 1999): some domains of the plasma membrane, 
caveolae-like domains (CDLs) (Kurzchalia and Patron, 1999; Campbell ef a/.. 2001), might 
be the sites where prions are propagated (Vey ef ai, 1996; Massimino ef a i, 2002). 
Moreover it has been proposed that folding intermediates may have a role in the 
conformational transition. In fact it was demonstrated that the PrP^ form while under native 
conditions shows very little tendency to undergo a transition to a (3-sheet-rich structure, at a 
given concentration of NaCI (50-150mM), the rate of the a-helix -> (3-sheet transition 
increases as the concentration of urea is increased up to approximately 3.5M. Since urea 
increases the population of the unfolded protein, there is the possibility that one or more 
monomeric folding intermediates of prion protein may be involved in the transition to the 
oligomeric scrapie-like form (Morillas ef ai, 2001).
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other studies on secreted oligomers of amyloid (3-protein (Walsh et al., 1999; 2002) and on 
aggregates formed by non-disease related proteins (Bucciantini et al., 2002), suggest that 
early aggregates may be the primary toxic species (Lansbury Jr., 1999; Ellis and Pinheiro,
2002). This is supported also by the experimental finding that significant tissue damage and 
clinical symptoms of most of the conformational diseases appear before protein aggregates 
can be detected (Soto, 2001). In this scenario, the formation of large protein aggregates 
deposited in the tissue could even be considered a protective device because this allows 
the deposition and isolation of the toxic abnormally folded proteins (Lansbury Jr., 1999).
The knowledge of the folding process that leads to the formation of fibrillar inclusions could 
help in finding ways to inhibit the transition from native structures or drive proteins away 
from non-productive or disease-forming states (Kelly, 1998; Guerois and Serrano, 2001). 
The fact that this strategy could be a useful approach towards the treatment of these kinds 
of diseases, is demonstrated by recent findings that synthetic peptides, called “mini- 
chaperones”, designed to be similar to the sequence of the protein region responsible for 
the self-association, dissolved amyloid aggregates in vitro and in animal models of 
Alzheimers’ disease (Soto ef a/., 1998, Sigurdsson et ai, 2000).
1.1.1.4 Folding in the cell
Many proteins require assistance to fold in the cell, although the basic principle remains that 
the amino acid sequence of a protein is sufficient to specify its three-dimensional structure. 
There are two major differences between the refolding of a denatured protein chain in a test 
tube and the folding of a newly synthesised chain inside the cell. Firstly, protein chains are 
made inside cells in a vectorial fashion by ribosomes. In many cases the rate of this process 
is slower than the rate of protein folding, thus there is the possibility that the elongating 
chain will misfold before it is complete and either be degraded or form aggregates. 
Secondly, the environment in which the folding takes place in vivo, is a complex one. High 
concentrations of different kinds of molecules (as well as the nascent chain) and ions are 
present, and this highly crowded macromolecular environment might lead to formation of 
potentially toxic aggregates (Ruddon and Bedows, 1997). Moreover the cellular 
compartmentalisation implies that the protein may be subject to various processing events 
important not only for function, but also for determining its extra- or intra-cellular location 
(Frydman, 2001; Ellis and HartI, 1999).
In the cell there are at least two classes of proteins involved in polypeptide folding; the first 
class Includes enzymes that catalyse specific isomerization steps or covalent changes 
essential for the formation of the native and functional conformations of the proteins 
concerned. A second class consists of families of proteins known as molecular chaperones
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that modulate and promote protein folding, assembly and disassembly, and facilitate the 
degradation of misfolded polypeptides (Gething and Sambrook, 1992). To the first class 
belong enzymes such as the protein disulphide isomerase (PDI, EC 5.3.4.1) (Gilbert, 1994) 
and the prolyl cis-trans isomerase (PPl, EC 5.2.1.8) (Nall, 1994); these lead to an increase 
in the refolding rate for many proteins in vitro (Weissman and Kim, 1993; McClelland et a/.,
1995).
The PPIs are enzymes that catalyses Xaa-Pro isomerization in vitro accelerating the 
refolding of proteins in which the cis-trans isomerization is responsible for an observed slow 
kinetic phase. Three families of PPl exist which do not show sequence similarity: the 
cyciophilins (Fischer et a!., 1984), the FK506-binding proteins (Sieklerka et a!., 1989; 
Harding et a/., 1989) and the parvulins (Rahfeld et a/., 1994). Some members of the PPl 
family are thought to be involved in some important processes such as cell signalling and 
regulation (Brazin et a/., 2002), protein trafficking and transcription (Schiene-Fischer and 
You, 2001; Harrar et a/., 2001).
PDI is an enzyme which is present in the lumen of the endoplasmic reticulum (ER) and 
which catalyses the rate-limiting reactions of disulphide-bond formation, isomerization and 
oxidation within the ER; it displays chaperone activity both in vitro and in vivo (McClelland et 
a/., 1995; Ferrari and Soling, 1999; Winter et a/., 2002). The chaperone and the isomerase 
activities are in a way independent from each other but function in collaboration, possibly at 
consecutive stages of the folding process of the target protein (Freedman et a/., 2002). 
Under the reducing condition of the cytoplasm, endosomes and cell surface, PDI catalyses 
the reduction of protein disulphides. At those locations, PDI has been demonstrated to 
participate in the regulation of various physiological processes such as cell adhesion 
(Pariser et a/., 2000), platelet activation (Essex et a/., 1995; 1999; 2001) and integrin- 
dependent adhesion, at least in one cell type, namely the lymphocyte (Lahav et a/., 2000), 
leading to the hypothesis that disulphide exchange takes place during the process.
The molecular chaperones (heat shock protein (HSP), so called because their expression is 
induced under condition of cellular stress, such as an increase in temperature) are proteins 
that bind to and stabilize an otherwise unstable conformer of another protein (Hlodan and 
HartI, 1994). HSPs are involved in a multitude of processes in different cellular 
compartments, wherever the folded state of a protein has to be achieved de novo, stabilized 
under stress conditions, or modulated to regulate its activity. HSPs are involved in the 
folding and assembly of proteins within cellular organelles, in the disassembly of oligomeric 
structures (Price, 1994) and in preventing incorrect interactions within and between non­
native polypeptides, thus typically increasing the yield but not the rate of folding reactions 
(HartI, 1996; Ellis and HartI, 1999). At present, the two best understood chaperones are the
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hsp70 and hsp60 families (Hendrick and HartI, 1993). The hsp70s are 70 kDa ATPases 
found in the cytosol which bind to the nascent polypeptide chain avoiding aggregation.
The hsp60 chaperones, called "chaperonins”, play a role in folding once the synthesis of the 
polypeptide chain is complete. They prevent aggregation of partially folded chains, allow 
folding in a protected environment, and also play a role in complex assembly and 
polypeptide translocation. The best-studied member of the family is GroEL, the E. coli 
chaperonin (Ranson et a!., 1998). The chaperonin GroEL and its ring shaped cofactor 
GroES facilitate protein folding in an ATP-regulated manner, forming the so-called GroE 
system (Houry eta!., 1999). GroEL recognizes non-native states in protein folding pathways 
and acts to prevent aggregation, which principally results from the exposure of hydrophobic 
surfaces in the early folding stages (Martin et a!., 1991; Wang et a!., 1999). Some proteins 
require several rounds of interaction with GroEL to reach their native state (iterative 
annealing) (Horovitz, 1998). GroEL interacts in vitro with almost any non-native model 
protein. However, in vivo GroEL is involved in the folding of only 10% of newly (so not under 
stress condition) translated polypeptides, indicating a preference for a subset of E.coli 
proteins. Structural analysis revealed that these proteins have a complex domain 
architecture, mostly containing two or more domains with a/p-folds (Houry et a!., 1999).
The role of HSPs is not restricted to assisting folding. They have an essential role in the 
mantainance of the translocation-competent state of precursor proteins. Because the 
formation of stable folded structure inhibits translocation of proteins across membranes, it 
was proposed that the “translocation-competent” conformations may resemble the “molten 
globule” or collapsed intermediate forms observed in the refolding of proteins in vitro. This 
provides a protein with the conformational flexibility necessary to adopt an extended 
structure during membrane transit.
HSPs are also involved in the degradation of misfolded proteins as well as in regulatory 
processes (HartI, 1996; Harwich et a!., 1999). Because the events of cell stress and cell 
death are linked, HSPs induced in response to stress appear to function at key regulatory 
points in the control of apoptosis. HSPs include anti-apoptotic and pro-apoptotic proteins 
that interact with a variety of cellular proteins. They are commonly overexpressed in human 
tumours and their expression in certain cancer types correlates with poor prognosis and 
resistance to therapy: the ability of HSPs to prevent apoptosis induced by several 
anticancer drugs as well as other apoptotic stimuli suggests that they could enhance 
tumorigenesis and limit the efficency of cancer therapy (Jaattela, 1999). This has lead to the 
hypothesis that apoptosis-inhibitory HSPs may participate in carcinogenesis (Garrido et al.,
2001). It was demonstrated that the high expression of Hsp70 is required for the survival of 
tumorigenic breast cancer cells, and abrogation of Hsp70 synthesis results in extensive cell 
death (Nylandsted et a!., 2000).
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In addition HSPs seem to have a role in the activation of integrins (Barazi et al., 2002) and 
in prion diseases (Talzelt et al., 1998; Stocke! and HartI, 2001). Recent studies have 
demonstrated that HSPs exit the mammalian cells, interact with the cells of the immune 
system and exert immunoregulatory effects (Asea et al., 2002). Some findings indicate that 
certain HSPs can function as effective vaccines against the same tumour from which they 
are purified by virtue of their ability to bind tumour-specific peptides (Bremers and Parmiani,
2000); some of these vaccines are already in clinical trials (no author listed - BioDrugs
2002).
The “steric chaperones” (e.g.: the pro-region of some proteases), are another kind of 
chaperones that work in a different way from the molecular chaperons (Ellis, 1998) having 
as a distinguishing feature a high substrate specificity (Braun and Tommassen, 1998).
The folding-related roles of the pro-region may be classified into two types: in the first, the 
pro-region acts as an intramolecular chaperone to overcome kinetic barriers to folding, as in 
the case of substilin (Shinde and Inouye, 1995 a, b); in the second the pro-region acts as a 
thermodynamic stabilizer, through uncleaved disulphide bonds, as in the case of zymogens 
(Ma et al., 2000). As an example of the first type are substilin and a-lytic protease pro­
regions. When the mature enzymes are purified and denatured they fail to refold into active 
enzymes on removal of the dénaturant. Instead, they adopt compact, partially folded 
conformations approximating the molten globule state. Such states are stable until the 
specific pro-sequence is added, when conformational changes occur resulting in the 
appearance of the correct tertiary structure for enzymic activity (Baker et al., 1992; Eder et 
al., 1993). Each pro-sequence is likely to act only on the molecule to which it is attached 
and it is then degraded. The pro-sequence seems to impart steric information for the folding 
of the protease domain, but after folding it is no longer required to maintain that particular 
conformation. In fact it was demonstrated that a mutation in the pro-sequence causes a 
conformational change in the mature substilin (Shinde and Inouye, 1997). Although identical 
in sequence to the wild type, this form of substilin shows slight differences in circular 
dichroism spectra, thermal stability and Km for a synthetic substrate.
Because these pro-peptides are necessary for the correct folding of these classes of 
proteins they were termed “intramolecular chaperones”. Summarising, the mechanism of 
maturation of intramolecular chaperones consists of three steps: 1) folding of the mature 
region, which is mediated by the intramolecular chaperone 2) cleavage of the intramolecular 
chaperone (autoprocessing) to give a non-covalently attached 1:1 pro-peptide-mature 
protein complex 3) removal of the pro-peptide by an autoproteolytic degradative process 
(Shinde and Inouye, 1995 a, b).
A covalent interaction of a steric chaperone with its target protein is not a prerequisite for 
substrate specificity. For example the folding of many lipases from Pseudomonas spp.
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requires the activity of a lipase-specific foldase, Lif, which is produced as a separate 
polypeptide (Braun and Tommassen, 1998).
Because of the difficulties in applying high resolution structural techniques to the acquisition 
of structure accompanying or following translation in vivo, the usual experimental approach 
has been to study the refolding of denatured proteins when conditions have been changed 
to promote folding. Several lines of evidence indicate that this approach can give valid 
insights into the process of protein folding in vivo (Jaenicke, 1987; Huth et a!., 1993).
In fact the rate of folding of small proteins in vitro seems to match the rate of folding in vivo, 
and the final product results to be the same (e.g.: for enzymes there is the recovery of 
catalytic activity). More importantly there are evidences that the steps of protein folding do 
not change when the refolding is carried out inside the cell or in vitro. Studies on structurally 
homologous dihydrofolate reductases (DHFRs) show that the kinetics of folding are the 
same in the presence and absence of GroEL, indicating that chaperonins increase the 
probability of correct folding simply by decreasing the probability of aggregation in bulk 
solution (Horovitz, 1998). Another example in which the folding process was studied and 
compared both in vivo than in vitro is the human chorionic gonadotropin (3~subunit (hCG-p): 
for this protein was found that the two pathways are indistinguishable because both the rate 
limiting step, than the other steps of the folding process are the same in both folding 
enviroinment. The presence of PDI increases the rate of folding in v/fro without changing the 
order of disulphide bond formation from that of intracellular folding pathway (Huth et a!.,
1993).
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1.1.2 Kinetics and mechanism of protein folding.
1.1.2.1 Folding models
Anfinsen’s original experiments (1973), on the oxidative refolding of bovine pancreatic 
ribonuclease (RNase) to a native, biologically active enzyme in vitro after reduction of 
disulphide bridges and disruption of tertiary structure, demonstrated that proteins fold 
spontaneously and reversibly into their native conformation. While, in reaction involving a 
small molecule, one or at most a small number of strong covalent bonds are broken or 
made, in the folding reaction not only there is the reorganisation of a very large number of 
weak non-covalent interactions but also the denatured state is extremely heterogeneous 
(Creighton, 1994; Pande ef a/., 1998; Dobson and Karplus, 1999). Moreover the number of 
possible conformations of a polypeptide chain is astronomically large: a protein randomly 
searching all avalilable conformational space to find the lowest energy state will never fold 
on physiological time scales (Levinthal paradox). The initial suggestions to solve this 
paradox involved the proposal that there must be specific pathways for folding (Levinthal, 
1968), where the protein molecules would pass through well-defined partially structured 
states. Different models were proposed, each of which gave a major role to a particular 
aspect of the refolding process (Creighton, 1994; Radford, 2000).
The nucléation growth model (Wetlaufer, 1973) proposed that residues adjacent in 
sequence form a nucleus from which the native structure then develops in a sequential 
manner. In this model the nucléation event is the rate-limiting step. This nucleus would 
serve as a template upon which the remainder of the polypeptide chain would fold rapidly. 
Thus, tertiary structure would form as a necessary consequence of the formation of 
secondary structure.
The framework model (Baldwin, 1989) suggested that the folded structure is formed by 
packing together pre-existing individual elements of secondary structure (that could form 
independently of tertiary structure) and that these then dock into the native tertiary structure 
of the protein, possibly by a diffusion-collision mechanism (Karplus and Weaver, 1979;
1994). Ptitsyn (1973) proposed a folding model which involves an early compact transient 
intermediate, the kinetic “molten globule” (Ptitsyn, 1995b), which is characterized by being 
condensed, containing native-like secondary structure, but still lacking the tight packing of 
the native structure. The absence of tight packing in these kinds of intermediates results in 
the high accessibility to the solvent of the non-polar groups within the hydrophobic core of 
the protein, and therefore leads to a strong binding of hydrophobic probes such as 1-anilino- 
8-naphthalene sulphonate (ANS) (section 1.3.3). In these two models the rate limiting step 
is considered the packing of these elements of secondary structure.
By contrast in the hydrophobic collapse model (Dill, 1985), it is hypothesised that a protein 
would rapidly collapse around its hydrophobic side chain early during folding. From this
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collapsed intermediate the native state develops by searching within this conformationally 
restricted space. In this model, the secondary structure would be directed by native-like 
tertiary interactions.
Finally, the iiqsaw model (Harrison and Durbin, 1986) suggests that each protein molecule 
could fold by a different path. For this model, as in a jigsaw puzzle, the pieces are joined 
together in a different order each time the puzzle is assembled, yet the final result is always 
the same. If there is a distinctive pattern to the puzzle, certain parts may tend to be 
assembled before others.
The hydrophobic collapse mechanism and the framework model imply the existence of 
folding intermediates, whereas nucléation does not. Kinetic intermediates of folding are 
sometimes sensitive to aggregation because they still have an increased amount of 
exposed hydrophobic surface. These compact imtermediates may represent not only 
important intermediates in folding pathways (Christensen and Pain, 1994) but they may be 
involved in number of cellular processes (section 1.1.1).
From theoretical and experimental results it is now clear that there is not necessarily a 
single specific folding pathway and that a multidimensional energy landscape or folding 
funnel better describes the folding process (Radford, 2000). Features of the models 
described above are relevant in the context of present ideas concerning energy landscapes.
1.1.2.2 Folding funnels
In this new context the transition from denatured to native state is considered in terms of a 
“folding landscape” in which kinetic flow can occur through a series of states of 
progressively lower energy in a "folding funnel” the slope of which effectively guides the 
protein down towards the energy minimum (Bryngelson et al., 1995; Dobson and Karplus, 
1999). This view is based on a description of protein folding in terms of a statistical 
ensemble of protein conformations, which fold via parallel multi-pathway diffusion-like 
processes (Baldwin, 1994; Wolynes et al., 1996; Dill, 1999). The accessible free energy 
surface has a “funnel-like" shape that guides the system along increasing contacts as it 
progresses toward the native conformation (Dobson and Karplus, 1999) (Fig.1.1- Brooks, 
1998). In this picture each conformation is represented as a point on the landscape where 
the vertical axis is the internal free energy and the two horizontal axes represent the many 
degrees of freedom (one axis is correlated with the fraction of native contacts and the other 
with the total number of contacts, native and non-native). So, while the width of the funnel is 
related to the configurational entropy of the polypeptide chain, the depth of the funnel 
depicts a free energy function (Dobson and Karplus, 1999; Honig, 1999). Considering a 
folding reaction, the starting point is the “unfolded” state composed of many conformations 
of similar free energy, so the accessible free-energy surface is very broad. As folding
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progresses (under conditions in which the native state is stable) there is increasing 
formation of native contacts, which are generally more stabilising than the non-native ones, 
leading to a decrease of the energy of the system. A funnel implies that, for protein folding, 
there is a decrease in energy and concomitant loss of entropy with increasing structure 
(Brooks, 1998). It is this global bias in the landscape guiding diffusion between non-native 
configurational traps toward the native configuration that gives a “solution” to the Levinthal 
paradox (Dill and Chan, 1997). The funnel therefore leads to a huge increase in folding rate 
(compared to the expected rate for a random diffusional process) and prevents entrapment 
in partially folded states (local energy minima). Thus there are potentially a number of 
routes to the native state and which pathways are populated will depend on the details of 
the system being studied (e.g. the amino acid sequence, the topology, and the experimental 
conditions) (Piaxo etal., 1998).
While the folding landscape theory has provided an elegant way out of the Levinthal 
paradox, the nature of the driving force leading to the native conformation it is still not 
completely understood. There are two different main models proposed: the hierarchical and 
non-hierarchical model (Baldwin and Rose, 1999a,b; Fersht, 1997). A schematic 
representation is given in figure 1.2 and these models will be discussed in the next two 
sections.
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Figure 1.1; The energy landscape for a folding protein.
Schematic representation of a “folding funnel”. Each conformation is represented as a point 
on the landscape where the vertical axis is the internal free energy and the width of the 
funnel is related to the configurational entropy of the polypeptide chain (Brooks, 1998).
Small Proteins Nucleation-condensation model: co-operative formation of 
all native interactions
Hierarchical model: intermediates not detectable
Large proteins 
( > 100 aa)
1. Hydrophobically collapsed state
2. Rearrangment of folded regions
1. Formation of the first folding domain
2. Formation of remaining structure
Figure 1.2: Scheme of models for folding of small and large proteins.
Scheme of the two different main models for folding, the hierarchical and non-hierarchical 
model (Radford, 2000; Baldwin and Rose, 1999 a,b) for both small and large proteins.
18
1.1.2.3 Folding of small molecules
Small proteins generally fold with a monoexponential kinetic indicative of a two state 
process (U -> N), but there are some exceptions. This has led to the division of small 
proteins into two classes that fold by different mechanisms; class I, that fold by a hierarchic 
process in which native-like secondary structure forms rapidly and is stabilized in molten 
globules-like intermediates, and class II, that do not involve intermediates.
Whiie it is widely believed that some sort of nucléation event is central to the mechanism of 
protein folding, the detailed nature of this nucléation mechanism, the existence of these two 
classes and the types of models to apply to protein folding is still under debate (Baldwin and 
Rose, 1999a,b; Fersht, 2000; Galzitskaya et al., 2001). A large number of studies have 
identified proteins that fold without accumulation of any detectable intermediates during 
folding (Fersht, 1995; Dobson and Karpius, 1999). These are generally small proteins of 
less than 100 amino acids that present the simple case of a one-step reaction, with a single 
kinetic phase. From the results on these " two state” folding systems a nucleation- 
condensation mechanism (non-hierarchic) has been proposed (Fersht, 1997). This is 
different from the classical nucléation model in that a large, more diffuse, nucleus is formed 
In the ground state. This nucleus develops in the transition state and is composed of both 
neighbouring residues in local secondary structure and long-range tertiary interactions. 
Nucleation-condensation is a coupled process in which the formations of the nucleus and of 
structure elsewhere are concerted. It is this view that has lead to the division of the small 
proteins between class I and class II folding mechanisms. Another view is the “hierarchic 
process” hypothesis (Baldwin and Rose, 1999a,b), that is to say a process in which folding 
begins with structures that are local in sequence and marginal in stability. These local 
structures then interact to produce intermediates of increasing complexity until the native 
conformation is formed. This hypothesis is opposed to the non-hierarchic models where the 
tertiary interactions not only stabilise local structures but also actually determine them. In 
the view of the hierarchic process hypothesis, the differences between class I and class II 
folding reactions lie not in the mechanism of their folding but only in the stability of their 
intermediates (Baldwin and Rose, 1999a,b).
This scenario has been compared to the old philosophical paradigm, “which was first - the 
chicken or the egg?”. A correlation analysis between the decrease in hydrodynamic volume 
and increase in secondary structure content for different globular proteins in native and 
partially folded conformational states has shown that a good correlation exist between these 
parameters (Uversky and Fink, 2002). This suggests that hydrophobic collapse and the 
formation of secondary structure occur simultaneously, rather than representing two 
independent and sequential processes.
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This conclusion is in agreement with recent findings on the structural features of unfolded 
proteins (Hammarstrom and Carisson, 2000). In fact there is evidence that, even in 
concentrated solutions of strong dénaturant, stabilising interactions may occurs reducing in 
this way the conformational space available. These structures in the unfolded state would 
probably guide the folding process and function as folding initiation-sites (Hammarstrom 
and Carisson, 2000; Uversky and Fink, 2002).
Moreover it appears that different proteins may use different mechanisms to search the 
energy landscape for folding. In fact recent results have shown that for single domain 
proteins, which display a two-state folding behaviour, there is a good correlation between 
folding rate and the “contact order” (i.e.: the average sequence separation of contacting 
residues in the native state) (Plaxo et al., 1998; Fersht, 2000; Grantcharova et al., 2001). 
This is consistent with the dominant role of native state topology in determining folding 
rates. Thus the way in which different small proteins fold may be related to the 
predominance of one or another kind of secondary structure in the protein. The hypothesis 
that non-iocal interactions can determine the secondary structure is not new (Honig, 1999). 
An experiment carried out by Minor and Kim (Minor and Kim, 1996) with an 11-amino acid 
sequence, shows that this “chameleon” sequence folds as an a-helix when in one position 
but as a p-sheet when in another position of the primary structure of the IgG-bindtng domain 
of protein G. From this work it was concluded that the topology of the protein native state 
influences the folding mechanism. However it has been argued (Baldwin and Rose, 1999b) 
that by performing a molecular dynamic simulation on the chameleon sequence with long- 
range interactions suppressed, it is possible to obtain a similar situation to the experimental 
one. This finding ieads to the conclusion that interactions that are local, but extend beyond 
the boundaries of the chameleon sequence itself, are sufficient to account for the observed 
position-dependent differences in conformation of this particular sequence.
For these reasons it would be interesting to undertake a large-scale systematic study of the 
folding properties of proteins belonging to different structural classes and to study the effect 
of factors such as amino acid sequence, chain topology, pH, co-solvent concentration and 
temperature on the folding process.
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1.1.2A  Folding of larger proteins
In the refolding of proteins consisting of 100-200 residues it is often found that there is a 
multi-exponential course of the folding reaction. This could be either due to the existence of 
slowly interconverting states or to the presence of folding intermediates. For a number of 
proteins slow phases observed in folding reactions have been attributed to the 
interconversion of cis and trans isomeric states of Xaa-Pro residues (Nall, 1994). Double 
jump experiments, mutational studies and/or the use of PPI are means of identifying a slow 
phase with Pro isomerization. When this is ruled out the observed multi exponential course 
is an indication of the accumulation of intermediates during the early stages of folding 
(Heidary et al., 2000). The nature of the intermediate(s) depends on the nature of the 
driving force of the initial steps.
in general two different kinds of mechanism are observed (Radford, 2000 - Fig. 1.2). In the 
first, protein folding is initiated by hydrophobically driven coilapse of the unfolded 
polypeptide followed by the formation of local structure. This leads to the formation of a 
compact intermediate in the first stage of folding (non-hierarchic) (Chan and Dill, 1990). The 
second mechanism considers the formation of local secondary structure as the driving force 
of folding: folding is initiated by local elements which gradually assemble to yield the final 
native fold through the interaction between these elements (hierarchic) (Baldwin and Rose, 
1999a, b). Some of the observed intermediates seem to be fundamental for the folding 
process (on-pathway) while others (off-pathway) seem to arise by non-specific collapse of 
the polypeptide chain or to accumulate because they are trapped by non-native interactions 
(Weissman, 1995). Although the role that these off-pathways intermediates play in the 
folding process is stili a matter of controversy (Roder and Colon, 1997), they are 
nonetheless important. In fact they form part of the energy landscape for folding and might 
be substrates for chaperones or precursors to aggregation (section 1.1.1) (Radford, 2000).
It has been reported that discrete structural elements of the native proteins are sometimes 
present in incompletely folded intermediates (Panchenko et al., 1996), pointing to their 
intrinsic stability in the absence of specific native interactions with the rest of the proteins 
(hierarchic). However there are some other findings which demonstrate the importance of 
the tertiary interactions in the formation of the “native” structure. These findings are both 
experimental (Arai et al., 1998; Capaldi and Radford, 1998) and theoretical (Dinner et al., 
1996; Dobson and Karpius, 1999). For example, (3-lactoglobulin, a predominantly p-sheet 
protein with a markedly high helicai propensity, forms non-native a-helical intermediates 
during refolding. Both the compaction and the secondary structure formation are quite rapid 
processes (millisecond time scale)(Arai et al., 1998). The burst phase intermediate was 
characterized as having a compact size, a globular shape, a hydrophobic core, substantial 
p-sheet and non-native a-helical structure, but little tertiary structure. These findings
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suggest that both local interactions and non-local hydrophobic interactions are important 
forces early in protein folding (Uversky and Fink, 2002). Hence the local interactions that 
stabilize the non-native helices in the p-sheet regions of this protein persist in the 
environment of the collapsed intermediate and can only be overcome when the precise 
tertiary interactions of the native state develop. From lattice simulation calculations it has 
been found that, for larger proteins, long-range contacts are important, but for other proteins 
a mixture of short-range contacts for initiation and long-range contacts for cooperativity lead 
to efficient folding. It has been proposed that these core residues are particularly important 
for defining both the protein fold and the folding rate and, hence, that they have been 
conserved during evolution (Shakhnovich et a/., 1996; Mirny et a/., 1998; Ptitsyn, 1998). 
Modular assembly was made a very attractive proposal by the discovery of split genes 
consisting of exons and introns. it was suggested that exons encode structural and 
functional modules. These modules or “foldons” are considered kinetically competent, 
quasi-independent folding units of a protein, and a large protein has to be considered 
structurally as a concatenation of domains, each comparable in size to smalier proteins 
which foids readily and having, in many cases, distinct physiological functions (Panchenk et 
al., 1996). The foldons can separately fold by nucleation-condensation and then dock 
together (Fersht, 1997) proceeding via a variety of mechanisms, depending on the stabiiity 
of the individual foldons and how nucléation and docking are coupled. The folding of 
barnase is an example of the folding of a modular structure (Fersht, 1993), where the 
individual foldons are so stable that they can form independently and produce a stable 
folding intermediate. The rate-limiting step is then the docking and rearrangement of the 
foldons.
Another point of view on the folding of larger molecules is in the framework of the 
“hierarchical” model. The main objection to the hierarchical model is how the secondary 
structures fold reliably into tertiary structures. To solve this question it was proposed that 
the missing step of the hierarchic folding model could be the existence of a segment in the 
protein chains that, acting like an intramolecular chaperone (section 1.1.1.4), can mediate 
and guide the final assembly of the protein tertiary structure. This segment is referred as 
“critical building block” (Ma et al., 2000). The mechanism proposed for the “building block" Is 
different from the concept of “folding nuclei” (the “folding nucleus” is the structure formed in 
the transition state by the protein chain). While the concept of folding nuclei focuses on a 
non-sequential distribution of the folding information along the entire protein chain, the 
chaperone-iike building block fragment proposal focuses on a segmental distribution of the 
folding information. This segmental distribution controls the distributions of the populations 
throughout the hierarchical folding process (Ma et al., 2000). Though this model has 
similarities to the more general hierarchic model, it reconciles the hydrophobic collapse
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model and the hierarchic model by considering the hydrophobic collapse of the local 
elements, with subsequent binding of these units: the hydrophobicity is considered as the 
driving force of this process. According to this model protein folding can be viewed as a 
process of intramolecular recognition. Hence, protein folding and protein-protein 
association, which involves intermolecular recognition, are similar processes. Both involve 
conformational selection, with the driving force being the hydrophobic effect, although 
charge and polar complementarity are also important contributors. The process of 
intermolecular recognition occurs between the "building blocks”. Some of the building blocks 
turn out to be important both for folding and for function: these particular building blocks are 
referred as “critical building blocks” (Kumar et al., 2001; Tsai and Nussinov, 1997a; Tsai et 
al., 1998; 1999a). It is these critical building blocks that have to be considered as 
“intramolecular-like” chaperones. These building blocks themselves may have not a stable, 
well-defined conformation in solution, but their conformations are stabilized by mutual 
interactions. A critical building block may be expected to fulfil three conditions: it should be 
in contact with most other building blocks in the structure; It is likely to be inserted between 
sequentially connected building blocks; in its absence the remaining building blocks are 
likely to mis-associate with each other. Moreover the amino-acid sequence of a critical 
building block is likely to be conserved in different organisms. An example of “critical 
building block” appear to be the P-loop in Adenylate kinases, a structural feature common 
also to Shikimate kinase, the protein studied in this thesis (Ma et al., 2000).
What is clear from the experimental data is that proteins larger than 100 amino add 
residues form populated intermediates early in folding and their existence is reflected in a 
rugged funnel landscape (Bai and Englander, 1996). These species vary in their 
conformational properties and stabilities; some are native-like, whereas others contain 
native-like structure in regions corresponding to domains or sub domains of the native 
protein, or may even contain highly non-native structures. The stability and nature of these 
on-pathway species would depend not only on the native topology but also on additional 
energetic factors. As a consequence it is not yet possible to make generalizations about 
these intermediates (Brockwell et al., 2000). Although in the case of larger proteins a 
correlation has not been observed between a topological parameter, such as the contact 
order, and the folding rate, there is evidence from theoretical and experimental studies 
showing the importance of the topology for the folding process (dementi et al., 2000).
The pivotal importance of some modules or “building blocks” in folding should direct 
attention toward the study of these “larger” proteins. In particular it seems important to 
understand how key modules In larger proteins influence the folding of the neighbouring 
“modules" and how this interaction drives the folding process to the “native state”.
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1.1.3 Protein structure, stability and cosolvent effects.
1.1.3.1 Protein structure and stability
The folded conformations of proteins exhibit marginal stabilities equivalent to only a small 
number of weak intramolecular interactions (Dill, 1990; Jaenicke, 2000): the values for Gibbs 
free energy of stabilization of a medium size globular protein are in the range of 20-60 kJ 
moM (Pfeil, 1998; Price, 2000). This is correlated to a high flexibility of the polypeptide chain, 
a prerequisite for the proper functioning of most proteins (Fischer and Schmid, 1990; Pace 
and Scholtz, 1997). In fact a folded protein does not exist in a single conformation but in a 
set of conformations whose Inter-conversion involves the making and breaking of non- 
covalent interactions. The term "native" conformation refers to the most populated 
conformational ensemble (macrostate) under conditions similar to the physiological 
conditions where the protein performs its biological activity.
The concept of folding funnels (section 1.1.2.2) can be used not only to describe the folding 
of the polypeptide chain but also for understanding the function of the folded protein (Ma et 
al., 1999). The more flexible the molecule, the larger is the ensemble of conformers, more 
“rugged” will be the bottom of the funnel. Hence the function of a protein and its properties 
are determined by the redistribution of its conformational sub-states in response to events 
like binding or a change in solvent conditions (Kumar et al., 2000). The observed three- 
dimensional structure in solution (e.g.: using circular dichroism) has to be considered as a 
weighted average of all the conformations accessibie, and this conformation depends on a 
number of experimental variables such as ionic strength, pH and temperature. Usually the 
native state is the thermodynamically most stable state, though there are some exceptions, 
such as, for example, in the case of protein presenting post translational modifications (Price,
2000), or when the refolding process is under kinetic control such in the case of some 
proteases (section 1.1.1) or their inhibitors (Price, 2000; Baker et al., 1992).
Two approaches have been used for the estimates of the stability of proteins, chemical and 
thermal dénaturation (Privalov, 1979) and the unfolding process is followed monitoring the 
changes in a chosen parameter varying the dénaturant concentration or the temperature. 
Urea and GdmCI offer several advantages over other means of unfolding a protein such as 
acid, heat, or detergents. First, the product is better defined because the degree of unfolding 
is maximised. Second, unfolding is more likely to approach a two-state mechanism. Finally 
dénaturation is more likely to be completely reversible (Pace and Scholtz, 1997). Urea is 
preferred to GdmCI when salt effects on the protein have to be investigated (Pace and 
Scholtz, 1997; Pace and Grimsley, 1988).
Generally single domain proteins give a two-state unfolding transition, while multi-domain 
proteins usually fold step-wise due to the separate unfolding of the single domains
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(Creighton, 1994). Multi-subunit proteins usuaiiy dissociate first, and then the subunits unfold 
(Price, 1994). For some proteins, foiding intermediates have been found which are stable in 
the presence of intermediate concentrations of dénaturant and/or in the acid or alkaline 
region (Fischer and Schmid, 1990). Such equilibrium intermediates are frequently observed 
for proteins with a low overall stability and they usually have some native-like secondary 
structure and lack of rigid tertiary structure (stable “molten globules”) (Jaenicke, 1991; 
Christensen and Pain, 1991; 1994). Because the difference in stability between these flexible 
intermediates and the native state is small, a weak perturbation, such as binding to a partner 
protein or a membrane (section 1.1.1), will be sufficient to arrest a folding protein in that state 
or to convert back it to a molten globular conformation (Fischer and Schmid, 1990).
When the unfoiding mechanism can be described in terms of a two-state unfolding reaction 
it possible to give an estimate of the conformational stability of the protein determining the 
equilibrium constant and the free energy change for the reaction: N-^ D as described in 
section 2.5.
1.1.3.2 Effect o f co-solvent additives: salts
As has been recognised for many years, co-solvents, in general, and salts, in particular, are 
known to have a number of effects on the properties of proteins. Peptides and proteins could 
display different conformations in different solvent systems and these can be correlated with 
their biological functions (Siligardi et al., 1991; Hope et al., 1996; Barter! et al., 1996; 
Damaschun et al., 1999). Co-solvents and salts are used in protein purification procedures 
(Scopes, 1994; Arakawa, 1986) and can affect enzyme activity (Cacace et al., 1997).
The ionic strenght of the solution is an important parameter affecting enzyme activity. Both 
the binding of charged substrates to enzymes and the movement of charged groups within 
the catalytic active site will be influenced by ionic composition of the medium. If charges are 
opposite then there is a decrease in the reaction rate with ionic strength whereas there will 
be an increase in the opposite situation. Moreover enzyme activity can be dependent on the 
type of ion present in solution. Generally kosmotrope anions (section 4.2) enhance enzyme 
activity. An example for the correlation between the enzyme activity and the Hofmeister 
series (section 4.2) is given by the herpex simplex virus type I protease which undergoes an 
increase in activity in the presence of salts in a way dependent on the position in the 
Hofmeister series (Cacace et a/., 1997). Other organic solutes and metabolites were found to 
enhance the protease activity, linking the activation to the presence of a suitable subcellular 
microenvironment such as that of the nucleus, with its abundance of nucleotide polyanions. 
Probably the most important effects of salts are on the solubility and stability of proteins (Von 
Hippel and Schleich, 1969; Timasheff and Arakawa, 1997). Generally salts stabilise the 
protein structure against thermal and chemical dénaturation (Oobatake et al., 1979; Pace
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and Grimsley, 1988; Batalia et al., 2000; Deswarte et al., 2001) and stabilising ions are 
widely used as protective agents (Timasheff and Arakawa, 1997; Price, 2000). The 
mechanism of stabilisation can be different ranging from preferential hydration to preferential 
binding (Timasheff and Arakawa, 1997; Muzammil et al., 2000) (section 4.2). This could well 
be of importance In maintaining the structural and functional integrity of, for example, 
recombinant therapeutic proteins on storage. On the other hand, destabilising salts could be 
useful in solubilising over-expressed proteins which have formed inclusion bodies (Thatcher 
and Hitchcock, 1994; De Bernardez Clark, 2001), or for undertaking unfolding/refolding 
studies of proteins (Jaenicke, 1987).
In addition, salts are used in many protocols for the growth of crystals for X-ray diffraction 
analysis (McPherson, 1982). As has been well documented, the presence of salts in the 
crystallisation medium can interfere with the properties of macromolecules such as ligand 
binding and the ability to undergo conformational changes associated with function (Chothia 
et al., 1983; Busch and Ho, 1990; Yonath, 2002). In the case of the apo-form of AK it is 
suggested that the average structure in solution is different to that found in the crystal (Sinev,
1996). In fact the enzyme structure derived from the X-ray analysis of one of the crystalline 
forms (crystal A) of the apo-AK from pig muscle contains two sulphate ions, one of which is 
tightly bound to the enzyme in the vicinity of the (3- phosphate of the ATP binding site. 
Therefore it can be assumed that this structure does not represent the real structure of the 
apo-enzyme. The crystal B form had no bound sulphates and had the widest cleft.
Salts that favour the compact protein conformation by means of preferential exclusion from 
the protein surface (Timasheff and Arakawa, 1997) stabilise the native state and also provide 
a useful tool for characterizing partially structured states in the refolding process (Bieri et al., 
1999; Otzen and Oliveberg, 1999; Krantz and Sosnick, 2000; Low etal., 2000).
For many proteins refolding experiments in the presence of salts have been carried out at 
acidic pH (acid denatured state) and the salt-induced refolding was generally lead to a 
molten globule state (Goto et al., 1990; Eder et al., 1993; Hamada et al., 1994; Nishii et al., 
1995; Uversky et al., 1998b; Staniforth et al., 1998; Nishimura et al., 2000) though not always 
(Bedell ef al., 2000). In these cases the effect of the anions is attributed to their minimizing 
the charge repulsion by binding to the positively charged groups. The study of the refolding in 
these conditions is interesting because the acid-denatured states are thought to be the 
starting points for the misfolding in some conformational disorders (section 1.1.1.3). In fact it 
has been found that addition of salts to these acid-unfolded proteins leads to the formation of 
amyloid-like fibers (Damaschun et al., 1999).
Effects at neutral pH are more difficult to elucidate because the influence of salts on the 
refolding properties of proteins is complex and a number of different effects, including 
electrostatic screening, protein stabilization, alteration of the properties of water (Jelesarov et
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al., 1998), and binding can all play a role (Kulkarni et al., 1999). Therefore salts could be 
useful in revealing insights into the roles that electrostatic interactions and anion binding play 
in the refolding; changing the refolding environment, the energy landscape of the refolding 
can be varied (Ferguson et al., 1999; Jaspard, 2000; Kulkarni et al., 1999). In fact the type of 
amino acid side chains in contact with the surrounding medium, and therefore the charge 
distribution of the molecule, greatly changes during the refolding and each transient 
conformation of the polypeptide chain must establish a unique pattern of interactions with 
the solvent. Therefore, it is likely that protein-solvent interactions are of major importance for 
the outcome of the refolding (Wiggins, 1997).
1,1.2 Methods for studying protein folding
One way of studying the unfolding-refolding process is by establishing equilibria between 
native and unfolded states. However, equilibrium studies give little insight into the 
mechanism of folding, since folding-unfolding transitions are often highly co-operative and 
partially folded intermediates states are not weil-populated at equilibrium.
In order to monitor the kinetics of folding the refolding reaction is triggered by rapid dilution 
of a denaturing agent or by a pH or temperature jump, and the refolding can be followed by 
monitoring the regain of the activity or the resulting conformational changes can be 
monitored by spectroscopic techniques. Some of the time-resolved spectroscopic 
techniques that can be used are summarised in the following lines: this wili be only a short 
overview of the different techniques and, the ones actually used in this work are analysed in 
more detail in section 1.3.
After the protein is transferred into a "refolding” environment, the initial stages of refolding 
involve changes in size, secondary, and tertiary structure content. The formation of the 
environment of aromatic residues or co-factors can be obtained following the changes in the 
absorbance in the near-UV region (Eaton et al., 2000; Roder and Shastry, 1999). Another 
technique used to monitor the regain of secondary (far-UV) and tertiary (near-UV) structure 
is circular dichroism (CD; section 1.3.1)(Kel!y and Price, 1997; Goldbeck et al., 1997; 
Akiyama et al., 2000). While the near-UV CD monitors the formation of the rigid 
environment of the aromatic side chains, the intrinsic fluorescence can be used to obtain 
information on the environment of aromatic side-chains as they become involved in tertiary 
structure interactions during folding and aiso provides a tool to assess the formation of the 
active site during the refolding process (section 1.3.2). The use of some fluorescent probes, 
as ANS, that are thought to bind to exposed hydrophobic regions, has been found to be 
very useful in the detection of eariy intermediates (section 1.3.3). Pulsed hydrogen-
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exchange techniques (HX) combined with the bi-dlmensionai nuclear magnetic resonance 
(2D-NMR) (Englander et a/., 1996; Englander, 2000) and mass spectrometry (pulsed HX- 
ESi-MS) (Miranker et al., 1993) have provided information respectively on hydrogen-bond 
formation in specific residues and on folding populations (Deng and Smith, 1999). The role 
of individual residues in stabilizing intermediates and transition states could be explored by 
protein engineering: side-chains are modified by site-directed mutagenesis and the kinetics 
and equilibria of folding of each mutant measured (Matouschek et al., 1994; Fersht, 1998). 
One example is the case of barnase were this strategy was applied and structural 
information on the intermediate and transition state were obtained (Matouschek et al.,
1994). Finally techniques like fluorescence resonance energy transfer (FRET), can be used 
to monitor changes in the distance between donor and acceptor probes that are close 
together in the native state and well separated in the unfolded state, giving information on 
the rate of collapse during folding (Eaton et al., 2000; Roder and Shastry, 1999). The 
protein compaction process could be monitored by small-angle-X-ray-scattering combined 
with stopped flow mixing (Pollack et al., 1999).
In parallel with the developments in the experimental techniques a number of theoretical 
methods have been developed to simulate protein folding (Dobson and Karpius, 1999).
The application of different techniques coupled with the theoretical developments have 
allowed the pathways of folding of a number of small proteins, such as barnase (Fersht,
1993), dihydrofolate reductase (Gegg et al., 1997), chymotrypsin inhibitor 2 (Itzhaki et al.,
1995), lysozyme (Radford et al., 1992) and CheY (Lopez-Hernandez and Serrano, 1996) to 
be mapped out and understood in reasonable detail.
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1.2 The Shikimate pathway and Shikimate Kinase
1.2.1 The Shikimate Pathway
1.2.1.1 An overview
The shikimate pathway is a seven step biosynthetic route that converts erythrose-4- 
phosphate to chorismic acid, the major precursor of aromatic amino acids (Haslam, 1993) 
(Fig. 1.3). Chorismate itself is a precursor not only for the aromatic amino acids but also for 
several other important aromatic compounds required in plants and micro-organisms: folate, 
via 4-aminobenzoate, the iron-binding compound enterochelin, via 2,3-dihydroxybenzoate, 
and ubiquinone, a component of the electron transport chain, and menaquinone, via 4- 
hydroxy-benzoate (Gibson, 1999; Roberts et al., 2002). All pathway intermediates can also 
be considered branch point compounds that may serve as substrates for other metabolic 
pathways (Hermann, 1999). The pathway is named after one of the intermediates, shikimic 
acid, which was isolated by Eykmann from the fruits lllicium religiosum (Eykmann, 1885). 
The importance of this pathway resides in the fact that it is found in microorganisms and 
plants, but not in higher animals. The existence of the shikimate pathway was recently 
demonstrated in apicomplexan parasites such as Plasmodium falciparum and Toxoplasma 
gondii (Roberts et a/., 1998), which causes toxoplasmosis. So compounds that target the 
enzymes of this pathway may also be effective as herbicides (Coggins, 1989; Kishore and 
Shah, 1998), antibiotics (Davies, 1994) and against other disease-causing bacteria or fungi 
that rely on the pathway. These include Mycobacterium tuberculosis, which causes 
tuberculosis, Staphylococcus aureus, a common and increasingly drug-resistant cause of 
serious post-operative infections, and Pneumocystis carinii, the most frequent cause of 
pneumonia in patients with AIDS (Roberts et al., 2002).
The shikimate pathway operates in the cytosol of bacteria and fungi, but in plants it is also 
known to operate in plastid organelles (Roberts et al., 2002). In micro-organisms the 
regulation of the pathway is achieved by feedback inhibition and by repression of the first 
enzyme. In higher plants, no physiological feedback inhibitor has been identified, 
suggesting that pathway regulation may occur exclusively at the genetic level.
This difference between microorganisms and plants is reflected in the unusually large 
variation in the primary structures of the respective first enzymes. Several of the pathway 
enzymes occur in isoenzymic forms whose expression varies with changes in 
environmental conditions and, within the piant, from organ to organ (Herrmann, 1999).
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1.2.1.2 The Steps of the pathway
The step is the condensation between erythrose-4-phosphate and phosphoenoipyruvate 
to form 3-deoxy-D-arabino-heptulosonic acid-7-phosphate (DAMP).The enzymatic synthesis 
of DAMP is catalysed by DAMP synthase (EC 4.1.2.15). The DAMP synthase studied in 
most detail is the enzyme from E. coli (Hermann, 1995), which produces three feedback 
inhibitor-sensitive DAMP synthase isoenzymes: a Tyr-sensltive, a Phe-sensitive, and a Trp- 
sensitive enzyme. These enzymes are oligomers with a subunit molecular weight of about 
39 kDa. DAMP synthase in £  coli is a metalloprotein that is inhibited by chelating agents 
(McCandliss and Hermann, 1978). In vitro analysis of pure enzymes indicates that the metal 
requirement can be satisfied by several divaient cations (Stephens and Bauerle, 1991). 
Piant DAHP synthases have been obtained in pure form from carrot (Suzich et ai., 1985) 
and potato (Pinto et ai., 1986) as oligomers with subunit molecular weights of about 54 kDa. 
Because of the large differences in the primary structure. Walker and co-workers made a 
distinction between a smail bacterial type I DAHP synthase of 39kD and a large plant type II 
enzyme of 54 kDa. However the "plant type 11" DAHP synthase is also found in prokaryotes 
and the “bacterial type I” in eukaryotic microorganisms (Walker etal., 1996; Paravicini et al., 
1989). DAHP synthase in E. coli is regulated at the transcriptional level by repression and at 
the protein level by feedback inhibition.
In bacteria, reactions two to six of the shikimate pathway are catalysed by five separate 
enzymes, but in fungi, a single polypeptide called the multifunctional AROM complex serves 
the same purpose. In these complexes, the enzymes do not appear (in terms of the amino 
acid sequence) in the order of the pathway reactions. Protein domains for DHQ synthase 
and EPSP synthase form the amino terminal part, domains for shikimate kinase, DHQ 
dehydratase, and shikimate dehydrogenase the carboxy terminal part (Hawkins and Smith, 
1991). It appears that the arom locus evolved by gene fusion. DNA encoding the entire 
AROM complex has been cloned and sequenced from A. nidulans (Charles et al., 1986), 
yeast (Duncan et al., 1987) and P. carinii (Banerji et al., 1993). In higher plants, a 
bifunctional enzyme catalyses reactions three and four of the pathway. The remaining three 
reactions of the shikimate pathway are catalysed by separate enzymes that are structurally 
rather similar to their prokaryotic homologues.
The 2"^ step is the formation of highly substituted cyclohexane derivative, 3-dehydroquinate 
by the exchange of the ring oxygen of DAHP for the exocyclic 0  of DAHP with the 
elimination of phosphate. The reaction is catalysed by Dehydroquinate (DHQ) synthase (EC 
4.6.1.3), a monomeric enzyme with a molecular weight of 39 kDa. The enzyme from E  coli 
requires divaient cations and NAD"  ^ for activity (Frost et al., 1984) and it is activated by 
inorganic phosphate. The mechanism o f this reaction was elucidated by Barlett and
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Knowles (Bartlett and Satake, 1988; Bender et al., 1989; Widlanski et al., 1989). The true 
substrate for the enzyme is apparently the pyran form of DAHP (Garner and Hermann, 
1984). The p-elimination of phosphate proceeds with syn stereochemistry and there is 
compelling evidence that the enzyme is a simple oxidoreductase (Bartlett and Satake, 1988; 
Bender et al., 1989; Widlanski et al., 1989). The phosphate monoester may either mediate 
its own elimination or may be aided by the enzyme. The remaining partial reactions proceed 
spontaneously. The enzyme itself provides a potential conformational template to prevent 
formation of undesirable side products (Bartlett et al., 1994; Parker et al., 1997).
The 3-dehydroquinate forms 3-dehydroshikimate by the elimination of water (3^  ^step). This 
step is catalysed by dehydroquinate dehydratase (Dehydroquinase, EC 4.2.1.10). The 
dehydration of 3-dehydroquinic acid to 3-dehydroshikimic acid is a central step in two 
separate metabolic pathways: one is the shikimate pathway in micro-organisms and plants, 
the other is involved in catabolism and is the quinate pathway in fungi which allows the use 
of quinate as the sole carbon source (Fig. 1.4). DHQase exist in two forms: type 1 and type 
il, depending on the bacterial source (Deka et al., 1992; Moore et al., 1993; White et al., 
1990; Garbe et al., 1991). Type I DHQase catalyses syr?-elimination and type II anti- 
elimination of water (Shneier et al., 1993). The mechanistic differences are reflected in the 
structures of these proteins; there Is no sequence similarity between type I and II enzymes, 
a rare example of convergent or parallel evolution. Type I enzymes, the most studied of 
which is the E.coli enzyme, are dimers of 25 kDa subunits and catalyse the dehydration of 
dehydroquinate by a Schiff base mechanism (Kleanthous et al., 1992). On the other hand 
the type II enzymes (the best studied example of which is the enzyme from Streptomyces 
coelicor) are dodecamers of 16-18 kDa monomeric molecular mass, which appear to 
catalyse the dehydration reaction via an enoiate intermediate (Kleanthous et al., 1992; 
Harris etal., 1996; Leech et al., 1998).
The 4^  ^step is the reduction of dehydroshiklmate (DHS) to shikimate. In E. coli, the reaction 
is catalysed by an NADP-dependent shikimate dehydrogenase (EC 1.1.1.25) of molecular 
weight 29 kDa. The pyridine nucleotide-dependent dehydrogenases are of two kinds: those 
with catalyticaily active metal Ions such as and Fe^ "’ and those without (Aronson et al., 
1989). Shikimate dehydrogenase is thought to be of the metal-independent kind because 
the presence of EDTA does not give inhibition of the enzyme. A histidine residue has an 
essential role in pyridine nucleotide-dependent dehydrogenases: it forms a hydrogen bond 
with the carbonyl group of the substrate (Adams et al., 1987), which then initiates the 
hydride ion transfer by polarization of the carbonyl group. In the metal-dependent kind, the 
hydride ion transfer is initiated by the bound metal ion.
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The 5^  ^ step is the phosphorylation of shikimate to give shikimate 3-phosphate and is 
catalysed by shikimate kinase (EC 2.7.1.71). This reaction wiii be discussed separately in 
section 1.2.2.1, since shikimate kinase is the subject of this thesis.
The 6^^ step involves an estérification reaction to give 5-enolpyruvylshikimate 3-phosphate. 
This irreversible reaction is catalysed by 5-enolpyruvylshikimate 3-phosphate (EPSP) 
synthase (EC 2.5.1.19) a monomeric enzyme of molecular weight 48 kDa. Several studies 
proposed an ordered (Anderson and Johnson, 1990) or a random (Gruys et al., 1993) 
kinetic mechanism for the enzyme-catalysed reaction that proceeds through a tetrahedral 
intermediate. This tetrahedral intermediate had already been suggested by Srinson and co­
workers and was verified through extensive physicochemicai investigations (Seto and 
Bartlett, 1994; Sikorski and Gruys, 1997). EPSP synthase is the only cellular target for the 
herbicide glyphosate (Steinrucken and Amrhein, 1980). Glyphosate binds to the enzyme- 
S3P complex, and is competitive with respect to phosphoenoipyruvate (PEP). Though 
initially the ternary complex enzyme-S3P-Glyphosate had been considered a transition state 
analogue, a number of experimental results have demonstrated that glyphosate and PEP 
binding are not totally equivalent. Since glyphosate is a competitive inhibitor with respect to 
PEP but does not bind in the same fashion as PEP, the inhibition is now termed an 
“adventitious allosteric interaction” (Sikorski and Gruys, 1997). Under specific in vitro 
conditions the EPSP synthase from Bacillus subtilis is an oligomeric protein with two non­
equivalent PEP binding sites. Glyphosate binding is competitive with respect to one site 
oniy; thus this enzyme has been considered a classical allosteric protein (Majumder et al.,
1995).
The final step of the main trunk of the shikimate pathway is the trans-1,4 elimination of 
phosphate from EPSP to form chorismate (Hermann, 1995; Balasubramanian et al., 1990, 
Hawkes et al., 1990). In this reaction, the second of the three double bonds of the benzene 
ring is introduced. The reaction is cataiysed by chorismate synthase (EC 4.6.1.4) and 
requires reduced flavin for activity even though the overall reaction is redox neutral. In the 
chorismate synthase catalysed reaction, the reduced flavin is apparently directly involved in 
the mechanism of the reaction (Ramjee et al., 1991; 1992). Depending upon the organism, 
chorismate synthase is either monofunctional, requiring the addition of reduced flavin to in 
vitro enzyme assays, or bifunctional, with an associated NADP-driven flavin reductase 
within the same polypeptide chain.
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Figure 1.4: Position of dehydroquinase in the shikimate and quinate pathways.
The formation of 3-dehydroshikimic acid is a central step in two separate metabolic 
pathways: the shikimate pathway and the quinate pathway.
1.2.2 Shikimate Kinase
1.2.2.1 The Shikimate Kinase reaction
Shikimate kinase (EC 2.7.1.71) catalyses the fifth step in the biosynthesis of the aromatic 
amino acids (the shikimate pathway) in bacteria (gene aroK or aroL), plants and in fungi 
(where it is part of a multifunctional enzyme which catalyses five consecutive steps in this 
pathway (Duncan et a!., 1987)). SK catalyses the specific phosphorylation of the 3-hydroxyl 
group of shikimic acid using ATP as substrate (Fig.1.5). In E. co//this reaction is catalysed 
by two different isoforms: types I and II that have 30% sequence identity (Griffin and 
Gasson, 1995; Whipp and Pittard, 1995). This unusual situation led to the suggestion that 
shikimate may be a branch-point intermediate for two different pathways (Weiss and 
Edwards, 1980). The two isoenzymes also have a different affinity for the shikimate: the 
type I has a of 20mM while the type II a Km of 200pM. The role of SKI is unclear but it 
has been suggested that it may have another function in the cell, possibly in the process of 
cell division (DeFeyter and Pittard, 1986a; 1986b; Vinella et a/., 1996) and that it 
phosphorylates shikimate only fortuitously. By analogy with other kinases the conserved 
Lys15 residue (section 1.2.2.2) is thought to be involved in the stabilization of the
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pentavalent transition state of the y-phosphoryl group during the phospho-transfer reaction 
(Sigal etal., 1986; Reinstein et a!., 1990; Muller-Dieckmann and Schulz, 1994). 
Understanding the mechanism of the phospho-transfer reaction is of great interest because 
this occurs in many biological processes such as energy transfer, signal transduction, 
protein biosynthesis, activation of metabolites, and cell growth (Bossemeyer, 1995; Mildvan,
1997). By comparing the structure of adenylate kinase (AK) in the presence of P \ P^-bis (5- 
adenosyl) pentaphosphate (ApsA), considered as reproducing the geometry before the 
phospho-transfer, with the structure of the uridylate kinase (UK) complexed with ADR; 
ADP/AMP, considered to represent the geometry after the phospho-transfer Muller- 
Dieckmann and Schulz (Muller-Dieckmann and Schulz, 1994) gave a model for the 
transition state of the phospho-transfer that corresponds to a trigonal bipyramidal transition 
state expected for the in-line Sn2 reaction. A similar mechanism has been proposed for AK 
on the base of NMR studies (Fry et a!., 1987). A recent quantum mechanical study on the 
phosphoryl transfer in the NMP kinases has proposed a synchronous shift of a proton from 
the monophosphate to the transferred POa '^ group (Mutter and Helms, 2000).
COOHCOOH
Shikimate Kinase
ADPATP ‘OHOOHHO
OHOH PO4
Shikimic Acid Shikimate-3-phosphate
Figure 1.5 Reaction catalysed by Shikimate Kinase.
1.2.2.2 The P-loop-containing nucleotide triphosphate hydrolases
The overall 3-dimensional structures of proteins are much better conserved than their amino 
acid sequences, giving rise to families of proteins having related folds but varying widely in 
sequence similarity. There are four main structural classes observed in proteins; mainly a, 
mainly p, a+p and alternating a/p (Murzin et al., 1995; Orengo, 1994). The o/p and a+p  
proteins differ in that the o/p proteins mainly are built up of parallel strands connected by 
helices (Pap motifs), while the a  -t- p proteins have strands and helices connected in a more 
irregular fashion. Various physical constraints on the packing of secondary and super 
secondary motifs gives rise to groups of folds within each class, containing common or 
favoured secondary structure arrangements (Murzin et al., 1995). Studies of these groups
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can generate valuable information on secondary structure packing, thereby identifying 
restrictions on fold topologies and improving ab initio fold predictions.
The most structurally diverse of the four classes of proteins is the a/B class which contains 
nearly 100 different kinds of protein folds. One of these subclasses is the P-loop-containing 
nucleotide triphosphate hydrolases. Amongst the mononucleotide triphosphate binding 
proteins only a few distinct caisses have been recognised; the cAMP-dependent kinase 
fold; the actin fold; the glutathione sinthetase; the type II tRNA synthetase; the nucleotide 
diphosphate kinase and, finally, the adenylate kinase fold, to which SK belongs. The core of 
this class forms a classical mononucleotide-binding fold (CMBF) found in a number of 
structurally diverse proteins such as myosin, elongation factor EF-Tu, p2T^®, the nucleotide 
binding domain (NBD) of the ABC transporter, Rec A and adenylate kinase (Yoshida and 
Amano, 1995). The family of nucleoside monophosphate kinases (NMP- e.g.: adenylate 
kinase, guanylate kinase, uridylate kinase and thymidine kinase) includes enzymes that 
catalyse the phospho-transfer to molecules other than NMPs, such as the kinase domain of 
the rat testis 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and shikimate kinase 
(Hasemann et ai., 1996). The members of this class show a high degree of three- 
dimensional structural similarity although the sequence identity between the members is 
very low except for two conserved peptide sequences named the Walker A (or “P-loop”, 
consensus sequence: GXXXXGKS/T, where X is a not conserved residue) and Walker B 
motifs (consensus sequence: ZZ-D-XX-G; Z= hydrophobic) (Walker et a!., 1982) that were 
proposed to be responsible for the binding of triphosphate and Mg^ "^ . On the basis of further 
work the Walker A consensus motif has been renamed kinase 1 motif and has the following 
fingerprint G(X)XXXXGKS/T (the X in parenthesis has been added to account for an 
insertion found in the sequence of the dethiobiotin synthetase) (Dever et a!., 1987; Traut, 
1994). The NMP kinases are generally composed of three domains: the central CORE 
domain, which contains the P-loop and consists of parallel strands flanked by helices; the 
LID domain, which closes over the bound ATP during catalysis; and the NMP binding 
domain (Milner-White ef a/., 1991; Story and Steitz, 1992; Vonrhein etal., 1995).
The structural conservation of the CORE within this group of proteins is illustrated by the 
fact that superimposition of the P-loops from proteins such as Rec A, adenylate kinase 
(AK), the elongation factor, G-proteins, and myosin results in root mean square deviations 
in alpha C atoms of only 0.3-0.4 A (Krell et al., 2001). In this family the kinase 1 motif is 
always found on a loop which typically forms a flexible connection between the first p-strand 
(P1) and the first a-helix (a l), that generates an anionic environment within which the p- 
phosphate of ATP can be accommodated (Smith and Payment, 1995; Dreusicke and 
Schulz, 1996). The Lys in the P-loop is an essential lysine which is thought to be involved in 
nucleotide binding by direct interaction with the p-phosphate of ATP (Saraste et al., 1990).
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The last Ser/Thr residue of the kinase 1 motif is directly or indirectly involved in the 
coordination of the cation essential for enzyme activity associated with the nucleotide. 
Another essential residue is a conserved aspartic acid, located in the kinase 2 motif (Walker
B) (Dever et al., 1987; Traut, 1994). This aspartate residue is usually found at the C- 
terminal segment of the second strand of the central p-sheet (Smith and Payment, 1996), in 
the immediate vicinity of the kinase 1 motif, on the Walker B (kinase 2) motif, ZZ-D-XX-G, 
(Walker et al., 1982). Not all ATP- or GTP-binding proteins contain this motif, but in these 
cases other residues fulfill the role of the kinase 2 Asp residue (section 1.2.2.3). The relative 
positions of the residues involved in catalysis are well conserved in the available structures, 
probably reflecting the precise adjustment needed for the proper function of the binding site. 
In fact it appears that the network of interactions that the residues of the P-loop establish 
with the rest of the protein play a crucial role in folding and activity. It was demonstrated, by 
engineering the kinase 1 and 2 motifs into a protein, namely CheY (that has the overall 
topology of this class of proteins but does not contain these motifs), that the structure of the 
P-loop is strongly influenced by the tertiary contacts (Cronet et al., 1995). The P-loop is 
maintained in its active conformation through a network of contacts with the rest of the 
structure (Table 1.2). The first contact is a van der Waals’ contact between the side-chain of 
a buried hydrophobic residue on the p-strand adjacent to the P-loop (e.g. Val81 in p2T®®) 
and the backbone of the three residues before the S/T of the kinase 1 motif; the second is a 
hydrogen bond between the S/T of the kinase 1 motif and the Asp of the kinase 2 motif (it 
should be noted that In the case of adenylate kinase, in which there is a single deviation 
from the P-loop pattern, Gly is found instead of Ser or Thr in the C-terminai position). The 
last observed contact is due to the main-chain carbonyl group of the Gly of the G KS/T that 
forms a hydrogen bond with a side-chain amide group of an Asn residue (in p2T^® and EF- 
Tu) or a van der Waals’ contact with an Arg from an adjacent loop (AK). The hydrophobic 
cluster formed by the packing of conserved hydrophobic residues (mainly Val) with the P- 
loop, and the other two interactions that could help in a synergistic fashion, could play a 
central role in determining its structure (Cronet et al., 1995) and could have a role as a 
nucléation point during the folding of these kinds of proteins (Kumar et al., 2001).
This work, together with other studies (Kinoshita et al., 1999), indicates that sequence or 
protein fold information is not sufficient to understand the variety of the binding modes with 
substrates: instead structural comparisons at the atomic level must be made.
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P2-i«s
(PDB entry; 5P21)
EF-Tu
(PDB entry: 1ETU)
AK
(PDB entry: 3ADK)
G N116 N135 R128
V81 V104 V118
K117
K D57 D80
T58 1192
A59 Y87 N193
G60
V81 V104 V118
srr T35
D57 D80 D93
Table 1.2: P-loop contacts in the classical mononucleotide-binding fold (CMBF) family:
the residues in italics and on the same line make conserved contacts with the corresponding 
residue of the P-loop throughout the whole CMBF family (Cronet et al., 1995).
1.2.2.3 The structure of shikimate kinase
The shikimate kinase (E.C.2.7.1.71) of E. chrysanthemi, which was cloned and sequenced 
by Minton et al. (1989), is a type II enzyme. It is a small a/p protein of 173 residues and 
molecular mass of 18,955 Da, with a theoretical isoelectric point (calculated by EXPasy) of 
5.58. From the X-ray structure of SK (Krell et al., 1998), it is clear that the ordering of the 
strands, 23145 in the parallel p-sheet core, places the enzyme in the same structural family 
as the NMP kinases (Fig. 1.6a, b). Adenylate kinases (AKs) have served as a template 
structure for previous modelling of 6-phosphofructo-2-kinase/fructose -2, 6-bisphosphatase 
enzyme (Bertrand et al., 1997) as well as for shikimate kinase (Matsuo and Nishikawa,
1994), although SK possesses only 19% sequence identity with AK. Four structures of 
shikimate kinases are available: two of the E. chrysanthemi wild type enzyme (PDB entry: 
Ishk  and 2shk - Krell et al., 1998)^’^ , one of the K15M mutant (PDB entry fe6c™ Krell et al.,
2001) and finally the structure of SK from Mycobacterium tuberculosis (Gu et al., 2002). The 
central five stranded parallel p-sheet core is flanked by a-helices, two on one side (a l and
 ^ Though the enzyme functions as a monomer, the two structures available for the W T are dimers: there is a 
disulphide bond between the Cys 162 residues, probably due to the crystallization procedure, which was carried 
out in the absence of DTT.
 ^ 1 shk: mol. A -  with shikimate; mol. B-no ligand ; 2shk: mol.A- with shikimate; mol.B- with ADP
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a8) and three on the other (a4, a5 and a l)  as shown in the figure 1.6 a and b (Krell et al.,
1998), with a topology similar to adenylate kinase.
Common to all proteins of the adenylate kinase family are three structural regions termed 
CORE, LID domain, and NMPbind (section 1.2.2.2), that in SK is the shikimate binding 
domain (SB)(Vonrhein et al., 1995; Krell et al., 1998; Gu et al., 2002 -  Fig. 1.6 c).
The central rigid CORE region includes the central parallel p-sheet and the P-loop 
(GXXXXGKT/S - Fig. 1.7), which forms a giant anion hole that accommodates the p- 
phosphate of the ADP by donating hydrogen bonds from several backbone amides.
The conserved P-loop lysine, Lys15, is thought to have both a catalytic and structural 
function. The structure of the K15M mutant shows that the mutation causes perturbations in 
the region of the P-loop (Krell et al., 2001). This, together with binding, activity and chemical 
modification data, confirms the role of K15 not only in stabilization of the pentavalent 
transition state, but also in mantaining the conformation of the P-loop. While AK does not 
have the T or S residue on the C-terminal side of the P-loop Lysine, this residue is present 
in SK (Thr16) and is involved in providing a hydrogen bonding ligand to maintain the Mg^  ^
cofactor in an octahedral coordination in the catalytic site. The importance of this hydroxyl 
residue has been investigated by site-directed mutagenesis on other P-loop containing 
proteins: the removal of the hydroxyl group often leads to substantially decreased affinity for 
substrate MgATP (Urbatsch et al., 2000).
The kinase 2 motif is usually located on the C-terminal segment of the second p-strand of 
the sheet but does not appear to be present in SK at a sequence level. SK has a modified 
kinase 2 motif; compared to other NMP kinases, it retains the Gly (GIy79) but the Asp is 
replaced by Ala76. The functions performed by the conserved Asp in the kinase 2 motif are 
accomplished in the SK by Asp32 (formation of H-bond to Thr16) and Asp34 (H-bond to a 
water molecule coordinated to the active site) (Krell et al., 1998). The D34N mutant of SK 
was expressed and purified (Krell et al., 2001), but it was found to be unstable under 
standard storage conditions and lacked enzyme activity. These pieces of evidence suggest 
that D34 may play an important role in maintaining the conformation of the enzyme.
The adenosine binding pocket in shikimate kinase II from E. chrysanthemi extends from 
residue 148 to residue 168 and is very similar to the adenine-binding motif found in bacterial 
shikimate kinase II, AK type II isoenzymes and also to the AK type I isoenzyme from yeast 
(Fig. 1.8), although only backbone interactions are responsible for adenine recognition. This 
motif has a consensus sequence Val/lle-Asp-X-Gln/Asn-X-Pro, or more generally Val/lle- 
Asp-XXX(X)-Pro (Gu et al., 2002), and is restricted to a small group of ATP-binding 
proteins. The adenine is sandwiched between Arg 110, whose side-chain is parallel to the 
adenine ring, and Pro 157, that forms part of a loop, which wraps around the bound 
adenine.
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The LID domain is one of the domains involved in the large hinged movement that 
characterizes the NMP kinases (section 1.2.2.4), where it closes over the bound ATP. The 
size of the LID domain In AKs varies between the small cytosolic variant (11 residues) and 
the large mitochondrial variant (38 residue). The LID domain of SK contains 15 residues, 
which makes it more similar to the cytosolic variant of AK and it is thought to close over 
bound ATP. This domain, which is disordered in the wild type shikimate kinase structure, is 
instead stabilised by contacts with neighbouring lid domains in the K15 mutant structure 
(PDB entry 1e6c) (Krell et al., 2001). The mutation does not have an effect on the overall 
conformation of the LID domain; a result which is very similar to the other NMP kinases with 
a short LID domain (Muller-Dieckmann and Schulz, 1994).
Shikimate binds at a site, which follows the p-strand 2; this binding site involves the a2 and 
a3 helices and the N-terminal region of the a4 helix and corresponds precisely with the 
AMP-binding site of adenylate kinase (Fig. 1.9 gives a schematic representation of the 
different binding regions of SK). Shikimic acid is a six membered ring with a carboxylate 
group (position 1) and three hydroxyl groups (positions 3, 4 and 5). The residues likely to be 
involved in binding the carboxyl group are Arg58 and 139 and there could be also a 
contribution from the backbone NH-groups Gly78 and 80, probably via a water molecule. 
The co-ordination of the hydroxyl groups is achieved by the charged side chain of Asp34 
which is positioned to allow binding of hydroxyls at C3 and/or C4. In addition, Glu61 is in the 
correct orientation for binding the hydroxyl at C5 of shikimate (Krell et al., 1998).
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Figure 1.6: The structure of shikimate kinase (Krell et al., 1998).
a) Ribbon structure of SK; the order of p-strands is reported on each strand: the ordering 
23145 in the parallel p-sheet classifies SK as belonging to the same structural family as 
the NMP kinases.
b) General topology of SK; the a-Helices and the single 3io helix are represented as 
cylinders; p-Strands are represented as arrows; the approximate position of bound ADP 
and shikimate are indicated.
c) Sequence of SK from Erwinia chrysanthemi, the yellow region indicates the position of 
the P-loop (kinase 1 motif); the red line indicate the missing residues of the LID domain.
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Figure 1.7: Structure of SK: P-loop region and bound ADP
Particulars of the structure of SK complexed with ADP (PDB code: 2shk). The P-loop, the 
area of the active site that interact directly with the phosphate group, is coloured in yellow. 
The P-loop lysine, K15, is coloured in green. This residue has both an essential structural 
and mechanistic role for the activity of the enzyme (Krell et a/., 1998; 2001)
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Figure 1.8: The adenosine binding motif.
Sequence alignment of shikimate kinases (isoensymes II) and adenylate kinases 
(isoenzymes II and yeast isoenzyme I) in the region of the adenine binding pocket. 
Conserved residues are highlighted. (Krell et a/., 1998).
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1.2.2.4 Hinge-bending movements
In solution proteins exist in an ensemble of conformational isomers whose distribution is a 
function of the degree of their molecular flexibility and of external conditions. It is widely 
accepted that structural flexibility of enzymes plays an important role in their function (Price 
and Stevens, 1996; Price, 2000). This role is most evident in the case of transferases. In 
order to avoid abortive hydrolysis and to facilitate transfer of charged groups, transferases 
must undergo substrate-induced structural changes or "induced fit” (Koshland, 1958) to 
screen the active centre from water. Molecules exhibiting large flexibility may be described 
by folding funnels with rugged bottoms.
Of special interest are hinge-bending movements, where rigid domains are connected by 
flexible joints, such as in the case of NMP kinases, which tether the domains and constrain 
their movement. These motions may be considered to manifest relatively rugged bottoms, 
with low energy barriers separating the minima wells (Sinha et a!., 2001). The low energy 
barriers, corresponding to low energy transitions, enable the molecule to flip and 
interconvert between the different "open” and “closed” conformations. The conformer that is 
most favourable for binding is the one that is selected, shifting the equilibrium in its favour. 
These changes are large hinged movements around two flexible regions, which in the NMP 
kinases are the NMP binding site and the LID domain. Based on the comparison of AK 
crystal structures representing the enzyme in different ligand forms, apo-form from pig- 
muscle (Dreusicke et a!., 1988), enzyme-AMP binary complex from beef heart mitochondrial 
matrix (Diederichs and Schulz, 1990) and enzyme -ApsA complex from E. coli (Muller and 
Schulz, 1992), Schulz and co-workers suggested that AK undergoes large structural 
changes upon substrate binding (Schulz et a!., 1990; Gerstein et al., 1993). Domain closure 
in solution was confirmed recently by time-resolved energy transfer studies of AKeco 
derivatives, labelled with fluorescent probes in both ligand-free and ApsA-bound forms 
(Sinev, 1996), and by ®^N NMR relaxation (Shapiro et a!., 2000). The observed structural 
changes involved domain displacements and resulted in the closure (or partial closure) of 
the enzyme interdomain cleft. This was followed by a dramatic reduction of solvent- 
accessible surface area of substrate bound inside the cleft and reduced flexibility.
The crystal structure of a mutant of AK in the presence of the ATP analogue AMPPCFgP 
(Schlauderer et al., 1996) indicates that the domain motions occur largely independently 
from each other in agreement with the kinetic studies indicating a random bi-bi mechanism 
(Rhoads and Lowenstein, 1968). In this structure the LID had closed over the ATP analogue 
while the NMP binding site remained open consistent with the absence of AMP. By analogy 
with AK, the LID domain of SK is thought to close over bound ATP. Similarly, the shikimate- 
binding domain, which is in the same position as the AMP-binding site of AK, is thought to 
undergo a significant movement associated with the binding of shikimate.
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The LID domain is disordered in the ligand-free structure of wild type SK {2shk-- molecule 
A), but becomes slightly more ordered when ADP is bound {2shk -  molecule B). In the 
closed state this domain should form a short loop folded over the bound nucleotide. 
Probably the absence of the y-phosphate in the structure of the SK-ADP complex leads to 
an Incomplete closure of the LID: this could be the reason for the high flexibility of the LID, 
and so account for the missing residues even in the presence of ADP. The structure of the 
K15 mutant of SK represents an open conformation, in contrast to the structure obtained for 
the wild type enzyme. The orientation of the two helices around the LID domain (a6 and a7) 
differs from that in the native structure because of hinge movements at A102 and R139. 
These hinge regions are in exactly the same structural position as the joints I and IV 
identified for the large variant of AK (Gerstein et al., 1993). Movements around the hinge 
regions can be observed not only in the LID domain but also in the shikimate binding region 
(Krell et a!., 2001). These differences between the wild type and mutant structures are a 
result of the absence of ligands in the structure of the K15M mutant that is stabilised by 
favourable crystal contacts between the two molecules of the asymmetric unit and result 
from the displacement of the plane of the p-sheet by hinge movements at 135 and R39.
1.2.2.5 Shikimate kinase as a model system for studying protein folding
SK has a number of experimental advantages as a system for establishing the mechanism 
of protein folding. First of all it is a monomeric enzyme without disulphide bonds and with a 
molecular mass of 19 kDa is amongst the smallest kinases so far reported, and much of the 
progresses toward understanding the mechanism of folding has been achieved by the 
analysis of the folding of monomeric proteins. Moreover, SK has a single Trp residue 
(Trp54) which is located in the region near the shikimate binding site (Krell et al., 1998 - Fig. 
1.9). Binding of shikimate leads to quenching of Trp fluorescence (Idziak et al., 1997), 
thereby providing a convenient probe to check for the integrity of the shikimate binding site. 
An additional feature of SK is that the side chains of A rg il, Arg58 and Arg139 provide a 
highly positively charged environment around the Trp side chain and the shikimate binding 
site (Fig. 1.10) (Krell et al., 1998). This allows the use of the iodide ion as a quencher of 
protein fluorescence as an additional means of investigating the integrity of this region of 
the protein.
For all these reasons SK was chosen as a convenient representative example of the 
subclass of P-loop containing proteins with which to examine the mechanism of protein 
folding.
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Figure 1.9: SK structure: position of the P-loop, adenine and shikimate binding domains
The figure shows in green the shikimate binding domain; in blue the P-loop and in cyan the 
adenine binding domain (Krell et a i, 1998).
Arg 11
Trp 64
Figure 1.10: Position of the side chains of Argi 1, Arg58 and Arg 139.
The figure shows the three arginines around the Trp side chain that provide a highly 
positively charged environment around this residue and the shikimate binding site (Krell et 
ai, 1998).
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1.3 Biophysical methods used in this work
1.3.1 Circular Dichroism
1.3.1.1 Introduction
The term Circular dichroism (CD) refers to the difference in absorption between left- and 
right handed circularly polarized light and the term optical rotatory dispersion (ORD) to the 
wavelength dependence of the optical rotation. These are two manifestations of optical 
activity, which is related to the asymmetry of the molecule, that may be caused by 
covalently bound groups or, in case of a macromolecule, by conformation.
In monochromatic, plane polarised, radiation the electric field and the magnetic field 
oscillate with a certain frequency along a fixed direction in the space. The oscillating 
direction of these two vectors is perpendicular to the propagation direction. The plane- 
polarised light can be divided in two circularly-polarised vectors, right (Er) and left (El) 
respectively. While in an ordinary (achiral) medium E l and E r rotate with the same velocity, 
in a chiral medium these two components have different velocities. This is due to the 
different indices of refraction for the right- and left- circularly polarised light, np and n,. The 
delay of the passage of the light passing throught a medium Is explained by considering that 
the refractive index is correlated with the molecular polarizability. The light propagation can 
be considered as the radiation induces a dipolar oscillating moment that subsequently 
irradiates by itself. This radiation will have the same frequency of the incident light but, as it 
will be at a lower frequency than an absorption band, the phase will be delayed from the 
interaction. The delay of the phase, growing with the molecular polarizability, delays the 
passage of the light. This delay corresponds to the increase of the refractive index (the 
refractive index is correlated to the velocity of the light in a medium, np = c/v where c is the 
velocity of the light in vacuo and v in the medium). This is called optical rotation. The 
variation of the optical rotation as a function of wavelength is called optical rotary dispersion 
(ORD). When the light passes throught a chiral medium and is absorbed there is the 
variation of two characteristics of the light: first the maximum amplitude is no longer 
confined in the plane, but it will form an ellipse in the plane x-y. This is due to the difference 
in the absorbance of the right or left circularly polarised light. The second difference is in the 
orientation of the ellipse due to the difference in the refractive index. When right- and left- 
cicularly polarised light is absorbed to different extents at some wavelengths the result is 
circular dichroism (CD) (Fig. 1.11) (Cantor and Schimmel, 1980; Woody, 1995). Since CD is 
an absorption difference, it is only observed in absorption bands.
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i
Figure 1.11; Effect of an absorbing chiral medium on linearly polarised light.
A linearly polarised light can be divided in two circularly-polarised vectors, right (E r ) and left 
(E l)  respectively, where the E l and E r components rotate with the same velocity. When the 
light passes through a chiral medium, and this medium present an absorption band, these 
two components have different velocities and amplitudes. The results is that the maximum 
amplitude is no longer confined in the plane and it will form an ellipse in the plane x-y.
1.3.1.2 The CD of proteins
CD is a solution technique that provides rapid determinations of protein secondary structure 
and it is a way to rapidly assess conformational changes resulting from different conditions 
eg.: protein concentration, pH, temperature and co-solute conentrations (if they do not 
absorb in the specific spectral region). CD has been used, in conjunction with other 
techniques, to study the kinetics and the intermediates of protein folding and unfolding 
(Labhardt, 1986; Kelly and Price, 1997; 2000). Finally CD is a useful tool for examining 
proteins made by site directed mutagenesis for structure-function studies, where it is 
important to know to what extent the conformation has been affected by the mutation. The 
far-UV spectrum will tell whether the mutant has folded with a backbone conformation 
similar to that of the wild-type protein, whereas the near-UV spectrum will detect many 
minor changes in conformation or dynamics.
The circular dichroism of biopolymers is usually measured in the region of electronic 
absorption (CD can be measured for any type of transition, for example vibrational CD is 
measured in the amide I and II region corresponding to the C=0 stretch and N-H bend/CN 
stretch modes). The absorption bands that are optically active result from chromophores 
that are inherently asymmetric or symmetric chromophores that become asymmetric as a 
result of interaction with an asymmetric environment, as in the case of peptide bond.
The far-UV region (240-180nm) is dominated by the contribution of peptide bonds for which 
the CD band position and intensity depend on their conformation. Hence this part of the 
spectrum can be used to determine the secondary structure content of proteins (Woody, 
1995; Kelly and Price, 2000).
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The a-helix has two negative bands (222nm, transition n tc* and 208nm, transiton 
with the transition dipole parallel) and one positive band (190nm, transition with the 
transition dipole perpendicular to the helix axis). The p sheet has a negative band in the 
region 216-217nm, due to a n-^7c* transition, and a positive band at 195nm, due to a 
transition but the position and magnitude of these bands are variable. Finally the random 
coil has a weak positive band at 218nm (n->7t*) and a more intense negative band at 
197nm (7i:->7t*).
An analysis of the secondary structure with CD is based on the idea that the mean residue 
ellipticity at any wavelength is a linear combination of the mean residue ellipticity of the 
individual secondary structures. The modern methods involve the use of databases of CD 
spectra and corresponding secondary structure contents derived from X-ray structure 
determination. A linear combination of these spectra is used to give a result that best fits the 
experimental spectrum for the test protein. The most accurate methods employ selection 
criteria in which only spectra similar to that of the experimental spectrum form the basis set 
(Johnson, 1988; Sreerama and Woody, 1994; Greenfield, 1996). It should be stressed that 
the far-UV CD of the peptide bond essentially reflects the dihedral angles so, when helices 
have strongly distorted angles, like those of transferrins, CD will underestimate the helical 
content (Bloemendal and Curtis Johnson Jr., 1995; Kelly and Price, 2000). Moreover the 
aromatic amino acid side chain or disulphide bonds can contribute to the CD spectrum in 
this region (Kelly and Price, 2000). Another source of error is when the spectra are not 
measured down to at least 184nm; although the a-helical content is reasonably reliable 
when deduced from spectra truncated at 200nm, estimates of the p-sheet content are not 
accurate (Bloemendal and Curtis Johnson Jr., 1995; Kelly and Price, 2000).
Since CD measures absorption differences highly sensitive detectors and bright light 
sources are prerequisites for good signal-to-noise ratios, expecially in the region below 
200nm where many buffer components may absorb. Synchrotron radiation sources are 
especially useful at these lower wavelengths. In a synchrotron charged particles, in 
particular electrons or positrons, are forced to move in a circular orbit, leading to the 
emission of photons. When these charged particles are moving close to the speed of light, 
accelerated through magnetic fields, photons are emitted in a narrow cone in the forward 
direction at a tangent to the orbit. In a high energy electron or positron storage ring these 
photons are emitted over a wide range of wavelength from X-rays to the IR. This radiation is 
called synchrotron radiation. Synchrotron radiation has a number of unique properties, e.g.; 
high brightness (it is extremely intense and highly collimated), a wide energy spectrum and 
it is highly polarised. As far as CD is concerned the key advantage of the synchrotron is the 
very large increase in intensity (over 1000-fold) in the far-UV region (below 200nm) 
compared with the xenon arc sources in conventional CD instruments (Kelly and Price,
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2000). In the near-UV (above 250nm), only the aromatic residues (and to some extent 
cysteine) absorb light. The tertiary fold of the polypeptide chain can place these side chains 
in chiral environments thus giving rise to CD spectra which can serve as characteristic 
fingerprints of the native structure (Kelly and Price, 1997; 2000). The position and 
sharpness of near-UV CD bands is influenced by the environment; hydrogen bonding 
usually yields a red shift, which can be up to 7nm, while hydrophobic environments tend to 
sharpen peaks. When an absorbing residue is highly mobile, CD from the different 
orientations will cancel each other (averaging of asymmetric environment) (Bloemendal and 
Johnson, 1995; Kelly and Price, 1997). This can be used to indicate flexibility changes in 
proteins. A slight loosening of a protein structure may not result in any change in solvent 
accessibility to aromatic residues and therefore will not change the maximum fluorescence 
wavelength of tryptophan. Such a change may also be outside the resolution of X-ray 
crystallographic analysis. The resulting change in dynamics of the residue, and hence in the 
asymmetry and detailed interactions with the immediate protein environment, will however 
affect the near-UV CD spectrum, usually quite markedly (Coligan et al., 1997).
Non-protein chromophores or cofactors, such as flavin and haem moieties, may absorb in 
the regions of the spectrum well separated from those of aromatic amino acids or peptide 
bonds giving rise to CD signals which depend on the precise environment of the 
chromophore concerned (Kelly and Price, 1997). If in solution an equilibrium exists between 
two or more conformations, as in the case of dénaturation, the CD gives an average 
indication of the conformational state of the protein. What will be observed, in the case of a 
two state transition, will be a sigmoidal transition that is a characteristic of these structural 
changes.
1.3.2 Fluorescence Spectroscopy
1.3.2.1 Theoretical background
Interaction of photons with molecules results in the promotion of valence electrons from 
ground state orbitals to higher energy level orbitals. Following excitation by absorption of 
energy, a molecule loses energy as heat by cascading through the closely spaced vibronic 
levels of the excited singlets {internal conversion). The molecule remains at the lowest 
vibrational level of the first singlet for a fraction of time because a relatively large amount of 
energy must be lost to go to the ground state. During this interval one of three things may 
happen; the molecule may convert to the triplet {intersystem crossing), it may revert to the 
ground state without emitting a photon, for example by collisional energy transfer to solvent 
or other molecules in the solution {non-radiative transition), or it may return to the ground 
state by emitting the excess energy as light. This process is called fluorescence.
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The fluorescence emission and the non radiative transition are competitive and the 
fluorescence intensity depends upon the relative importance of each process (Lakowicz, 
1983a; van Holde et al., 1998; Sheehan, 2000). Fluorescence spectroscopy provides a 
powerful methodology for investigating the dynamic properties of solutions of biological 
interest. This is because the lifetime of the excited state is long and a broad range of 
interactions can influence this state and thereby the emission spectrum. These interactions 
include: collision with quenchers, rotational and translational diffusion, formation of 
complexes with solvents or solutes, and reorientation of the environment surrounding the 
excited fluorophore.
The fluorescence intensity is often defined in terms of quantum yield, Q (Lakowicz, 1983a; 
van Holde et al., 1998; Sheehan, 2000) :
Q= number of photons emitted / number of photons absorbed
The basic requirement for fluorescence in a molecule is a highly delocalised system of 
electrons in fact most fluorescent molecules are aromatic (but note that not all aromatic 
molecules are fluorescent). Fluorophores are conveniently divided into "intrinsic" (i.e. those 
which are naturally occurring in the biological systems, or are very close analogues of parts 
of the system), and "extrinsic" (i.e. those which are added to the system and have no 
necessary structural relationship to the biological molecules) (Lakowic, 1983a). In both 
categories the fluorophores can be linked covalently or non-covalently to the biological 
system. Two types of factors may affect the intensity of fluorescence, internal and external 
(environmental) influences. Internal factors, such as the number of vibrational levels 
available for transition and the rigidity of the molecules are associated with the properties of 
the fluorescent molecules themselves. The external factors that affect Q give information 
about the macromolecule conformation and molecular interactions between small molecules 
(ligand) and larger biomolecules. Chromophores can be divided into those having a strongly 
polar excited state, in which separation of charge is much larger than in the ground state, 
and apolar fluorophores, in which there is a much more regular electronic distribution in 
both ground and excited states (Weber, 1997). The spectral changes of the first class of 
chromophores (to which the side chain of Trp residue belong- section 1.3.2.2) exhibit 
sensitivity to the environment. There could be two kinds of solvents effects: general and 
specific. General solvent effects depend on the polarizability of the solvent, and an increase 
in the dielectric constant usually shifts the fluorescence to longer wavelength. Specific 
solvent effects are the results of chemical reaction of the excited state with the solvent, 
important chemical reactions include hydrogen-bonding, acid-base chemistry, and the 
formation of a charge transfer complexes where an electron in the fluorophore is transferred 
to another group on excitation (van Holde et al., 1998).
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1.3.2.2 Protein Fluorescence
The fluorescence spectrum of protein is usually dominated by the indole side chain of Trp 
residues, with the Tyr side chain also contributing, though fluorescence from tyrosine side 
chains is normally effectively quenched by energy transfer to Trp (Lakowicz, 1983b).
The fluorescence maximum of Tyr residue remains at 303nm irrespective of its molecular 
environment; the unfolding of proteins containing only Tyr is often accompanied by changes 
in intensity but not in emission wavelength. Decreased Tyr fluorescence in the native state is 
frequently observed. It is thought to originate from hydrogen bonding of the tyrosyi hydroxyl 
group and/or proximity of quenchers, such as disulphide bonds, in the folded state.
The environment of the tryptophan residue can be selectively investigated by exciting the 
protein at a wavelength of 295nm or greater because, at this wavelength, the fluorescence 
emission is essentially due to tryptophan residues (Eftink, 1991). The fluorescence spectrum 
of tryptophan appears to be sensitive to both specific and general solvent effects so, in 
proteins containing Trp residues, both shift in wavelength and changes in intensity are 
generally observed during unfolding. In a hydrophobic environment, such as in the interior of 
a folded protein, Trp emission occurs at lower wavelength (308nm for the deeply buried Trp 
in azurin) and is usually shifted to about 356nm in the unfolded state (Lakowicz, 1983b). 
Fluorescence from other reporter groups, intrinsic or extrinsic, can also be monitored. One 
example of this kind of probes is ANS, that binds non-covalently to proteins interacting 
mainly with hydrophobic surfaces. This probe has been used in protein folding studies to 
characterise structural features of folding intermediates (sections 3.4.2.8 and 9).
1.3.2.3 Binding Studies
The characterization of the ligand-binding interaction is of pivotal interest because the 
function of almost all proteins is related to their ability to bind ligands. Though there are 
several methods that can be used, fluorescence, because it is a solution method, allows us 
to study the effects of varying solution conditions, pH, ionic strength, and temperature.
To study ligand binding by fluorescence spectroscopy (Ward, 1985), it is necessary that a 
change in quantum yield be consequent upon ligand binding, whether one is observing 
ligand fluorescence or intrinsic protein fluorescence. The binding of a ligand to a protein 
affects the fluorescence in different ways: the ligand could act as a quencher (collisional 
mechanism), or it can interact physically with the fluorophore changing its environment or 
accessibility to solvent, or the binding can bring about a conformational change which leads 
to a change in the Trp environment (Eftink, 1997). In this work, the variation of the 
fluorescence intensity of SK on binding substrates has been used to determine their 
dissociation constants (section 2.3).
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1.3.2A  Quenching of Trp Fluorescence
Tryptophan appears to be uniquely sensitive to quenching by a variety of substances. This 
allows the determination of the accessibility of the Trp residue in proteins by quenching 
measurements. Fluorescence quenching can occur by a variety of mechanisms. One of the 
most important is that of collisional quenching which involves physical contact between the 
quencher and an excited indole ring. Certain compounds and ions are known to be 
particularly effective quenchers of fluorescence, usually by forming short lived collisional 
complexes with the excited state; in these complexes the energy of the excited state is 
dissipated as heat. The extent of quenching will not only depend on the nature of the 
quencher, but also on the accessibility of the fluorophores. While small molecules (e.g. 
oxygen) can penetrate via small crevices in the structure to the interior of the protein and so 
can quench the fluorescence of even deeply buried Trp side chains, other larger quenchers, 
such as acryiamide and succinimide, quench to a more limited extent. There is a strong 
relationship between the extent of quenching and the accessibility of the fluorophore (Eftink 
and Ghiron, 1976; 1981). Succinimide has proved particularly useful in this respect, e.g to 
examine the flexibility of the enzyme dehydroquinase (Moore et al., 1993).
In addition to sensing the degree of exposure of the tryptophanyl residues, quenching 
studies can be used to reveal certain details concerning the microenvironment of the Trp 
residues. This can be done by comparing the quenching profiles for a protein obtained 
using quenchers of different charge or polarity. The local concentration of the quencher in 
the vicinity of the fluorophore may, in some cases, be affected by interactions between the 
quencher and the protein, thereby enhancing or reducing the effectiveness of the quencher 
leading to an under- or over-estimation of the exposure of a fluorophore. For example 
charged quenchers, such as iodide and caesium ions, are very suitable for examining the 
nature of the charged environment of fluorophores: a tryptophan that is flanked by positive 
charges (Lys or Arg residues), such as the W54 in SK (Fig. 1.10), might be quenched to a 
much greater degree by an anionic quencher than would normally be expected (Eftink and 
Ghiron, 1981).
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1.3.3 Stopped flow CD and fluorescence
The stopped flow apparatus employs a rapid mixing and detection system that allows early 
events during a reaction to be examined. The dead time of a stopped flow instruments is 
usually of 5 msec (Kelly and Price, 2000). To detect changes, which occur in this time 
range, it is necessary to use low time constants and so, to improve the signal-to-noise ratio 
is then necessary to accumulate a certain number of traces. The high sensitivity and rapid 
response of fluorescence spectroscopy make it an ideal technique for stopped flow studies, 
which have been widely used in studies of protein folding (Eftink and Shastry, 1997). 
Coupling CD to stopped flow systems gives much higher noise and so it is necessary to 
employ low time constants and to accumulate a significant number of individual 
measurements to increase the signal-to-noise ratio (Kelly and Price, 2000). SF-CD data can 
provide useful information about the recovery/loss of secondary structure during the folding 
/unfolding transitions, reporting information over the entire protein, whereas the SF- 
fluorescence data provides information that is specific to the fluorescent sites. For this 
reason the two methods are complementary (Eftink and Shastry, 1997). Fast reactions, 
which occur within the dead time of most stopped-flow instruments, can be detected by the 
existence of “missing amplitude" in a kinetic experiment. SF-CD and fluorescence, 
(including the use of the fluorescent probe ANS; section 3.2 and 3.4.2), make SF a very 
useful approach to detect the accumulation of early transient intermediates in folding 
(Kuwajima et al., 1987 ).
1.4 Aims of the project
The project involved the study of the unfolding and refolding of the enzyme to define the 
refolding pathways and the intermediates involved in this process. For this purpose 
spectroscopic techniques (fluorescence and CD) were used and activity and binding studies 
were undertaken. The refolding pathway was analysed using urea as dénaturant (Chapter 
3) and a study of the effect of salts on the conformation, stability, activity, binding, and 
refolding of SK was undertaken (Chapter 4; Appendix 4.1). Finally some experiments on the 
reactivity of the Lysine 15 side chain were performed to study the reactivity of this important 
side chain at the active site (Appendix 3.1).
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Chapter 2: Materials and Methods
2.1 Enzyme purification
The purification protocol used for purifying the SK from E. crhysanthemi is based on the 
previous purification of the enzyme (Krell et a/., 1997) and was carried out largely by John 
Greene. This method was adapted from the one used for the purification of SK from E. coli 
(Millar et a i, 1986) by reducing the salt concentration so as to prevent protein precipitation. 
After cell breakage, all steps were performed at 4°C, E. coli BL21(DE3) pLysS cells (lOg) 
were resuspended in 10 ml of buffer (20mM Tris/HCI, pH 7.5 containing 0.4mM dithiothreitol 
(DTT) plus one tablet of “Complete™” (Boehringer) to inhibit protease action). Cells were 
broken by two passes through a French pressure cell at 6.9 MPa and the resulting mixture 
was centrifuged at 100,000g for 1h. The supernatant was dialysed for 4h against buffer A 
(20mM Tris-HCI, pH 7.5 containing 0.4mM dithiothreitol and ImM MgCb) and loaded on to a 
pre-equilibrated DEAE-Sephacel anion exchange column (30cm x 2.6 cm diameter, flow 
rate 50 ml/h). The column was then washed with buffer A until the absorbance at 280nm 
was less than 0.1. Elution of shikimate kinase was achieved using a linear gradient of 0-300 
mM KCI in 600 ml buffer A with a flow rate of 50 ml/h and a fraction volume of 14ml. Pooled 
fractions were dialysed against buffer A. Before adding the solution to a Phenyl Sepharose 
CL-4B column (4 x 2cm), solid (NH4 )2 S0 4  was added to 30% saturation (164g/l). The 
solution was stirred for 20min and then centrifuged at 20,000g for 15min. The supernatant 
was loaded onto the column pre-equilibrated in buffer B (lOOmM Tris-HCI, pH 7.5 
containing 0.4mM dithiothreitol and 1.2M (NH4 )2 S0 4 ). The column was washed overnight 
with buffer B at low flow rate (5ml/h) and 10ml fractions were collected. The enzyme was 
eluted using a linear gradient of 400ml 1.2-0.0 M (NH4 )2 S0 4  in buffer B with a flow rate of 
20ml/h and a fraction volume of 10ml. At the end of the gradient the column was washed 
with 250ml of lOOmM Tris-HCI, pH 7.5 containing 0.4mM dithiothreitol until residual 
shikimate kinase had been eluted. Active fractions were dialysed overnight against buffer A 
containing 10% (v/v) glycerol to concentrate the enzyme sample. After this step, the sample 
was loaded on to a pre-equilibrated Sephacryl S200 (superfine grade) column (120cm x 2.5 
cm) and eluted at a flow rate of lOml/h in buffer C (50mM Tris-HCI, pH 7.5 containing 
0.4mM dithiothreitol, 5mM MgCb and 500mM KCI) with a fraction volume of 4ml.
Active fractions were pooled and dialysed overnight against 50mM Tris-HCI, pH 7.5 
containing 0.4mM dithiothreitol, 5mM MgCl2  and 50% (v/v) glycerol. The purified SK was 
stored at -20 “C. Before use, SK was dialysed against buffer D (35mM Tris-HCI, pH 7.6 
containing 5mM KCI, 2.5mM MgCb and 0.4mM dithiothreitol) and used within a two-day 
period. Enzyme activity, fluorescence and CD measurements showed that the protein is 
stable if stored at -20°C in this buffer (section 3.3.1).
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The concentration of SK was determined spectrophotometrically using a value of 0.62 for 
the A2 8 0  of a 1 mg/ml solution in a cuvette of 1cm pathlength. This value was calculated from 
the amino acid composition of the enzyme (Gill and von Hippel, 1989), using the observed 
ratio (1.09) of absorbances in buffer and in 6M GdmCI. This value was within 10% of that 
obtained using the dye-binding method (Bradford, 1976; Sapan et al., 1999). The ratio of 
absorbances at 280nm and 260nm was greater than 1.8, confirming the absence of 
significant contaminant by nucleotide.
2.2 Assay of enzyme activity
The activity of the shikimate kinase was determined by a double-coupled assay involving 
pyruvate kinase (PK) and lactate dehydrogenase (LDH). The production of ADP in the 
shikimate kinase-catalysed reaction leads ultimately to the conversion of NADH to NAD^, 
which is monitored by the decrease in A3 4 0 - The assay was carried out at 25°C in a buffer 
consisting of 50mM triethanolamine hydrochloride containing 50mM KCI and 5mM MgCb, 
titrated to pH 7.2 with KOH (assay buffer). The reaction scheme is shown in figure 2.1. 
Concentrations of the assay components were 1.6mM shikimate, 5mM ATP, ImM PEP, 
0.2mM NADH, 1 unit of each of PK and LDH. Stock solutions of the substrates were stored 
at -20°C after neutralisation with KOH (except NADH prepared fresh daily). Under these 
conditions, the specific activity of the enzyme was 350pmol/min/mg (average of 5 assays).
In order to measure the activity of SK in the presence of dénaturants or salts it was 
necessary to use a quenched assay because of the possible effects of these agents on the 
coupling enzymes (Johnson and Price, 1987). The SK-catalysed reaction was carried out in 
an assay solution containing 5mM ATP, 1.6mM shikimate and the appropriate concentration 
of GdmCI, urea or salts in the assay buffer. The stock solutions of salts used were prepared 
as described in section 2.7. At chosen times, after the start of the reaction, aliquots of this 
solution were diluted 30-fold into a quench mixture containing the appropriate 
concentrations of PEP, NADH, PK and LDH. From the decrease in A3 4 0 , the concentration 
of ADP produced in the SK-catalysed reaction at the chosen times can be determined, and 
hence the rate of this reaction calculated. Controls were performed to check that the 
conditions used had no influence on the coupling enzymes. For these was used an ADP 
stock solution which concentration was controlled spectrophotometrically using the 
absorbance at 260nm ([ADP]= ImM -> A2 6 0  =15). This stock solution was diluted in the 
proper conditions in an “incubation solution” and then assayed. The calculated and 
theoretical values were then compared to check any interference.
The apparent Km values for each substrate, in buffer and in the presence of salts, were
determined as follows: for ATP the concentration of shikimate was maintained at 3mM and
55
the ATP concentration was varied in the range from 0.1 mM to 3mM; for shikimate the 
concentration of ATP was maintained at 5mM and the shikimate concentration varied in the 
range from O.ImM to 4mM. The appropriate range of ATP or shikimate for each salt 
concentration was determined by a preliminary experiment. Kinetic parameters were 
obtained by direct fitting to the hyperbolic saturation curves using Microcal Origin software. 
All the salt and dénaturants used were of analytical grade.
Shikimate + ATP
SK (shikimate Kinase)
Shikimate- 3 - P + ADR , PEP
PK (pyruvate kinase) 
ATP + Pyruvate
NADH
LDH (lactate dehydrogenase)
Lactate + NAD+
Figure 2.1: Double coupled assay scheme
The production of ADP in the shikimate kinase-catalysed reaction leads to the conversion of 
NADH to NAD"^ , which is monitored by the decrease in absorbance at 340nm. The assay was 
carried out at 25°C in assay buffer (50mM triethanolamine hydrochloride containing 50mM 
KCI and 5mM MgClg, pH 7.2).
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2.3 Substrate binding studies
Shikimate kinase undergoes conformational changes upon substrate binding (section
1.2.2.4). This leads to a quenching of the fluorescence intensity (Fig. 3.9) and allows the 
binding of ligands to be studied using fluorescence spectroscopy (section 1.3.2.3).
Assuming equivalent and independent binding sites and a consistent change in 
fluorescence on ligand binding the binding constant can be calculated by means of titration 
of a protein solution with ligands. Considering the binding equilibrium the dissociation 
constant can be expressed as follows:
A X  <=> A  + X
Kd= [A]eq[X]eq/[AX]eq
Were A  is the protein and X  the ligand at the equilibrium. Titrating in conditions where 
[X ] t  »  [A ]t  and so [ X ] t =  [A X ]e q + [X ]ffe e  [X ]free  
Kd can be expressed in this way:
Kd= [A]eq[X]T/[AX]eq [AX]eq= [A],q [X ] t /  Kq (3)
The binding of the ligand causes a change in the fluorescence so:
A F= Fn -  Fo cx:[AX]eq 
AFmax = Ff — F 0 [A ]t
were Fn is the fluorescence intensity after n-addition of ligand, Fo is the initial fluorescence 
and Fmax is the fluorescence of the solution after saturation. So:
A F/AFmax=[AX]eq/ [A ]j
This corresponds to the fraction of protein molecules bound ( [A ]j=  [A]eq+ [AXJgq):
A F/AFmax= [AXleq / [A]eq + [AX]eq
Substituting the (3) in this expression it is obtained:
A F/AFmax = [X ]t /  Kd + [ X ] t
So the plot of 1 “ Fn/Fo vs [X] (M) will give a rectangular hyperbola from which the values of 
Kd and (1- Fmax/Fo) the limiting degree of quenching (between 0 and 1; zero in the case of no 
quenching, and so no detectable binding, and one, in the case of complete quenching) 
could be determined.
Experimentally the binding of substrates (shikimate, ADP and ATP) to SK, monitored by the 
quenching of protein fluorescence (Idziak et al., 1997), was performed by titrations. These 
were carried out using the “CONCENTRATION" mode setting on the Perkin-Elmer LS50B
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spectrofluorimeter (with the parameters modified for the purpose) and adding aliquots of the 
substrate stock solution, usually 10x10p1 of the 10mM stock solution, of shikimate or ADP, 
followed by 3x10pl of the 50mM stock solution, measuring the fluorescence intensity at 
350nm (excitation wavelength 295nm; T= 20°C). The stock solutions of substrates were 
made up in buffer D (35mM Tris-HCI, pH 7.6, 5mM KCI, 2.5mM MgCb, 0.4mM DTT) or in 
buffer E (MOPS - section 2.7). The protein concentration used in the titration experiments 
was in the range 0.04-0.06mg/ml and the volume of the SK solution was 1ml. The results 
were expressed as Kd (dissociation constant) and Qmax (fluorescence of the limiting 
quenching). In the case of ADP or ATP, a correction for the inner filter effect (Ward, 1985) 
was made using a parallel titration with the model compound N-acetyltryptophan amide 
(NATA). Each recorded intensity, Fn, was multiplied by the factor Fo (nata) / Fn (nata), as 
described previously (Price, 1972). The concentration of the NATA stock solution was 
determined spectroscopically noting that a lOOjiiM NATA solution has an absorbance at 
280nm of 0.564. A control experiment was carried out for every set of titration experiments 
when the effects of dénaturants or salts on binding parameters were investigated. The 
dissociation constants were determined by fitting the saturation curve (1- Fn/Fo vs 
[substrate] (M)) to a hyperbolic function (Microcal Origin software) giving the Kd and Qmax 
values.
The binding of substrates (shikimate and ADP) to SK at different salt concentrations was 
monitored by the quenching of protein fluorescence as described before. The solutions 
were made up in the same range of protein concentration in buffer D (0.04-0.06mg/ml) and 
in the presence of the stated concentration of salt or dénaturant. The binding of shikimate 
under these conditions was also measured in the presence of 2mM ADP. In the case of 
ADP, a correction for the inner filter effect was made using a parallel titration with the model 
compound NATA, as described previously. The dissociation constants were determined by 
direct fitting to a hyperbolic saturation curve.
Some of the titration experiments were performed by titrating a protein solution (0.04- 
0.06mg/ml) in the presence of shikimate (2mM) with stock solutions of salts. The instrument 
settings were the same as for the other type of titrations, while the addition of salts was 
usually 10 X 11)^ 1 of the salt stock solution. The concentrations of the salts stock solution 
used are reported in section 2.7.
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2.4 Spectroscopic measurements
Except where indicated, all spectroscopic measurements were made on enzyme samples in 
buffer D (35 mM Tris-HCI, pH 7.6, 5 mM KCI, 2.5 mM MgCb , 0.4mM DTT). Spectroscopic 
measurements, such as CD and Fluorescence used in this work, are widely employed to 
study protein conformation (Price, 2000).
CD spectroscopy is useful to obtain information on the secondary structure and tertiary 
packing (section 1.3.1). The parameter used in CD is As, the molar absorption difference, 
which is directly correlated to normal absorption and follows from the Lambert-Beer law;
As — AA/cd — ( A l- A r ) /  Cd
where C is the concentration in mole/litre (M), d is the pathlength in cm and As is the molar 
absorption differences in M'^  cm'^ between the absorption of left- and right-handed polarized 
light. Thus CD bands can be either positive or negative, depending on which type of light is 
absorbed more strongly. All commercially available CD Instruments measure AA. The 
ellipticity is an angular measure that is related to AA as follows;
0 = 32.98 AA
where 0 is in degrees.
To eliminate the effects of pathlength and concentration, the molar ellipticity (deg. cm^ 
dmol^) is defined as:
[0]x=MRW0/1OdC
where 0 is the observed ellipticity (degrees), d is the pathlength (cm) and C is the 
concentration (g/ml). At any wavelength the relation between the mean residue ellipticity 
and the difference in molar absorbance is:
[Q]x = 100 0/dc = 3298 Ac
(Cantor and Schimmel, 1980; Woody, 1995; Kelly and Price, 2000).
Most CD measurements were made using a Jasco J-600 spectropolarimeter, using cells of 
pathlength 0.05 or 0.5cm and protein concentrations in the range 0.1 to 0.5mg/ml, depending 
on the spectral region. Some CD data were obtained on experimental station 3.1 of the 
CLRC Daresbury Laboratory's Synchrotron Radiation Source (SRS). This facility comprises a 
vacuum-UV 1m Seya-Namioka monochromator, which provides a high flux of linearly 
polarised light in the wavelength range 120 to 300nm, which is converted to circularly 
polarised light (Clarke and Jones, 1999). The SRS CD facility was particularly useful when 
spectra were recorded in the presence of high concentrations of NaCI or urea which absorb
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strongly in the far UV (Kelly and Price, 1997). Spectra were recorded using cells of 
pathlength 0 . 1  or 0 . 0 1  mm and protein concentrations in the range 1 to 2 mg/ml.
The other spectroscopic technique used is Fluorescence spectroscopy (section 1.3.2). 
Fluorescence data were obtained using a Perkin Elmer LS50B spectrofluorimeter and 
protein concentrations in the range 0.1-0.15mg/ml. Protein fluorescence was excited at 
295nm, and emission spectra obtained over the range 300 to 400nm. ANS fluorescence 
was excited at 380nm, and emission spectra obtained over the range 400-600nm. The 
concentration of ANS stock solution was checked spectrophotometrically using a value of
6.0 for the A3 5 0  of a ImM solution in a cuvette of 1cm pathlength (Dodd and Radda, 1968).
The degree of fluorescence quenching of Trp residues is a valuable means of obtaining 
information about the microenvironment and dynamics of the Trp side chain (section
1.3.2.4). The quenching reaction between the excited state of an indole ring, M*, and a 
quencher, Q, can be described by the following scheme:
kd Ki
M +Q <=> (M  Q) M + Q + A
k-d
(M * Q) is the complex formed by diffusional encounter between M* and Q with rate
constant kq. The experimentally observed rate constant for the quenching reaction, kd, is 
equal to y kd, where y is the efficiency of the quenching process. The classical relationship 
often employed to describe the collisional quenching process is the Stern-Volmer equation:
Fo/F=1+Ksv [Q]
Where Fo and F are the fluorescence intensities at an appropriate emission wavelength in 
the absence and presence of quencher, Ksv is the collisional quenching constant (Stern- 
Volmer constant) (Eftink and Ghiron, 1981; 1984). The magnitude of the Stern-Volmer 
constants is a valuable tool for monitoring the environment, mobility and accessibility of the 
Trp side chain. If the quenching yields a linear Stern-Volmer plot, this implies that the 
fluorescence quenching takes place on a simple collisional basis.
The quenching of the intrinsic fluorescence of Trp54 in SK by sodium iodide and 
succinimide in the presence of salts or salts and urea was analysed by Stern-Volmer plots 
(Moore et al., 1993). Sodium iodide was chosen because it is sensitive to the environment 
of the single Trp present in the SK due to the presence of three positively charged arginines 
that surround this residue in the native conformation (Fig. 1.11). The concentration of 
enzyme used for the quenching experiment was about 0.1 mg/ml (1ml). The stock 
concentration of quencher (2M) was made up in buffer D or E, aliquots were added and the 
intensity recorded after each addition (lOplxlO additions). The “CONCENTRATION” mode
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setting was used with the excitation wavelength 295nm, the emission wavelength 350nm 
(band width 3nm; integration time 5sec). To study the effect of dénaturants and salts (over 
the range of quencher concentrations from 0 to 0.2M) the Ksv was measured and the K@v for 
the model compound NATA was calculated to assess the influence of the solution 
conditions on the changes in Ksv The values reported in different solvent conditions were 
corrected for the values obtained for NATA :
Ksv(SK+x) *  Ksv (nata) /  Ksv(nata+x) O f [Fo /Fn  ( F q/ F h )(nata) /  ( F q/ F n) (natacond.x)]-
Stern-Volmer constants (Ksv) were determined from the slope of the Stern-Volmer plot (Fo 
/Fn vs. [Q]) over the quoted range of quencher concentrations.
Light scattering was measured using the Perkin Elmer LS50B spectrofluorimeter with 
excitation and emission wavelengths of 320nm. This measurement gives a qualitative 
indication as to whether aggregation has occurred.
Stopped flow measurements (section 1.3.3) were made using an Applied Photophysics SX- 
17MV apparatus using a 10:1 mixing ratio. The dead times for the fluorescence and CD 
modes have been determined as 1.7ms and 8ms respectively (McClelland and Price, 1998). 
Kinetic analysis was undertaken using the Pro/K software supplied with the instrument. 
Unless otherwise stated, the errors in the amplitudes and rate constants derived were less 
than 10% of the stated values. The concentration of enzyme during refolding was in the 
range 60-110pg/ml in different experiments, with no significant variation in rate constants 
observed over this range.
61
2.5 Unfolding and refolding studies
The unfolding of SK was studied using chemical dénaturation (GdmCI and urea) and the 
changes monitored by far-UV CD (loss of secondary structure) and fluorescence (loss of 
tertiary interactions).
Stock solutions of GdmCI (8M) and urea (10M) (both ultra pure grade) were made by weight 
and the concentration checked measuring the refracting index. To study the unfolding 
process, SK was incubated in the appropriate buffer and in the stated concentration of 
dénaturant for 1h at 20°C, before the CD and fluorescence data were recorded. The 
unfolding was followed by monitoring the change at 222nm in the CD spectra and the 
change at 350nm in the fluorescence spectra (Price et al., 1999). The far-UV CD and 
fluorescence spectra were recorded at 20*C as described in section 2.4. Protein 
concentration was approximately 0.1 mg/ml and pathlength 0.05cm. The results were 
expressed as a percentage of total change of CD or fluorescence signal or as relative 
fluorescence;
%Total change= (Fn-Fo)/(Ff-Fo) *100
Relative Fluorescence= Fn/Fo * 100
where Fn is the signal at a certain concentration of dénaturant, Fo is the signal at zero 
concentration of dénaturant, and Ff is the signal at the higher concentration of dénaturant 
used. A set of experiments was performed including different salts in the Tris buffer and 
another experiment was done using a chloride-free buffer system, namely MOPS, 3-[N- 
Morpholino] propanesulphonic acid. The salts concentrations were chosen to have 
comparable ionic strength, calculated as follows: p = % Cj (section 2.7).
Since many globular proteins that have been found to approach closely a two state 
mechanism this kind of treatment was applied to SK in order to estimate of the free energy 
of stabilisation of native state (Pace, 1986):
N  ^ D  K o =  [D ]e q  /  [N le q
In which only the native state, N and the denatured state, D, are present at significant 
concentrations in the transition region. For a two state mechanism
fn+fd=1 and Y = Ynfn+Ydfd (3)
where Y is the observable parameter, and fn and fd represent the fraction of the protein 
present in the native and denatured states respectively. Combining the equations (3), it 
follows that:
fd= ( Y - Y n ) /  (Y d  -Y n )  and fn=( Y d  - Y ) / ( Y q  -  Y n ) .
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Thus, an equilibrium constant, Kd, and a free energy for unfolding, AGd , can be calculated 
using:
K d  =  =  fd /  f„  =  (  Y  -  Y n )  /  (  Y d  -  Y )
The simplest method of estimating AGd*^ °^ is to assume that the linear dependence of AGd 
on dénaturant concentration observed in the transition region continues to zero 
concentration, i.e. that the data obey an equation of the form:
AGd = AGD^^° -  m (dénaturant) = -RT In K unf
The kinetics of unfolding were determined in manual mixing mode by performing a 1/10 
dilution into a buffer containing 4M urea, and monitoring the unfolding at 350nm 
(fluorescence) after excitation at 295nm.
The refolding was monitored by measuring the regain of the Fluorescence signal at 350nm 
(excitation at 295nm) or the regain of ellipticity at 225nm using both manual mixing and 
stopped flow techniques. When ANS was present in the refolding buffer the fluorescence 
was measured at 480nm (excitation at 380nm).
Refolding was initiated after unfolding in the presence of either 2.8M GdmCI or 4M urea for 1 
hour (protein concentration about 1.1 mg/ml), by dilution with 10 volumes of the specified 
buffer. The residual concentrations of dénaturant were thus 0.25M GdmCI or 0.36M urea 
respectively while the protein concentration was in the range of 0.1 mg/ml after dilution.
Other concentrations of proteins were tested to check for any concentration dependence of 
the refolding reaction. Each refolding curve is an average of at least 3 experiments (in the 
manual mixing mode) and of at least 10 shots in the stopped flow mode. The refolding curves 
were fitted with a single or double exponential as appropriate. The spectra of the start, end 
and refolded solutions were acquired each time.
When appropriate ANS, Nai, shikimate or salts were included in the refolding mixtures at a 
concentration of 40 pM, 0.1M, 2mM respectively and as specified for the salts, and a proper 
control (end point) was prepared in the stated condition.
ANS is used in the refolding experiments (section 3.4.2) to identify compact intermediates, 
especially during the early stages of folding. The ANS stock solution (10 mM) was made up 
in buffer D and its concentration checked spectrophotometrically after a 50-fold dilution as 
described previously (section 2.4). When different conditions were employed controls were 
performed to check the integrity of the protein solution used. In the case of refolding in the 
presence of ANS, spectra in both the Trp and ANS region were acquired.
In the case of refolding in the presence of shikimate the refolding was monitored by 
fluorescence at 330nm and not at 350nm because the fluorescence change at 350nm,
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between the end and start point, was very small due to the shikimate quenching of Trp 
fluorescence (section 3.4.2.5). A control was performed at this wavelength (normal refolding 
without shikimate) in order to show that the kinetics were the same when monitored at 
330nm or 350nm.
In order to study the salt-induced refolding of enzyme in the presence of 4M urea (an ionic 
strength jump), the unfolded enzyme was diluted with 10 volumes of buffer containing 4M 
urea and salt at a concentration of 1.1M for NaCI or D.36M for Na2 S0 4 . After dilution, the 
concentrations of dénaturant and added salts were thus 4M urea and either 1M NaCI or 
Û.33M Na2 S0 4  (to give equivalent ionic strengths).
To monitor the regain of activity during the refolding, an unfolding solution was prepared, 
generally at a protein concentration of 1.1 mg/ml. To start the refolding lOOpI of this solution 
were diluted in 1ml of refolding buffer (buffer D alone or with different concentration of co­
solutes) and the time was started. At different intervals of time 50pl of this solution was 
diluted into 950pl of assay buffer and immediately 20pl of this solution was assayed for 
enzyme activity. In the calculation of the refolding curve the delay due to the mixing and to 
the assay was considered. In these experiments, when appropriate, ANS or Nal were also 
included in the refolding mixtures.
64
2.6 Chemical modification by pyridoxal-5’-phosphate (PLP)
Chemical modification experiments represent one of the means, together with site directed 
mutagenesis, to investigate the role of single amino acid residues in catalysis. Chemical 
modification experiments have been performed on SK, using a lysine specific reagent (PLP) 
to investigate the role of the conserved P-loop lysine (K15) which, using site directed 
mutagenesis, has been demonstrated to have both a catalytic and structural role in SK 
(Krell et al., 2001 - section 1.2.2.2).
The experimental situation considered here is when there is a considerable excess of 
modification reagent with respect to the residues that are modified: under these conditions 
the reaction can be regarded as pseudo-first order. The modification can be monitored 
either by following directly the appearance of product (the pyridoxyl derivatives of lysine 
possess characteristic white-blue fluorescence and they have an absorption maximum at 
325nm with cm= 9710 M'^cm'l) or by following the effect of modification on some parameter 
of the enzyme (e.g. activity), as was done here.
The rate of inactivation, Vmact is given by
Vinact =  - d [ E ] / d t  = k in act[E ]
Rearrangement and integration between the limits 0  and t  for time and E g  and E t  for [ E ]  
gives
ln{[Et]/[Eo]} = “kinactt
where E t  is the activity at time t and E g  is the initial activity. Since l n { [ E t ] / [ E o ] }  is the log of the 
residual activity at any time t, a semi-log plot of log (residual activity) versus time should give 
a straight-line plot, from the slope of which the values of the rate constant of inactivation, ki 
can be determined. This analysis of the time dependence of inactivation assumes that the 
modification process is the only one utilizing the modification reagent. If the reagent is 
subject to a competing process, such as hydrolysis, this process will contribute to a decrease 
in reagent concentration as a function of time.
Pyridoxal phosphate (PLP) has been used in the modification of lysine residues. Generally 
PLP inhibits enzymes by formation of a Schiff base with a reactive Lys residue. This linkage 
is rapidly hydrolysed, so the Schiff base is often trapped by reduction with sodium 
borohydride (NaBH4 ) (Valinger et al., 1993). A number of protocols have been devised for the 
reduction; in the present work the procedure was chosen taking into account the fact that a 
double-coupled assay was used to determine enzyme activity. To set up a reliable method, 
controls and test reactions with and without reduction by NaBH4 were performed. The first 
sets of controls were performed to check the feasibility of this kind of experiment using a 
double-coupled assay (section 3.3.6).
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A control, using a stock solution of ADP was set up (Fig. 2.2). The stock solution of ADP 
(12mM) was diluted so that in a final volume of 2ml (“incubation volume”) the concentration 
of ADP was 8mM. After dilution, the final concentration of ADP in the assay solution was 
20|liM. Three assays were performed: for the first one, performed to check the precision of 
the dilutions, 10p1 of the “incubation” solution was diluted in 30^1 of assay buffer and then 
10pl was assayed (see section 2.2 for details of the assay solution). An experimental value 
of ADP concentration of 22.6pM was obtained, close to the calculated value (20p.M).
The second assay was performed to assess the influence of the NaBH4  (used to reduce the 
PLP-protein complex), on the coupling enzymes. For this purpose 10pl of the 8mM ADP 
solution were mixed with 30^1 of NaBH4 (5mg/ml) and 10pt of this solution assayed. There 
was no detectable activity: this experiment showed that any remaining trace of NaBH4  could 
seriously affect the coupling enzymes.
The third assay was performed to check the influence on the activity of the coupling enzyme 
of an excess of PLP which had not been reduced. For this purpose 50pl of PLP 2mM was 
added to the ADP solution (8mM) and 10pl of this solution mixed with 30|ul of NaBH4  
(5mg/ml). The concentration of ADP determined in this experiment was similar to the 
theoretical one (Fig. 2.2).
A second control experiment was done to check the effect of incubation at room 
temperature and stirring on the SK activity. A solution of SK (0.046mg/ml) was incubated at 
room temperature and assayed at time intervals (Fig. 2.3).
Effect of NaBH4 on the coupling enzymes:
[ADP] in assay solution (theoretical) = 20juM
10|iii in SOjal of assay buffer lOpI in 1ml assay Sol. Assay iA)8mm
ADP
Vf—2mi
+ 50|il PLP 
[PLP]= 2mM
10|Lil in SOfil NaBH4 5mg/ml -> 10^ 1 in 1ml assay Sol. Assay IBI
10^ 1 in 30^ 1 NaBH4 5mg/ml ->10[il in 1ml assay Sol. Assay fC)
Assay fAI : [ADP] measured = 22.Q\M 
Assay fB) : [ADP] measured -  OjiM 
Assay fCI : [ADP] measured = 26.9|4M
Figure 2.2 : First set of controls for the chemical modification experiments.
These controls were performed to check the feasibility of this type of experiment involving a 
double-coupled assay using a stock solution of ADP of known concentration.
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stability of SK upon incubation
[SK] in assay solution = 0.114^g/ml
0.046 mg/ml
Vf”  1 ml ■->10fil in 30pl of a. buffer -> 10pl in 1ml assay Sol.-^ Assays (Time) 
0 269pmol/min/mg
10min -> 254|imol/min/mg 
40min -> 211|j,mol/min/nrig 
60min -> 178^mol/mln/mg
Figure 2.3: Effect of incubation time and stirring on SK activity .
The final control was performed to check the effect of different concentrations of NaBH4 on 
SK activity. Three assays were performed by dilution of 10pl of the SK solution (0.046 
mg/ml) with 30pl of buffer or water containing NaBHi and assaying 10pj of the resulting 
solution (Fig. 2.4). In this case there is an effect on the activity. So an eventual excess of 
NaBK* will have an effect on the SK activity leading, probably, to an overestimation of the 
inactivation, especially for the first data points in the time-course inactivation curve.
Control for the effect of the residual NaBH4 on the activity
[SK] in assay solution = 0.114pg/ml
1) 10^ 1 in 30|xl of assay buffer -> 10|il in 1ml assay Sol.^ Assay (Ai 
_^2) 10^ ,1 in 30|il NaBH4 (10mg/ml)-^10|al in 1ml assay Sol.-> Assay (Bi 
3) 10^ 1 in 30|j,l NaBH4 (5mg/ml) 10|il in 1ml assay Sol."> Assay fC)
Assay (A): Activity: 269pmol/min/mg 
Assay IB): Activity: 151fimol/min/mg 
Assay fCi: Activity: 178pmol/min/mg
0.046 mg/ml
Vf= 1 ml
Figure 2.4: Effect of residual concentration of NaBH4 on SK activity.
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For inactivation experiments SK (0.046mg/ml) was incubated at room temperature (20°C) 
while stirring in test tubes (2ml) protected from the light with metal foil (protection from light 
sources was necessary to avoid photolytic degradation of PLP). Reactions were carried out 
in assay buffer (section 2.2) containing various concentrations of PLP (0.5; 1; 1.4mM). Zero 
time activity was determined by sampling prior to PLP addition; the effect of dilution (by 
addition of PLP) was taken into account. At chosen time intervals, samples (lOfil) were 
added to 30pl of water (non-reduced samples) or to a solution of 5mg/ml of NaBH4 in water 
(reduced samples), mixed, and immediately assayed (lOpI of the resulting solution in 1ml of 
assay solution).
Some equilibrium protection experiments were carried out to check the effect of ligand 
binding on the inactivation reaction (Chen and Engel, 1974 ;1975). The effect of ligands on 
inactivation of SK by PLP was investigated by incubating the enzyme with PLP (1.4mM) in 
the presence of certain concentration of ligands (2mM shikimate, 2mMATP or 2mM ADP; 
2mM shikimate and 2mM ADP; 2mM shikimate and 0.1 M NaF). The zero-time activity was 
measured on the sample, containing the ligand, before the addition of PLP.
2.7 Studies of SK in the absence of chloride ions
In order to assess the effect of low concentrations of chloride on the conformational stability 
and function of the enzyme, some studies were performed in a chloride-free buffer (Buffer 
E), consisting of 60mM MOPS (3-[N-Morpholino]propanesulphonic acid), pH 7.6, containing 
2.5mM K2SO4, 2.5mM MgS0 4  and 0.4mM dithiothreitol. A range of unfolding, refolding 
studies and binding experiments were carried out in this buffer.
The salts and the concentration of the stock solutions used were: NaCI (6M), Na2 S0 4 (1 M), 
NaF (1M). KOI (4M), MgS0 4  (2.5M), NaBr (5M), CaClz (2.5M), MgCL (1M), Ca(N0 3 ) 2  
(2.5M), NaNGs (5M). All the salts used were of analytical grade and the stock solutions 
were prepared by weight.
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Chapter 3: The folding of type II shikimate kinase
3.1 Abstract
Shikimate kinase was chosen as a convenient representative example of the subclass of 
a/(3 proteins with which to examine the mechanism of protein folding (section 1.2.2.5).
A study of the unfolding and refolding of the type II SK, using studies of CD, protein 
fluorescence, activity and ANS fluorescence, and employing both manual mixing and 
rapid reaction techniques (sections 1.3.1-1.3.3) has been undertaken. The secondary 
structure content in solution was determined analysing CD data acquired over a more 
extended range of wavelengths using the SRS CD facility (section 3.3.1.1). When excited 
at 295nm, the fluorescence emission maximum of SK is 346nm, indicating that the single 
Trp (W54) is significantly exposed to the solvent, a conclusion consistent with the high 
value of the Stern-Volmer constant for quenching of the fluorescence by succinimide 
(Idziak et al., 1997). For quenching experiments the quenching agents used were both 
succinimide and Nal, the latter giving information on the charged Trp environment 
(section 3.3.6) and providing reference values of Ksv when Nal was used in the refolding 
experiments (sections 3.4.1.4 and 3.4.2.6). When incubated in 4M GdmCI or 6 M urea, 
the fluorescence emission maximum shifts to 356nm, indicating that the Trp has become 
completely exposed to solvent, and there is a complete loss of secondary structure, with 
the ellipticity at 225nm reduced to less than 10% of the value characteristic of native 
enzyme. The equilibrium unfolding was performed both with SK alone and in the 
presence of shikimate (sections 3.3.2 and 3.3.3) and using both guanidinium chloride 
(GdmCI) and urea as denaturing agents. For both the dénaturants used the unfolding 
curves were analysed in terms of the 2-state model and the stability of the folded state 
could be estimated as 17 kJ/mol. The activity (section 3.3.1.2 and 3.3.5) and the 
dissociation constants (Kd) for substrates (sections 3.3.1.2 and 3.3.4) were also studied in 
the presence of dénaturants. Differences were found between the two dénaturants used, 
especially when comparing the variation of the activity profile or the Kd with the 
dénaturant concentration and the degree of unfolding measured by CD and fluorescence. 
This led to subsequent studies on the effects of different salts on the enzyme activity, 
binding of ligands, structure and folding kinetics (Chapter 4). The refolding experiments 
were at first carried out using GdmCI as dénaturant (section 3.4.1). Due to the high extent 
of aggregation, highlighted by elevated light scattering during the refolding and by the 
anomalous pattern of the refolding in the presence of ANS (section 3.4.1.5), urea was 
used for further characterisation of the refolding kinetics (section 3.4.2). On the basis of 
these results a model of folding pathway was proposed (section 3.4.2.10). The relevance 
of the results to the folding of other a/(3 domain proteins is discussed (section 3.4.2.11).
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3.2 Introduction
The determination of the secondary structure content in solution reflects the conformation 
of the protein under the actual experimental conditions; analysis of the CD spectrum in 
the far-UV region gives this estimation (section 1.3.1.2). To facilitate a reliable analysis, 
especially of the p-sheet content, it is very useful to obtain a good signal-to-noise ratio 
below 184nm. This is not always possible with commercial spectropolarimeters because, 
in this region, several components used in the most common buffer systems absorb 
strongly. Data below 200nm can be obtained using a bright light source (synchrotron 
radiation), and for this purpose the SRS facility in Daresbury (section 3.3.1.1) has been 
used. The effects of the storage conditions on the activity and conformation of the 
enzyme have been investigated to find the best storage conditions to avoid experimental 
artefacts (section 3.3.1.3). Shikimate kinase, as other kinases, is thought to undergo 
conformational changes upon substrate binding (hinge bending movements - section
1.2.2.4). The conformational changes can be investigated by studying the binding of 
substrate (section 1.3.2.3). Because the binding of shikimate, ADP and ATP give a 
quenching of the intrinsic Trp fluorescence (W 54), this can be used to calculate the Kd by 
titration (sections 2.3; 3.3.1.2 and 3.3.4).
The study of the unfolding transition should be undertaken before studying the refolding 
reaction; it gives information on the eventual existence of stable intermediates in the 
unfolding process, provides an estimation of the stability of the enzyme and allows a 
determination of the conditions to use in the refolding experiment. The unfolding was 
measured following the CD change at 222nm, the fluorescence at 350nm and the change 
in the ratio F3 5 5 /F3 3 7  (used to measure the degree of exposure of Trp because of the 
change in emission maxima). The ratio F3 5 5 /F3 3 7  has the advantage of being independent 
of small variations of protein concentration between different experiments and reflects 
mainly the shifts in emission maxima upon dénaturation or varied solvent composition, 
due to changes in polarity of the local environment surrounding tryptophan (Kleppe et al.,
1999). The unfolding transition has been studied using two dénaturants, GdmCI and urea, 
with different chemical properties. In some cases estimates of protein stability obtained 
using both dénaturants has revealed mechanistic differences (Gianni et a!., 2 0 0 1 ) or has 
revealed insights on the properties of intermediates on the unfolding pathway (Hung and 
Chang, 2001). It has been suggested that these differences depend on the electrostatic 
and hydrophobic interactions in the particular protein. In fact urea, apart from the 
hydrogen bond breaking effect, also acts on hydrophobic bonds, while ions arising from 
GdmCI modulate electrostatic interactions. The chemical dénaturation was also 
performed in the presence of substrate (section 3.3.3). This together with the data on the 
dissociation constants (Kd) of substrates and activity measurements in the presence of
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dénaturants (or salts) permit the possibility of quantifying the effects of these co-solvents 
on the active site and can give useful information about the kind of interactions 
responsible for binding substrates. These kinds of experiments can give useful insights 
into the unfolding process; for many proteins it has been demonstrated that the presence 
of the substrate protects the enzymes against chemical or thermal dénaturation 
(Kleanthous et a i, 1991; Ribas de Pouplana et a i, 1991) while other reports (Wang et ai,
2000) have shown that during the dénaturation of a number of enzymes by GdmCI, urea 
or heat, inactivation occurs before noticeable conformational changes of the enzyme 
molecule as a whole can be detected. It was suggested in these cases that the active site 
of the enzyme is usually situated in a limited region of the molecule that is more flexible 
than the enzyme as a whole (Tsou, 1986; 1993).
The refolding studies involved the study of the folding kinetics using CD and fluorescence 
with manual and rapid mixing techniques and the kinetics of refolding were monitored by 
activity, amide CD, intrinsic fluorescence, ANS fluorescence and changes In fluorescence 
due to binding of ligands. This allows one to monitor, respectively, the regain of the 
specific three-dimensional structure of the active site, the generation of the backbone 
conformation, burial of aromatic groups in the interior of the protein, formation of compact 
intermediates and formation of the substrate binding site (McClelland and Price, 1997). 
Finally the use of Nal, a quencher the Trp fluorescence (section 2.4), in the refolding 
buffer allowed an assessment of the regain of the charged Trp environment.
The P-loop lysine (K16) is one of the conserved residues In the family to which SK 
belongs and is involved in the binding of nucleotide (section 1.2.2). On the way to 
investigate the importance of a residue for catalysis is by chemical modification. 
Experiments on SK carried out using TNBS (2,4,6-trinitrobenzenesulphonic acid) as 
modifier showed an enhanced chemical reactivity toward this compound, with a second 
order rate constant of inactivation calculated as 6.15 X 10"^  M'^min'^ (Krell et al., 2001). 
This seems to be due to the proximity of the side chain of C13 to K15, with the formation 
of an ion pair between these residues. It was suggested that the TNBS cause a rapid 
modification of C l 3 followed by intramolecular transfer of the TNBS group to the lysine 
residue (Krell et a i, 2001). Though TNBS is a reagent selective toward the a and y amino 
group, some reaction with the sulphydryl group may occur. The use of PLP (pyridoxal-5’- 
phosphate) seemed to be a good solution to this problem, this reagent being more lysine- 
specific than TNBS; in fact the reaction with the Cys SH group would form an 
hemithioacetal, an unstable compound rapidly hydrolysed in an aqueous environment. 
For this reason some preliminary experiments of chemical modification using PLP as 
modifier were carried out (Appendix 3.1).
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3.3 Unfolding of the enzyme
3.3.1 Conformation of the enzyme in solution, kinetic parameters and aggregation
3.3.1.1 SK circular dichroism spectra
The far-UV CD spectrum of SK in buffer D (35mM Tris-HCI, pH 7.6, 5mM KCi, 2.5mM 
MgCh, 0.4mM DTT) in the absence of dénaturants shows pronounced double minima at 
208nm and 222nm and a maximum at 193nm (Fig. 3.1a). An initial analysis of the spectrum 
over the range 240nm to 195nm by the CONTIN procedure (Provencher and Glockner, 
1981) gave 28% a-helix, 34% (3-sheet, 15% turn and 23% remainder, while using the 
SELCON procedure (Sreerama and Woody, 1993) over this range of wavelengths, the 
values were 30% a-helix, 19% (3-sheet, 21% turn and 30% remainder (Krell et ai, 1998).
A possible reason for the discrepancy between these estimates and those obtained from X- 
ray crystallography (50% a-helix and 13% p-sheet) could be that the analysis was carried 
over a restricted range of wavelengths. By analysing CD data (Figure 3.2) acquired over a 
more extended range of wavelengths (260nm to 178nm) at the SRS CD facility, using the 
SELCON procedure (Sreerama and Woody, 1993) the secondary structure content was 
estimated as 41% a-helix, 15% p-sheet, 17% turn and 27% remainder (section 1.3.1.2). 
These values are in closer accord with the crystallographic data.
The chloride-free buffer M O P S  (50 mM 3-[N-Morpholino] propanesulfonic acid, pH 7.6, 
containing 2.5 mM K2SO4, 2.5 mM MgS0 4  and 0.4mM dithiothreitol - section 2.7) was used 
to assess the effect of the relatively low chloride concentration in buffer D on the structure 
and kinetic parameters of the enzyme. CD spectra in the far and near-UV region were 
acquired to check that no conformational changes were due to the change of buffer (Fig. 
3.1a,b). No major differences were observed in the fluorescence spectra as is shown from 
the comparison between the normalised fluorescence spectra (Fig. 3.3). The normalisation 
(Fn/Faso) was necessary in order to compare results obtained on different days from S K  
solutions at slightly different concentrations. These data indicate that there are no 
differences in the overall secondary and tertiary structure in the chloride-free buffer.
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Figure 3.1 : Comparison of the far- (a) and near- (b) UV CD spectra in Tris and MOPS
Spectra were recorded at 20°C using samples dissolved in buffer D (35 mM Tris-HCI, pH 7.6, 
containing 5 mM KCI, 2.5 mM MgCb and 0.4mM dithiothreitol) or in buffer MOPS (50 mM 3- 
[N-Morpholino] propanesulfonic acid, pH 7.6, containing 2.5 mM K2SO4, 2.5 mM MgS0 4  and 
0.4mM dithiothreitol). (a) Far-UV CD spectra. The protein concentration was 0.15mg/ml and 
the cell pathlength 0.05cm; (b) Near-UV CD spectra. The protein concentration was 
0.5mg/ml and the cell pathlength 0.5cm. Black line: SK in Tris buffer; Red line: SK in MOPS 
buffer; Blue line ((a) only): SK in Tris after storage.
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Figure 3.2; The far UV CD spectrum of SK.
The spectrum was recorded in buffer D (35 mM Tris-HCI, pH 7.6, containing 5 mM KCi, 2.5 
mM MgCb and 0.4mM dithiothreitol) using the Daresbury SRS CD facility at a protein 
concentration of 2 mg/ml and a cell of path length 0 .0 1 mm.
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Figure 3.3: Normalised fluorescence spectra (Fn/Faso) in Tris-HCI and MOPS
Spectra were recorded at 20°C using samples dissolved in buffer D (35 mM Tris-HCI, pH 7.6, 
containing 5 mM KCI, 2.5 mM MgC^and 0.4mM dithiothreitol) or in buffer MOPS (50 mM 3- 
[N-Morpholino] propanesulfonic acid, pH 7.6, containing 2.5 mM K2SO4, 2.5 mM MgS0 4  and 
0.4mM dithiothreitol) and protein concentration 0.15mg/ml.
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3.3.1.2 Specific activity and kinetic parameters.
The specific activity in buffer D was determined as 350|Amol/min/mg (average of 5 assays). 
The activity of SK measured in MOPS buffer was within 10% of the activity of enzyme 
stored under the same conditions in Tris-HCI buffer.
The Kd for shikimate (in the absence and in the presence of 2mM ADP), for ADP and ATP, 
were determined by titration (section 2.3); the reported values are the averages of at least 6  
experiments (Table 3.1- Figure 3.4). The apparent Km values for shikimate and ATP (Table
3.1) were determined as described in section 2.2.
A substantial difference between Tris-HCI and MOPS is observed in the binding of 
shikimate (Fig. 3.4a) that seems to be stronger in MOPS than in Tris-HCI with the value of 
Kd being reduced from 0.6mM (Tris-HCI) to 0.22mM (MOPS) (Table 3.1). This seems to be 
due to the presence of chloride ions. In fact the value of Kd is restored to the value found in 
Tris-HCI if the chloride concentration present in the Tris buffer is restored by adding 45mM 
NaCI to the MOPS buffer (Fig. 3.4a). Moreover, this effect is dependent on the chloride 
concentration, as is demonstrated by the higher values of the Kd obtained in the presence of 
lOOmM NaCI (Table 3.1). The binding of shikimate in Tris-HCI buffer, is strengthened by the 
presence of 2mM ADP, but when similar titrations were performed in a chloride-free buffer 
(MOPS) this synergism was no longer observed; the Kd value is changed from 0.25mM to 
0.36mM in the presence of ADP. Interestingly this effect appears to be due to the presence 
of chloride ions, which weaken the binding of shikimate. In chapter 4 there will be reported 
data that demonstrate that this effect of NaCI is reversed, to some extent, by the presence 
of ADP giving a decrease of the Kd.
The binding of ADP does not appear to be influenced by the change of buffer the Kd values 
being 1.71mM and 2.16mM in Tris-HCI and MOPS respectively (Fig. 3.4b; Table 3.1).
The ATP binding is affected to a certain extent with the Kd value changing from 2.58mM 
(Tris-HCI) to 1.41mM (MOPS) and this difference is not dependent on the chloride ion 
concentration (Fig. 3.6; Table 3.1). An initial analysis of the data indicated that the binding 
of ATP was affected by the presence of both sulphate and chloride ions. In figure 3.4c the 
ATP binding curves, both in Tris-HCI and in MOPS buffer, are fitted with a hyperbolic 
function though the best fit in the both cases is obtained with a sigmoidal curve. The curve 
in MOPS plus 45mM NaCI gives instead a good hyperbolic fitting. These findings prompted 
a more detailed study of the effects of salts on ATP binding which will be discussed in 
section 4.4.
The nucleotide binding to SK occurs with relatively low affinity, as shown by the Km (ATP) 
and by direct measurement of Kd (ATP) by the fluorescence quenching technique.
This indicates, in general, that the sites are relatively “open” when binding nucleotide.
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Ligand Buffer Kd (mM) Km (mM)
Shikimate Tris-HCI
Tris-HCI + 2mM ADP 
MOPS
MOPS + 2mM ADP 
MOPS + 45 mM NaCI 
MOPS + lOOmM NaCI
0.60 ± 0.02 
0.38 ± 0.02 
0.25 ± 0.01 
0.36 ± 0.01 
0.43 ± 0.02 
0.86 ± 0.03
0.134 ±0.02
ATP Tris-HCI
MOPS
MOPS + 45mM NaCI
2.58 ±0.51 
1.41 ±0 .19  
1.47 ±0 .18
0.266 ± 0.02
ADP Tris-HCI
MOPS
1.71 ±0.1 
2.16 ±0.1
Table 3.1: Kinetic and binding parameters of shikimate kinase
Km values were calculated using a hyperbolic fitting to the Michaelis-Menten equation. The 
assay conditions used are described in section 2.2 and the assay mix contained 5mM ATP 
and 3mM shikimate for Km (shikimate) and Km (ATP) respectively. Kd values were determined 
using fluorescence quenching experiments as described in section 2.3.
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Figure 3.4: Binding of substrates determined by fluorescence quenching experiments.
Aliquots of the substrate stock solution were added (10x10p.l of the 10mM stock solution 
followed by 3x1 OpI of the 50mM stock solution) and the fluorescence intensity (T= 20°) at 
350nm was measured after every addition after excitation at 295nm. The protein 
concentration was in the range 0.04-0.06mg/ml. The dissociation constants were 
determined by fitting the saturation curve to a hyperbolic function giving the K<j and Qmax 
values.
a) shikimate titrations: MOPS (black), Tris (red) and MOPS + 45 mM NaCI (blue).
b) ADP titrations:MOPS (black), Tris (red)
c) ATP titrations: MOPS (black). Tris (red) and MOPS + 45 mM NaCI (blue).
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3.3.1.3 Protein Stability
The protein used for the experiments was generally freshly dialysed against buffer; frozen 
samples being used only occasionally. The stability of SK was investigated under different 
conditions and using a variety of measurements. For the measurements of the SK stability 
on storage at -20°C using activity, aliquots of an enzyme preparation were frozen and 
assayed after different periods of storage. Table 3.2 reports the activity values at different 
times of storage: further investigation should be undertaken to check for the observed 
increase irr activity. After prolonged storage (45 days) at -20°C, there are no significant 
differences in the far-UV CD spectrum (Fig. 3.1a), in the fluorescence spectrum or in the 
binding parameters as well (the binding values acquired after storage were within 1 0 % of 
the values obtained for the freshly prepared sample). The effect of incubation of protein 
solution at room temperature was also investigated. Spectra were acquired of a protein 
solution freshly dialysed and after Incubation. There is a decrease in fluorescence intensity 
at 350nm with time of 6 % after 45 min of incubation and 14% after two hours. In a further 
experiment, the effect of incubating a concentrated solution of SK at room temperature was 
investigated. After storage for 10 hours at room temperature the spectra were acquired of
the protein solution at two different concentrations. Though the more concentrated solution
has a lower intensity compared to the more diluted solution (Figure 3.5a), they have the 
same emission maxima. Comparison of these normalised spectra with that of freshly 
prepared SK shows that a shift of the maximum wavelength of 8 nm has occurred indicative 
of a partial unfolding (Figure 3.5b). Increasing the concentration of the SK lead to an 
increase in aggregation, as shown by the A 3 1 0  values which represent light scattering:
[SK] = 0.1 mg/ml -> A 3 1 0 = 0.022
[SK] = 0.68mg/ml -> A 3 1 0 = 0.043
[SK] = 2.06mg/ml -> A 3 1 0 =  0.30
Assayed Activity ((imol/min/mg)
Same Day 396/350*
After 1 day storage 375
After 4 days storage 383
After 10 day storage 328
After 11 day storage 445
After 14 day storage 489
Table 3.2: Stability measurements. Activity
The assay was carried out at 25°C in a buffer consisting of 50mM triethanolamine 
hydrochloride containing 50mM KCI and 5mM MgCb, titrated to pH 7.2 with KOH (assay 
buffer). The concentrations of the assay components were 1.6mM shikimate, 5mM ATP, 
ImM PEP, 0.2mM NADH, 1 unit of each of PK and LDH. The protein concentration in assay 
solution was O.lpg/ml. (*) average value of 5 assays.
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Figure 3.5: Fluorescence spectra effect of storage at room temperature (20°C)
The spectra were recorded at 20°C using samples dissolved in buffer D (35 mM Tris-HCI, pH 
7.6, containing 5 mM KCI, 2.5 mM MgCl2 and 0.4mM dithiothreitol). The data show:
a) Fluorescence spectra after storage at room temperature (20°C); black line: 0.1 mg/ml 
SK; grey line: 0.05mg/ml SK.
b) Normalised fluorescence spectra: effect of storage at room temperature (20°C). 
Protein concentration 0.1 mg/ml: black line: SK fresh prepared; grey line: SK stored at 
20°C.
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3.3.2 Equilibrium Unfolding with GdmCI and Urea
The unfolding of SK was examined using the dénaturants GdmCI and urea as described in 
section 2.5. Losses of secondary and tertiary structure were monitored by changes in far- 
UV CD at 222nm and fluorescence at 350nm (excitation at 295nm) respectively. The 
change in the ratio F355/F337, which reflects the change in emission maxima (section 3.1), is 
reported as well. Figure 3.6 shows the dénaturation curves obtained from different sets of 
experiments.
The unfolding data for SK could be analysed satisfactorily in terms of a 2-state model 
(Pace, 1986; section 2.5) for both dénaturants used: the coincidence of different structural 
probes suggests that no intermediate species were populated to any significant extent. 
From the plot of free energy change against dénaturant concentration the stability of native 
enzyme in the absence of dénaturant could be estimated as 17+1 kJ/mol with no significant 
difference in stability observed between the two dénaturants employed (Figure 3.7).
The value of the stability is towards the lower end of those observed for a range of globular 
proteins (Pace, 1990), but is similar to the value estimated for the structurally similar 
enzyme adenylate kinase (19.6 kJ/mol) from studies of its unfolding by urea (Zhang et al., 
1998).
The unfolding was carried out in the chloride free buffer MOPS as well (50 mM 3-[N- 
Morpholino] propanesulfonic acid, pH 7.6, containing 2.5 mM K2 SO4 , 2.5 mM MgS0 4  and 
0.4mM dithiothreitol). In this buffer system there is a small stabilisation against urea 
dénaturation, as shown in figures 3.8a and b, probably due to the presence of sulphate 
anions as buffer constituents. In fact, as will be described in section 4.8, the sulphate 
stabilise more than chloride anions toward urea dénaturation.
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Figure 3.7; The unfolding of SK in the presence of urea and GdmCI.
The structural changes were monitored by changes in ellipticity at 222nm (triangles) and 
protein fluorescence at 350nm (squares) as described in the text.The open and filled 
symbols refer to urea and GdmCI respectively. The estimation of AGo""° was done assuming 
the linear dependence of AGd on dénaturant concentration (AGd = AGo"^ -  m (dénaturant) 
= -RT In K unf) as described in section 2.5. The average m values for urea and GdmCI are respectively 7830 and 1294 j/mol^.
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Figure 3.8: Urea dénaturation in MOPS buffer.
SK (0.15mg/ml) was incubated in the appropriate buffer and in the stated concentration of 
dénaturant for 1h at 20°C fluorescence data were recorded (section 2.5). The data show:
a) The unfolding curves in MOPS (black) and Tris (red) respectively.
b )  The change in the ratio F 3 5 5 / F 3 3 7  (triangles) (these reflect the shift in the emission 
maximum of the fluorescence spectra).
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3.3.3 Dénaturation of SK in the presence of substrates
The binding of a ligand can influence the fluorescence of Trp by different mechanisms 
(Eftink, 1997). The ligand can act as a quencher (by collisional or energy transfer 
mechanism), it can physically interact with the fluorophore changing the polarity of its 
environment and/or its accessibility to the solvent or it can bind at a site that is remote from 
the Trp residue and may induce a change in conformation that alters the Trp 
microenvironment. It has been previously reported that the addition of shikimate leads to 
quenching of SK fluorescence (Idziak et al., 1997) (Fig. 3.9). To make a comparison 
between the spectra in the presence and in the absence of substrate the spectra were 
normalised (Fn/Fsso)- Because after normalisation (Fp/Faso) no shift in the À^ ax of the 
fluorescence spectra is observed, it is possible that shikimate acts merely as a quencher 
without altering the Trp environment. This is also suggested by the CD near-UV spectrum in 
the presence of shikimate that shows no major differences from the spectrum in the 
absence of substrate (Fig.3.10).
When the enzyme was incubated with increasing concentrations of dénaturants in the 
presence of shikimate (2mM), although no stabilization against chemical dénaturation was 
observed, the changes in fluorescence showed an unusual pattern (Fig. 3.11). GdmCI at 
concentrations below 1M leads to a marked increase in fluorescence; under these 
conditions there are only very small effects on the overall secondary structure of the 
enzyme as judged by far-UV CD. The changes observed in the presence of urea are by 
contrast much less marked.
Other studies on different enzymes have shown that during dénaturation inactivation occurs 
before noticeable conformational changes can be detected (Ribas de Pouplana et a!., 1991 ; 
Wang et al., 2000) suggesting that the enzyme active site is situated in a more flexible 
region than the enzyme molecule as a whole. In order to check if the observed effects were 
due to a local unfolding of the shikimate binding site or to the effects of ionic strength on the 
binding, spectra were acquired at different concentrations of NaCI in the presence of 
shikimate. NaCI was chosen because it is a neutral salt in the Hofmeister series (section
4.2) and it should not have any effect on protein conformation, as was experimentally 
confirmed (section 4.3). Although there is a relief of quenching (an enhancement of 
fluorescence) at low concentrations of both dénaturants, the magnitude of this effect is 
different for GdmCI and urea. Moreover the shape of the first part of the dénaturation curve 
obtained with GdmCI resembles that obtained in the presence of different concentrations of 
NaCI suggesting that the main effect on the shikimate binding is due to the ionic strength 
(Figure 3.11). To complete the study of the unfolding process and of the effect of dénaturant 
on protein structure, the changes in activity and dissociation constants have been studied in 
the presence of different concentrations of dénaturants (section 3.3.4 and 3.3.5).
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Figure 3.9: Quenching of the fluorescence due to the presence of shikimate
Spectra of SK (0.15mg/ml) were recorded at 20°C using samples dissolved in buffer D (35 
mM Tris-HCI, pH 7.6, containing 5 mM KCI, 2.5 mM MgCb and 0.4mM dithiothreitol) or in 
buffer D + 2mM shikimate. The data reports in black SK and in red SK in the presence of 
shikimate.
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Figure 3.10: Effect of shikimate on the near-UV CD spectrum of SK.. Near UV spectra, 
protein concentration 0.5mg/ml, cell pathlength 0.5cm. The black and the red lines refer 
to enzyme in the absence of shikimate and in the presence of 2mM shikimate.
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Figure 3.11: Unfolding of SK in the presence of shikimate.
SK (0.15mg/ml) was incubated in the appropriate buffer containing 2mM shikimate and in the 
stated concentration of dénaturant or NaCI for 1 h at 20°C, before the fluorescence data were 
recorded (section 2.5). The data shows: changes in the fluorescence intensity at 350nm in 
the presence respectively of GdmCI (squares), urea (triangles) and NaCI (circles).
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3.3.4 Changes in of substrates In the presence of dénaturants
The decrease in fluorescence intensity accompanying the binding of ligands can be used to 
measure the dissociation constant of the binding (Kd) and the limiting degree of quenching. 
This is carried out by performing a titration of the protein solution with substrates and 
correcting the data for the volume changes during the titration (section 2.3).
By performing titrations with shikimate in the presence of fixed concentrations of GdmCI and 
urea, after 1-hour incubation, the variation in Kd for the substrate could be assessed. The 
results are shown in Fig. 3.12a and confirm the smaller effect of urea on the binding of 
shikimate. Control experiments performed at different concentrations of NaCI shows that an 
increase in the ionic strength weakens the binding of shikimate in a similar manner to low 
concentrations of GdmCI. This could indicate that the change in ionic strength has the 
largest effect on shikimate binding. To check this hypothesis titrations with different salts 
were performed (section 4.4).
The same type of titrations were carried out to study the binding of ADP correcting the 
intensity values for the inner filter effect using a reference compound (NATA). The results 
indicate that whereas there is a small increase in the Kd for ADP in the presence of 1M 
urea, the effects of GdmCI and NaCI are to decrease the Kd to a limited extent (Fig. 3.12b). 
However, it should be noted that the accuracy of the estimates of Kd at concentrations of 
GdmCI or NaCI above 0.25M was seriously affected by the marked reduction in the degree 
of quenching by the nucleotide under these conditions (from 55% quenching in the absence 
of GdmCI or NaCI to less than 25% quenching in the presence of 0.5M GdmCI or NaCI). 
The effects of urea appear to be more marked in the case of the ADP binding than for the 
shikimate. In fact there is a drastic increase of the Kd at low urea concentrations (from 1.71 
to 4.52mM in 1.5M urea). The discrepancy between the effects of the two dénaturants on 
the Kd of the substrates can suggest that, while in shikimate binding electrostatic 
interactions play a major role, in nucleotide binding the main factor is hydrophobic 
interactions, accounting for the larger effect of urea on the ADP binding.
The data obtained in this section together with the later study on the effect of salts on the 
binding of ligands (section 4.4) and a re-analysis of the crystallographic data using the final 
model (1SHK), that has led to the identification of specific chloride binding sites on the 
enzyme, could explain why in the crystallographic structure there is only a weak intensity for 
shikimate though both shikimate and ADP were present in the crystallization medium. At the 
NaCI concentration in question no binding of shikimate would be expected but, as explained 
in chapter 4, the simultaneous presence of ADP leads to a partial reversal of the effect of 
chloride that could explain the weak binding of shikimate observed in the X-ray studies. This 
will be discussed in more detail in Chapter 4.
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Figure 3.12: The effect of dénaturants and NaCI on the binding of substrates to SK.
Binding data were obtained and analysed as described in section 2.3. Changes in the Kd for 
shikimate (a) and ADP (b) are shown in the presence of GdmCI (squares), urea (triangles) 
and NaCI (circles).
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3.3.5 Changes of activity in the presence of dénaturants
Incubation with GdmCI leads to a marked loss of activity of SK. In the presence of 0.5M 
GdmCI over 75% activity is lost and less than 5% activity remains in the presence of 1M 
GdmCI. These changes occur at concentrations of dénaturant at which the change is less 
than 20% of the total observed for fluorescence and less than 10% of the total observed for 
CD. Incubation with urea leads to much less marked losses in activity which run roughly in 
parallel with the structural changes, with approximately 85% and 40% activity retained in the 
presence of 1M and 2M urea respectively. In the presence of 4M urea, shikimate kinase 
retains no detectable activity (<0.1% of the control value). A significant part of the effect of 
GdmCI appears to be due to the chloride ions, since incubation in the presence of 0.5M and 
1M NaCI leads to losses of 45% and 65% activity respectively (Fig. 3.13).
The effect of NaCI on the activity and binding resembles that of GdmCI suggesting that the 
ionic strength has a major contribution to the inactivation and in the weakening of binding of 
substrates. Since NaCI at these concentrations has little effect on the far-UV CD, or on the 
fluorescence of SK, as is shown in chapter 4, the ionic strength effects must be localised to 
the area of the shikimate binding site. The effect of NaCI and other salts on the stability and 
activity of SK will be discussed in detail in Chapter 4.
In summary, the loss of enzyme activity and the weakening of shikimate binding occur at 
much lower concentrations of GdmCI than do the overall losses of secondary and tertiary 
structure of the enzyme. This appears to be due to local effects of ionic strength in the area 
of the shikimate binding site. By contrast the loss of activity in the presence of urea occurs 
in the range of dénaturant concentrations over which the major structural changes take 
place.
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Figure 3.13: Effect on the activity of dénaturants and NaCI.
A quenched assay was used in order to measure the activity of SK in the presence of 
dénaturants as described in section 2.2.The data shows the effects on activity of GdmCI 
(squares), urea (triangles) and NaCI (circles).
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3.3.6 Effect of dénaturants on quenching of Trp fluorescence
From the position of the emission maximum in the fluorescence spectra (346nm) it is 
evident that the Trp side chain is substantially exposed to the solvent. Another method to 
obtain this type of information is to study the Trp quenching by different agents.
In fact the quenching of the fluorescence of Trp residues by addition of particular low 
molecular weight agents (O2 , succinimide, acrylamide, I', N O 3" , etc.) can be used to probe 
for the exposure of the indole ring. These quenchers act by physically interacting with the 
excited indole ring and this interaction will be more pronounced for exposed residues.
So the quenching of the Trp fluorescence, quantified by the Stern-Volmer constants, gives 
information on the environment and mobility of the Trp side chain (section 2.4). In order to 
take into account the influence of the solution conditions, the values of Ksv in the presence 
of dénaturants were obtained correcting the observed values by reference to the values 
obtained for the model compound NATA under the same conditions as described in section 
2.4. The use of different quenchers can extend the information available: for example 
charged quenchers such as iodide could be used to examine the nature of the charged 
environment of fluorophores (section 1.3.2.4).
In the case of SK, the iodide ion is a very effective quencher as shown by its high Kgv 
(20.05 M‘ )^ when compared with the one obtained for the model compound, N- 
acetyltryptophan amide (10.1M'^). It is likely that the high degree of quenching of SK is due 
to the positively charged environment provided by the three arginine side chains (A rg il, 
Arg58 and Arg139 ; Fig. 1.11) in the neighbourhood of Trp54 (Krell et al., 1998) that create 
a positively charged environment increasing the effectiveness of the quenching by the 
negatively charged iodide ion. This is confirmed by the observation that in the presence of 
4M urea the Ksv values for SK is reduced dramatically to 4.0 M '\ by contrast the addition of 
4M urea has only a very small effect on the Ksv of the model compound (9.5 M'^). The 
values of Ksv for Nal in 50 mM MOPS, pH 7.6, containing 2.5 mM K2 SO4 , 2.5 mM MgS0 4  
and 0.4mM dithiothreitol is similar (20.9 ± 0.21 M'^) to that obtained in Tris buffer.
Using a neutral quencher as succinimide a high value of Ksv has been obtained both for the 
native and the denatured (4M urea) protein, 5.56 ± 0.11M'  ^ and 5.19 ± 0.045 M'^  
respectively. This confirms the high degree of solvent exposure of the Trp.
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3.4 Refolding of the enzyme
3.4.1 Refolding after unfolding in GdmCI
3.4.1.1 Regain of activity
The regain of activity during the refolding was measured following the procedure described 
in section 2.5. SK was denatured in 2.8M GdmCI and then diluted 11-fold to lower the 
GdmCI concentration to 0.25M to initiate refolding. At this residual concentration of GdmCI 
the protein is in its native conformation (section 3.3.2). The control sample was a solution of 
SK in 0.25M GdmCI. The activity value of this solution is 233pmol/min/mg, which is lower 
than the activity in the absence of dénaturant (350fxmol/min/mg). This is in agreement with 
the observed decrease in activity measured by quenched assay at different GdmCI 
concentrations (in 0.25M GdmCI, 65% of the activity of the enzyme in buffer was observed- 
section 3.3.5). Under these conditions, approximately 75% of the activity of a control sample 
could be regained in a first order process with rate constant of 0.0043s^ (Figure 3.14).
The regain in activity was also followed in the presence of 40pM ANS because this probe 
was used in other refolding experiments and its influence on the refolding process had to be 
checked. The regain of activity in the presence of ANS is 15% less than in the absence of 
ANS (Figure 3.14).
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Figure 3.14: The kinetics of regain of activity of SK after dénaturation in 2.8M GdmCI.
Squares: regain in activity ; closed circles: regain in activity in the presence of ANS. Activity 
values are expressed relative to a control sample incubated in the presence of the final 
concentration of GdmCI, i.e. 0.25M and 0.25M GdmCI + 40pM ANS. The dashed line shows 
a fit to a first order process with a rate constant of 0.0043s'\
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3.4.1.2 Regain of fluorescence intensity
The refolding was started by dilution as already described. Figure 3.15 shows an average 
of 10 curves obtained in manual mixing mode following the regain in fluorescence intensity 
at 350nm, after excitation at 295nm. Presumably 55% of the control fluorescence is 
regained in the dead time, 10.5 % with a rate constant of 0.0113s"  ^ and 17.9 % with a rate 
constant of 0.0024s'^ (these constants are only indicative because they refer to a manual 
mixing experiment). Performing light scattering experiments (section 2.4) the refolded 
solution presented a light scattering signal greater than the upper experimental detection 
limit (1000 units), indicating that some aggregation has occurred during the refolding 
process (section 3.4.1.5). The stopped flow experiments that followed were unsatisfactory, 
because of the lack of agreement with results previously obtained (Boam, 1999) probably 
due to aggregation. It has to be pointed out that, though the intensity of the refolded solution 
is not the same as that of the control solution, the normalised spectra coincide, indicating 
that after refolding the environment of the Trp is native-like (Fig. 3.16).
100
-  40
0 200 eoo 800 1000 1200
Time (s)
^  002
Time (s)
Figure 3.15; The kinetics of changes in protein fluorescence
The regain in fluorescence intensity at 350nm was followed after dénaturation in 2.8M 
GdmCI. Refolding was initiated by manual mixing. The pattern of residuals to the curve fitting 
is shown.
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Figure 3.16: Normalised spectra of the solutions of the refolding experiment in GdmCI.
Spectra were recorded at 20°C using samples dissolved in buffer D (35mM Tris-HCI, pH 7.6, 
containing 5mM KOI, 2.5mM MgCb and 0.4mM dithiothreitol) in the 300-400nm range after 
excitation at 295nm, T= 20°C. Black: SK + 2.8M GdmCI; Green: SK + 0.25M GdmCI 
(refolded); Red: SK + 0.25M GdmCI (end solution).
3.4.1.3 Refolding in the presence of shikimate
Because the shikimate binding was weakened at the final GdmCI concentration used in the 
refolding experiment (0.25M), it was not possible to check the formation of the shikimate- 
binding site during the refolding reaction.
3.4.1.4 Refolding in the presence of Nal
From the kinetic profile obtained in the presence of Nal (Fig. 3.17), it could be seen that the 
formation of the charged Trp environment is complete after the first 30s (considering a dead 
time in the manual mixing experiment of 20s). No further stopped flow experiments were 
undertaken because of the aggregation indicated by the refolding experiment undertaken in 
the presence of ANS (section 3.4.1.5).
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Figure 3.17: The kinetics of changes in quenching of fluorescence by iodide
The regain in fluorescence intensity at 350nm was followed after dénaturation in 2.8M 
GdmCI. Refolding was initiated by manual mixing with an 11-fold dilution in a buffer 
containing 0.11M Nal. The start and end solution contained 0.1M Nal as well. Black : start 
solution (SK + 2.8M GdmCI); Red: end solution (SK+ 0.25M GdmCI ); Blue: refolding in the 
presence of 0.1 M Nal.
3.4.1.5 Light scattering measurements and refolding in the presence of ANS
To check if aggregation had occurred during refolding, a light scattering experiment was 
carried out (X.ex =^m = 320nm) (section 2.4). Both the control (0.25M GdmCI, equilibrium 
solution) and the refolded solutions give saturation of the detector (>1000 units), while the 
start solution (unfolded in 2.8M GdmCI) does not. This could indicate the possible formation 
of aggregates during the refolding process. To check if the observed saturation of the 
detector was due to the residual ionic strength, the light scattering was checked in the 
presence of 0.25M NaCI. Although no saturation of the detector was observed in 0.25M 
NaCI, when an ionic strength jump from 2.8M NaCI to 0.25M NaCI was carried out, it led to 
saturation of the detector. These control experiments using NaCI showed that the increase 
in light scattering resulted both from the rapid decrease in ionic strength and from the 
specific effects of the final concentration of GdmCI (0.25M). The observed aggregation can 
provide an explanation of the irreversible binding of the hydrophobic probe 1-anilino-8- 
naphthalene sulphonate (ANS) during the refolding after unfolding in GdmCI. This probe is 
commonly used to study the early stages of protein folding giving information on possible 
compact intermediates on the refolding pathway (a more detailed discussion on the use of 
this probe will be given in the sections 3.4.2 8 and 3.4.2.9).
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During the refolding experiment a large increase in the binding of ANS (15-fold compared 
with the enzyme in 2.8M GdmCI) was observed and the dye was not subsequently 
released from the enzyme (Fig. 3.18). This is not due to the residual ionic strength in 
solution, because the equilibrium solutions in 2.8M GdmCI and 0.25M GdmCI do not give 
the same intensity and spectra of the refolded solution, but could be due to formation of 
aggregates: kinetic intermediates of folding are sometimes sensitive to aggregation 
because they still have significant amount of exposed hydrophobic surface (section 1.1.1.3).
In view of these difficulties, subsequent experiments on the refolding of SK were performed 
using urea as a denaturing agent; the procedure involved unfolding in 4M urea for unfolding 
and 11-fold dilution (to 0.36M urea) to initiate refolding. During this process, there was no 
significant increase in light scattering at 320nm during refolding showing that aggregation 
occurred to a negligible extent.
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Figure 3.18: The kinetics of changes in ANS fluorescence at 480nm
Refolding of SK after dénaturation in 2.8M GdmCI (manual mixing). The red, black, and blue 
curves refer to enzyme in the presence of 2.8M GdmCI, enzyme in the presence of 0.25M 
GdmCI, and enzyme during refolding respectively.
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3.4.2 Refolding after unfolding in urea
3.4.2.1 Regain of activity.
The refolding was performed as described in section 2.5. The first time point at which 
activity can be accurately assessed was estimated to be about 80s after the start of 
refolding, taking into account the time taken for appropriate dilution into the assay solution 
and for the double-coupled assay system to achieve a constant rate. By this time between 
35 and 40% of the activity of the control sample (in the presence of 0.36M urea) had been 
regained. Over the next 15 min, a further 50% activity was regained in a first order process 
with a rate constant 0.0067s \  Thus overall approximately 90% of the activity of the control 
was regained. If dithiothreitol was omitted from the unfolding and refolding buffers, the 
extent of regain of activity was reduced to approximately 60%, showing that some damage 
had occurred to either or both of the 2 Cys side chains (Cys 13 and Cys 162) in the enzyme 
(Fig. 3.19).
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Figure 3.19; The kinetics of regain of activity of SK after dénaturation in 4M urea.
Activity values are expressed relative to a control sample incubated in the presence of the 
final concentration of urea, i.e. 0.36M. The dashed line shows a fit to a first order process 
with a rate constant of 0.007s \  The blue curve shows the regain of activity when DTT was 
not present in the unfolding and refolding buffers.
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3.4.22 Regain of secondary structure on refolding
When the enzyme was unfolded in 4M urea and refolded by an 11-fold dilution to a final 
concentration of urea of 0.36M (section 2.5), approximately 75% of the recovery of ellipticity 
at 225nm was complete within the dead time (20s) of the start of the manual mixing 
experiment (Fig. 3.20). A further 15% of the signal was regained over the subsequent 500s 
with a rate constant of 0.009s \  At the end of this period the far-UV CD spectrum of the 
refolded enzyme was very similar to that of native enzyme (Fig. 3.21). Using stopped flow 
mixing to initiate refolding it was shown that the regain of ellipticity at 225nm occurred in a 
number of phases. From data obtained over the first 20s of refolding, it was shown that, 
within 20ms, 15% of the total signal corresponding to the folded enzyme (i.e. the difference 
between denatured and folded enzyme) had been regained. A further 20% of the signal was 
regained in a first order process with a rate constant of 8s '\ in the third phase a further 40% 
was regained with a rate constant 0.08s'\ Finally from data over the time range 20-200s, a 
fourth phase was observed accounting for an additional 10% change with a rate constant 
0.008s'\ Taken together, the four phases account for a regain of 85% of the native 
secondary structure (Fig. 3.22).
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Figure 3.20: The kinetics of changes in ellipticity at 225nm
Refolding of SK after dénaturation in 4M urea. The refolding was initiated by manual mixing. 
A: SK + 0.36M urea (end solution); B: SK + 4M urea (start solution); C: refolding solution
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Figure 3.21; CD spetra of the refolded solution after dénaturation in 4M urea
Far-UV CD spectra (protein concentration 0.15mg/ml, cell pathlength 0.05cm) were recorded 
at 20°C using samples dissolved in buffer D (35mM Tris-HCI, pH 7.6, containing 5mM KCI, 
2.5mM MgCl2 and 0.4mM dithiothreitol) as described in section 2.4. The data shows: SK in 
buffer Tris-HCI and 0.36M Urea (black, end point; equilibrium solution) and SK in the same 
conditions after the refolding by dilution (red).
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Figure 3.22: The kinetics of changes in ellipticity at 225nm
Refolding of SK after dénaturation in 4M urea.The refolding was initiated by stopped flow 
mixing; the inset shows data in the first 2s o f the reaction. Traces A, B and C refer to enzyme 
in the presence of 4M urea, enzyme in the presence of 0.36M urea, and enzyme during 
refolding respectively. The pattern of residuals to the curve fitting is shown.
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3.4.2.3 Unfolding kinetics and effect of incubation time on the refolding kinetics
A set of experiments on the unfolding kinetics were performed mixing the native protein with 
a buffer containing urea in such a way that after dilution the concentration of urea was 4M, 
and the protein concentration 0.1 mg/ml. After 5min the protein has a fluorescence intensity 
that corresponds to the unfolded protein (Fig. 3.23). The kinetic constant of the process, 
obtained with a first order fitting, is: k =0.02831 ± 0.0001s \
The effect of the incubation time on the refolding kinetics was investigated as well (manual 
mixing). The unfolding in 4M urea for periods ranging from 5min to 3h had no effect on 
either the spectroscopic properties of the unfolded enzyme, or the kinetics of refolding (table 
3.3) as monitored by changes in protein fluorescence (Fig. 3.24).
Incubation
time Ai ki (s ') A2 k2(s') B
5 min 
30 min 
3 hours
32.91 ± 0.28 
27.37 ± 0.31 
27.80 ± 0.29
0.060 ± 0.001 
0.075 ±0.0017 
0.071 ± 0.0015
29.03 ± 0.23 
34.05 ± 0.23 
33.41 ± 0.23
0.0075 ± 8  10^ 
0.0083 ± 1.1 10^ 
0.0085 ± 9 10 ^
169.62 ±0.042 
169.64 ±0.092 
167.95 ±0.051
Table 3.3: Effect on the incubation time on the kinetic parameters.
Refolding of SK after dénaturation in urea by manual mixing. Ai. Ag are the amplitudes of the 
first and second phase with rate constants ki and k2 respectively; B is the final fluorescence 
value. The dead time amplitude can be calculated by difference: B - (Ai +A2).
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Figure 3.23: The kinetics of changes in protein fluorescence during unfolding
Unfolding was initiated by manual mixing by dilution in Tris buffer containing 4M urea (black 
curve). Fluorescence was monitored at 350nm. The red and green traces are referred to the 
unfolded (4M Urea) and native (0.36M Urea) SK respectively.
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Figure 3.24: Effect of the incubation time on the refolding kinetics as monitored by 
fluorescence.
Refolding of SK after dénaturation in 4M urea. Refolding was initiated by manual mixing and 
the fluorescence was monitored at 350nm. The unfolded solution was incubated for different 
times before starting the refolding by dilution. The data show the traces obtained when the 
refolding was carried out with the SK solution incubated, respectively, 5min (black), 30min 
(red), 3 hours (green).
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3.4.2.4 Regain of fluorescence intensity on refolding
The regain of tertiary structure was monitored by changes in protein fluorescence at 350nm 
after dilution of the dénaturant from 4M to 0.36M urea. In the manual mixing mode, the first 
time point at which reliable data could be obtained was approximately 20s after refolding 
had been initiated. Within this dead time, 35 % of the fluorescence of native enzyme (in the 
presence of 0.36M urea) had been regained. Over the course of 20min, a further 55 % of 
the fluorescence was regained in a first order process with a rate constant of 0.009s \  Thus 
overall 90% of the signal of native SK was regained (Fig.3.25).
100
0)
3U_
c
40c
DU
20
100 200 300
Time (s)
400 500 600
02
01SUro3 00.■D(/)(D -01OS
-02 100 200 300 400 500 000
Figure 3.25: The kinetics of changes in protein fluorescence at 350nm using manual mixing
Refolding of SK after dénaturation in 4M urea. Refolding was initiated by manual mixing. 
Fluorescence was monitored at 350nm. The pattern of residuals to the curve fitting is shown.
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Using stopped flow mixing techniques, it was found that less than 5% of the total change 
occurred within 5ms and that the subsequent changes in fluorescence occurred in two 
phases with amplitudes 42% and 45% of the total change with first order rate constants of 
0.08s*^ and 0.009s‘  ^ respectively. The rate of the slower process corresponds to that 
observed using manual mixing techniques (Fig.3.26). Using urea there is good agreement 
between the stopped flow and manual mixing experiments.
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Figure 3.26:The kinetics of changes in protein fluorescence at 350nm using stopped flow 
mixing.
Refolding of SK after dénaturation in 4M urea. Refolding was initiated by stopped flow 
mixing. The fluorescence signals have been corrected for the buffer signal. Curves A, B and 
0  refer to enzyme in the presence of 4M urea, enzyme in the presence of 0.36M urea, and 
enzyme during refolding respectively. Fluorescence was monitored at 350nm. The pattern of 
residuals to the curve fitting is shown.
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3.4.2.5 Refolding in the presence of shikimate
Refolding of shikimate kinase in the presence of shikimate was carried out in order to 
assess the stage in the process at which the shikimate binding site is formed, using the 
quenching of the protein fluorescence by the ligand as index of binding. This was possible 
using urea as dénaturant, as the effects on the shikimate binding at 0.36M urea are 
negligible. In a preliminary experiment the binding of shikimate to the enzyme in the 
presence of 0.36M urea was shown to be very rapid. When 2mM shikimate was added to 
the enzyme (0.09mg/ml), over 95% of the fluorescence change occurred within the dead 
time of the stopped-flow instrument (1.8ms), implying a rate constant for the association 
reaction >7x10® M‘ s^ \
For the refolding experiments it was necessary to monitor the refolding by changes in 
fluorescence at a different wavelength from 350nm. At the latter wavelength, the quenching 
caused by the binding of shikimate to the folded enzyme was nearly equal to the 
enhancement of protein fluorescence which occurred on refolding, leading to a very small 
overall change (Fig. 3.27). To choose the optimum wavelength different control experiments 
were undertaken and 330nm was chosen to follow the process.
A control refolding, performed at this wavelenth in the absence of shikimate, showed little 
difference in kinetics from the curve acquired at 350nm giving, when fitted with single 
exponential function, a rate constant of 0.06s‘  ^ (Fig. 3.28).
When the refolding was carried out in the presence of 2mM shikimate, however, a markedly 
different pattern was observed (Fig. 3.29a, b). From the manual mixing trace it is evident 
that there is not a complete quenching even after 800 seconds. In the stopped flow trace 
after a rapid increase in fluorescence, essentially complete within 15s, there was a slow 
small decrease over the next 185s (Fig. 3.29 b). The rate constant for this decline (0.025s‘ )^ 
was rather higher than that of the slow increase in the absence of shikimate (0.009s’ )^, 
which could indicate that the presence of ligand has a nucleating effect on folding of this 
area of the enzyme (Jaenicke, 1987). The folding of the protein (which would be expected 
to lead to an increase in protein fluorescence) leads to binding of shikimate and the 
consequent quenching results in the overall small decrease in fluorescence in this phase of 
the process. The simplest interpretation of these results is that only the slowest phase of 
folding leads to the formation of a shikimate binding site.
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Figure 3.27: Fluorescence spectra before and after refolding in the presence of shikimate
Spectra were recorded at 20°C in the 300-400nm range after excitation at 295nm, T= 20°C. 
The samples were prepared in buffer D (35 mM Tris-HCI, pH 7.6, containing 5 mM KCI, 2.5 
mM MgCl2  and 0.4mM dithiothreitol) + 2mM shikimate and containing, respectively, 0.36M 
urea (black- end solution) and 4M urea (red- start solution).
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Figure 3.28:The kinetics of changes in protein fluorescence at two different wavelegths
Refolding of SK after dénaturation in 4M monitored at two different wavelegths: 330nm 
(black): 350nm (red).
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Figure 3.29:The kinetics of changes in protein fluorescence in the presence of shikimate.
The refolding of SK in the presence of 2mM shikimate, monitored at 330nm, after 
dénaturation in 4M urea, was initiated by a) manual mixing and b) stopped flow mixing (the 
fluorescence signals have been corrected for the buffer signal).
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3.4.26 Refolding in the presence of ADR and ATP
The refolding experiments in the presence of 2mM ATP and 2mM ADR were performed only 
with manual mixing (Fig. 3.30). It seems that ATP gives a small increment in the refolding 
rate, while ADR gives a small decrease. For drawing any valid conclusion it would be 
necessary to repeat these experiments with the stopped flow apparatus.
For this reason these results are reported as a possible starting point for further 
investigations and will not be considered in the discussion.
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Figure 3.30; Kinetics of changes in protein fluorescence in the presence of nucleotides
Refolding of SK after dénaturation in 4M urea. Fluorescence was monitored at 350nm. 
Refolding was initiated by manual mixing in buffer (black), and in buffer containing 2mM ATP 
(red), and 2mM ADP(green).
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3.4.2.7 Refolding in the presence of sodium iodide
In these experiments the iodide ion was used as a probe to monitor the reconstitution of the 
charged environment of Trp54 during refolding. The value of the Stern-Volmer constant 
(Ksv) in 0.36M urea was determined as a preliminary control for the refolding experiments. In 
the presence of 0.36M urea the Ksv for SK (19.0M’ )^ is very similar to that of native enzyme 
(Fig. 3.31), demonstrating the integrity of the Trp environment at this urea concentration. 
The values obtained with the other quencher used (succinimide), which is neutral, are 
reported for comparison (Table 3.4). The changes in protein fluorescence during refolding of 
SK in the presence of 0.1 M Nal were investigated to assess at what stage in the folding 
process the positively charged environment of Trp 54 in native enzyme is formed.
From the data obtained using manual mixing techniques to initiate refolding (Fig. 3.32a), it 
was found that after 600s, the degree of quenching caused by 0.1 M Nal corresponded to a 
Ksv of 17.8M”^  (i.e. very similar to that of enzyme in the presence of 0.36M urea). After 20s, 
the degree of quenching corresponded to a Kgv of 12.0M'\ The changes in fluorescence 
over the period from 20s to 600s could be fitted to a first order process with a rate constant 
0.008s‘\  which is very similar to that observed in the absence of Nal (0.009s'^). Using 
stopped flow mixing to initiate refolding (Fig. 3.32b), the degree of quenching after 20s was 
found to correspond to a Kgv of 12.0M"\ identical to that observed by manual mixing. After 
2s, the quenching corresponded to a Ksv of 6.4M’\  which is similar to the value for 
denatured enzyme. From these results, it is clear that the high degree of quenching and 
hence the positively charged environment of the Trp is formed progressively during the two 
(relatively slow) processes during which the changes in the Trp fluorescence itself occur.
Solution Ksv (Nal) Ksv (succinimide)
SK 20.05 ±  0.30 5.56 + 0.11
SK + 0.36M Urea 20.71 ± 0.29 5.52 ± 0.20
SK + 4M Urea 4.67 ±0.1 5.19 + 0.045
Table 3.4: Ksv values for SK under different conditions 
The values quoted are the means of at least 4 experiments.
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Figure 3.31: Stern-Volmer plots of SK in different conditions.
The fitting was performed by linear regression in the range 0 - 0.095M of quencher (Nal). 
The quenching was corrected for the effect of solvent on the fluorescence of NATA.
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Figure 3.32; The kinetics of changes in quenching of fluorescence by iodide.
Refolding of SK after dénaturation in 4M urea, (a) Changes observed using manual mixing to 
initiate refolding, b) Changes observed using stopped flow mixing to initiate refolding.The 
concentration of Nal present during refolding was 0.1M, and the Ksv value at any given time 
was calculated by comparing the fluorescence intensities in the absence (Fo) and presence 
(F) of iodide, using the equation Ksv = ((Fq/F) - 1)/(0.1) M \  Curves A, B and C refer to 
enzyme in the presence of 4M urea, enzyme in the presence of 0.36M urea, and enzyme 
during refolding respectively.
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3.4.2.8 ANS as a probe for the formation of early intermediates. Preliminary experiments
8-AnilinO“1-naphthalene-sulphonate (ANS) is one of the most frequently used fluorescent 
probes for the investigations of structural properties of protein molecules.
The ANS ftuorophore is virtually non-fluorescent in aqueous solution but becomes 
fluorescent in organic solvents or when bound to the interior of certain proteins. The probe, 
which is thought to bind to clusters of hydrophobic side chains of proteins (Goldberg et al., 
1990), was extensively used in the identification of early compact intermediates 
(Christensen and Pain, 1991; 1994; Ptitsyn, 1995a).
It has been found that during the folding of a number of proteins, there is rapid rise in ANS 
fluorescence (within about Is) followed by a slower decline in the fluorescence (lasting up to 
about IDs) (Goldberg et a i, 1990). This has been interpreted as reflecting the formation of 
an intermediate state during the folding process. Such intermediates are frequently 
observed for proteins with a low overall stability (Fischer and Schmid, 1990).
This intermediate state has been termed "molten globule": in this state the protein is 
compact, but the amino acid side chains are reasonably fluid, i.e. the precise interactions 
stabilising the native tertiary structure have not been formed. This state is thought to bind 
ANS preferentially: the probe is then "squeezed out" when the final tertiary structure 
interactions are formed. However, there have been concerns raised that the presence of 
ANS may perturb the folding process (Engelhard and Evans, 1995). From other studies it 
has been proposed that the ANS binding could be dictated by the concentration of the 
chaotropic agent used for dénaturation, which displaces the dye by sheer competition 
(Kumar et a i, 1996), but the existence of an increase of ANS fluorescence observed upon 
pressure-induced dénaturation (Uversky et a i, 1996) confirms the validity of the use of this 
probe as indicator of the involvement of compact intermediates in the refolding process.
Before using ANS in the refolding buffer, a number of control experiments were carried out 
to check if this probe had any effect on the structure and activity of SK.
The far-UV CD spectrum of SK (Fig. 3.33) in the presence of ANS shows small changes 
compared to the spectrum in the absence of this probe. The measure of the regain of the 
activity when the refolding is carried out in the presence of ANS is another test to check if 
the dye perturbs the refolding process. When the refolding was performed in the presence 
of 40jLiM ANS, the regain of activity was 96% that of the control (with ANS); this activity was 
regained in a first order process with a rate constant 0.008s"' (Fig.3.34). From these data, it 
is clear that ANS has only relatively minor effects on the catalytic site of the enzyme and its 
ability to refold after dénaturation.
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Figure 3.33: Effect of ANS on the secondary structure of SK.
The far-UV CD was acquired as described in section 2.4. The protein concentration was 
0.15mg/ml. The data shows the spectra of SK in the absence (solid line) and in the presence 
(dashed line) of 40^iM ANS.
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Figure 3.34: The kinetics of regain of activity of SK in the presence of 40|xM ANS.
Dénaturation in 4M urea. Activity values are expressed relative to a control sample incubated 
in the presence of the final concentration of urea, i.e. 0.36M+ 40nM ANS. The dashed line 
shows a fit to a first order process with a rate constant of 0.008s \
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The effects of different medium conditions on both ANS florescence and on the 
fluorescence of the ANS bound to SK were investigated, since it has been reported that for 
some other proteins there is a change in these characteristics with an alteration of the 
solvent composition (Nerli and Pico, 1994). Fluorescence spectra of ANS (40pM) in buffer, 
in the presence of 4M urea and in the presence of 0.36M urea, both in the absence (Fig. 
3.35a) and in the presence of protein (Fig. 3.35b) have been acquired and the difference 
spectra, to check the bound-ANS fluorescence, have been calculated (Fig. 3.35c).
From these data it seems that the presence of urea leads to an increase of the free ANS 
fluorescence, with this effect being more pronounced in 4M urea than in 0.36M urea. The 
intensity of ANS in the presence of SK in 4M urea is lower, as expected, than in buffer, 
while there is an increase of fluorescence intensity in 0.36M urea when compared to the 
sample in buffer (Fig.3.35b). This situation has already been observed for bovine serum 
albumin and it was deduced that low concentrations of urea induced binding of the probe 
(Nerli and Pico, 1994). Making the assumption that the free ANS and bound ANS are both 
present in solution and contribute to the fluorescence intensity, the difference spectra in 
each condition have been acquired:
(SK. ANS) (cond. X) — (ANS) (cond. X)
this “approximation” should give information on the spectra of bound ANS. The fact that this 
approximation is reasonable is given by the difference spectrum of the solutions in 4M urea, 
which is practically zero (Fig. 3.35c). From these difference spectra it appears that there is 
no significant increase in the binding of ANS in 0.36M urea, but that the observed increased 
intensity is mainly due to an increase in the fluorescence intensity of the free ANS in 
solution brought about by the presence of 0.36M urea (Fig. 3.35a).
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Figure 3.35: ANS spectra (40pM) in buffer, in 4M urea and in 0.36M urea.
Solid line : ANS and buffer; dotted line: ANS in the presence of 0.36M Urea; dashed line: 
ANS in the presence of 4M Urea respectively in the absence (a) and in the presence of 
protein (b). (c): difference spectra: (SK.ANS) (cond x)- (ANS) (cond. x)
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Spectra were recorded in the presence of substrate (Fig. 3.36) and binding titrations were 
also performed (Fig. 3.37) to validate the use of ANS as a probe during refolding in the 
presence of substrate. The influences of ANS on SK activity was also studied.
The presence of 40pM ANS caused less than 10% change in the for shikimate giving a 
value of 0.69mM (using the fluorescence quenching titration), and an 18% decrease in the 
activity of enzyme (when assayed under the standard conditions).
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Figure 3.36; SK.ANS spectra (40 ^M) in in the presence of 2mM shikimate.
The emission spectra were acquired after excitation at 380nm. The protein concentration 
was 0.15mg/ml. The data shows: SK + ANS (black line); SKII + ANS+shikimate (red line) and 
ANS (green line).
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Figure 3.37: Shikimate titration in the presence of ANS.
The titrations were performed as described in section 2.3. The data show the titration curves 
obtained for SK alone (black) and in the presence of 40pM ANS (red).
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3A .2.9 ANS as a probe during refolding
Using urea as a denaturing agent, a characteristic pattern of changes in ANS fluorescence 
during refolding was observed. When refolding was initiated by manual mixing techniques, 
there was a rapid increase in fluorescence within the dead time of observation (20s) 
corresponding to approximately 10 times the fluorescence of the starting solution (enzyme 
in 4M urea) and 2.5 times the value of the end solution (enzyme in 0.36M urea).
This increase was followed by a decrease over the subsequent 600s to reach a value 
similar to that observed for the enzyme in the final concentration of urea (0.36M) (Fig. 3.38); 
the rate constant for this decrease was 0.009s'\
Using stopped flow mixing techniques (Fig. 3.39 a and b) to initiate refolding, the initial rapid 
increase in ANS fluorescence was found to be at least 50% complete within 5ms. Further 
analysis of the changes in fluorescence over the first 200ms after mixing suggested that the 
increase occurred in two phases of approximately equal amplitude, one very fast (k >100s'^) 
and the other with a rate constant 11s'\lt should be noted that the magnitude of the faster 
rate constant could not be estimated accurately; the value quoted is based on the half time 
being less than or equal to 5ms). The subsequent decrease in ANS fluorescence (to reach 
a value similar to that of the enzyme in the presence of the final concentration of urea) 
occurred in two first order processes with rate constants O.OBs*^  and 0.012s '\ the amplitude 
of the faster of these two phases corresponded to 25% of the total decrease observed.
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Fig. 3.38: The kinetics of changes in ANS fluorescence at 480nm
Refolding of SK (manual mixing) after dénaturation in 4M urea. Curves A,B, and 0  refer to 
enzyme in the presence of 4M urea, enzyme in the presence of 0.36M Urea, and enzyme 
during refolding respectively.
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Figure 3.39: The kinetics of changes in ANS fluorescence at 480nm 
Refolding of SK after dénaturation in 4M Urea (stopped flow mixing).
a) Curves A,B, and C refer to enzyme in the presence of 4M urea, enzyme in the presence of 
0.36M Urea, and enzyme during refolding respectively.
b) The kinetics of changes in ANS fluorescence at 480nm during refolding of SK after 
dénaturation in 4M urea. The first 20ms of the refolding curve are shown.
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Preliminary refolding experiments in the presence of shikimate and ANS were performed 
using stopped flow mixing (Fig. 3.40a, b). In Figure 3.40 a there is the comparison between 
the first part of the refolding curves in the presence and absence of shikimate (ANS region) 
(the two curves were obtained using different slit widths). It should be noted that the 
presence of shikimate in solution leads to a decrease of the intensity of the spectrum 
(Fig.3.36) so differences observed in the kinetics of the different phases could give useful 
indications of the effect of substrate on the refolding process. These data should be repeated 
to draw any valid conclusions and could serve as a basis for further investigation.
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Figure 3.40. The kinetics of changes in ANS fluorescence in the presence of shikimate.
Refolding of SK after dénaturation in 4M Urea (stopped flow mixing). The ANS fluorescence 
was measured at 480nm after excitation at 380nm. The protein concentration was 0.1 mg/ml 
during the refolding. The data shows the refolding curves obtained in the absence (black 
curve) and in the presence (red curve) of 2mM shikimate.
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3.4.3 Model of folding pathway and properties of intermediates
For many proteins a burst (millisecond) phase was observed which is characterized by 
partial formation of the secondary structure and partial condensation, typical of the “pre- 
molten” globule (Ptitsyn, 1995; Eaton et al., 2000). The next intermediate usually resembles 
the molten globule state: it has a degree of native-like, protected secondary structure, and 
even some native tertiary contacts (Ptitsyn 1995; Roder et al., 1988). The further formation 
of native state can take from a fraction of a second to hours, expecially if there is a slow 
rearrangement of packing of non-native proline isomers or non-native disulphide bonds 
(Galzitskaya et a!., 2001).
Approximately 95% enzyme activity could be recovered on dilution of the urea from 4M to 
0.36M. The results of spectroscopic studies indicated that refolding occurred in at least 4 
kinetic phases, the slowest of which (k = 0.009s"^) corresponded with the regain of 
shikimate binding and of enzyme activity. The two most rapid phases were associated with 
a substantial increase in the binding of 8 -anilino-1 -naphthalenesulphonate with only modest 
changes in the far-UV CD, indicating that a collapsed intermediate with only partial native 
secondary structure was formed rapidly.
Detailed studies of the refolding of a number of proteins after dénaturation have led to the 
development of the nucleation-condensation model; this seeks to draw together ideas from 
earlier proposals which focussed attention on aspects such as formation of secondary 
structure or hydrophobic collapse (Fersht, 1999). In energy terms, the transition from 
denatured to native state is viewed in terms of a “folding landscape” in which kinetic flow 
can occur through a series of states of progressively lower energy in a “folding funnel” 
(Fersht, 1999; Brockwell eta!., 2000).
Although there are some differences in detail between the results of the various techniques 
employed in the present work to monitor the refolding of SK after dénaturation in urea, when 
taken together the data indicate that there are probably four kinetic phases contributing to 
the folding process. The average rate constants for these phases are >100s'^ (half life 
<7ms), lOs'^ (half life 70ms), 0.08s'^ (half life 9s) and 0.009s"^ (half life 80s). A simple 
outline model could thus be proposed which involves 3 intermediates (b, b and I3) between 
the unfolded state (U) and the native state (N).
> 1 0 0  s"' 10S^ 1 0.08 s"”' 1 0.009 S'" ^
U   g» '1  >  *2  ----------- >  13 —------- >  M
The properties of these are indicated in Table 3.5, in which the various properties of the 
unfolded and final states have been normalised to 0  and 1 0 0  respectively in order to 
facilitate comparison.
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The increase in ANS fluorescence occurs very rapidly Implying that the formation of a 
collapsed intermediate precedes substantial regain of secondary structure. This type of 
result is analogous to that previously observed for the refolding of the 89 amino acid protein 
barstar (Agashe et a/., 1995) and for the small all p-sheet protein CTX(III) (Sivaraman et at., 
1998). It might be informative to explore the nature of the early formed intermediate(s) by 
using CD over a wider range of wavelengths in the far-UV. The regain of the majority, if not 
all, of the activity occurs during the final slow phase which is associated with the completion 
of regain of native fluorescence and its quenching by I", the further extrusion of ANS, 
together with small changes in secondary structure.
Property U ki l1 kz I2 ka I3 k4 N
( s ' ) ( s ' ) ( s ' )
ANS fluorescence (480nm) 0 >100 180 11 360 0.085 300 0.012 100
CD at 225nm 0 20 8 40 0.08 90 0.008 100
Protein fluorescence (350nm) 0 0 5 0.08 50 0.009 100
Fluorescence quenching (f) 0 0 10 0.09 50 0.008 100
Activity 0 0 0 <10 0.007 100
Table 3.5: Properties of intermediates in the refolding of shikimate kinase
U and N represent the unfolded and refolded states of the enzyme and h, I2 and I3 the 
intermediates inferred from the kinetic analysis of changes in activity and spectroscopic 
parameters during refolding. In order to facilitate comparisons, the values of U and N have 
been normalised to 0 and 100 respectively. In each case, more than 85% of the property of 
native enzyme was regained after refolding.
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3.4.4 Comparison with studies on the refolding of adenylate kinase
The refolding of SK to generate active enzyme occurs considerably more slowly than for 
many proteins of a similar size (Jaenicke, 1987; Grantcharova et al., 2001; Gunasekaran et 
al., 2001). It has been suggested that the low rate might be a feature of a number of a/(3 
domain proteins, where the formation of the p-sheet is expected to be a slow process 
requiring the formation of a large number of specific long-range contacts in the proper 
orientation (Houry et al., 1999; Plaxco et al., 1998; Sivaraman et a/., 1998). By contrast, 
formation of a-helices is much more rapid, since short-range interactions are involved.The 
final steps in formation of the native structure of a/p domain proteins can involve slow 
rearrangement of domains, as observed in the case of the p21^* protein (Zhang and 
Matthews, 1998).
In the refolding of a number of proteins, the cis/trans isomérisation of Xaa-Pro imide bonds 
appears to account for some or all of the slow steps involved (Schmid et a/., 1993; Nall, 
1994). On unfolding the protein, a slow isomérisation (with a time constant of the order of 
100 - 1000s (Schmid et a/., 1993)) of the Xaa-Pro imide bonds occurs to give a mixture 
containing typically 10-20% c/s species at equilibrium. Upon refolding, proteins in which the 
Xaa-Pro bonds are in their native state can refold rapidly. Slow refolding species represents 
proteins in which a Xaa-Pro imide bond is trapped in the non-native conformation; productive 
folding can only occur after isomérisation has occurred. In many (but by no means all) such 
cases, the slow step(s) can be accelerated by addition of peptidyl prolyl isomerase.
While it is possible that the slowest phase of the folding of shikimate kinase could reflect 
Xaa-Pro isomérisation, there are good grounds for believing that this is not the case. Firstly, 
none of the 7 proline residues in the native enzyme contains a c/s imide bond. Secondly no 
difference in the rates or amplitudes of the slow phases of the refolding process using 
unfolding times ranging from 5mln to 3h has been found (section 3.4.2.3). Thirdly, the 
amplitudes of those slow phases which require c/s -> trans isomérisation are typically 10- 
20%, reflecting the proportion of c/s Xaa-Pro imide bonds at equilibrium in the unfolded state. 
In the case of shikimate kinase the slowest phase in the refolding has an amplitude of 55% of 
the total fluorescence change, and greater than 55% of the total changes in ANS desorption, 
shikimate binding and catalytic activity (Table 3.5). Further detailed studies of the refolding of 
mutants of SK in which the proline residues had been systematically substituted and of the 
refolding after very short periods of unfolding (the "double jump" technique (Nall, 1994)) 
would help to establish the role (if any) played by isomérisation of Xaa-Pro bonds in the 
refolding of the enzyme.
The results obtained can be compared with those reported (Zhang et al., 1998) on the
refolding of the structurally similar adenylate kinase after unfolding in urea. Because Zhang
et al. (1998) used only manual mixing techniques to initiate refolding, the early steps in the
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refolding pathway were not examined. Zhang et a/. (1998) observed that most of the 
etlipticity at 225nm of adenylate kinase was regained within 18s of the start of refolding and 
estimated the rate constant for the regain of secondary structure as >0.16s"' at 25°C. The 
data on shikimate kinase show that 75-80% regain of ellipticity at 225nm occurs within 20s, 
but that this occurs in three stages. The last stage during which most of the remaining 
ellipticity is regained occurs with a rate constant of approximately 0.009s"' at 20°C. The 
rate constant for the regain of activity of adenylate kinase reported by Zhang et al. (1998) 
was 0.025s"' at 25°C, which is of a comparable magnitude to the value obtained for SK 
(0.009s"' at 20°C) in the present work. In agreement with the observations reported in this 
thesis, Zhang et al. (1998) reported that there was a rapid increase in ANS fluorescence 
upon initiation of the refolding process, followed by a decline as the probe was released 
from the protein. The desorption step in the case of adenylate kinase occurred with a single 
rate constant (0.004s"'), which is of a similar magnitude to that of the slowest step 
observed, associated with regain of the activity of shikimate kinase. The results extend the 
less complete data available for the refolding of adenylate kinase (Zhang et al., 1998) 
indicating that the pathway described for SK should act as a model for many other members 
of this subclass of a/p proteins.
124
Appendix 3.1: Chemical modification of SK by pyridoxal-5’-phosphate.
Chemical modification techniques can be used to investigate the mechanism of an enzyme 
or the role of a specific residue in the catalysis. In this case pyridoxal-5’-phosphate (PLP) 
was chosen as a modifier because it react specifically with lysine residues forming a Schiff 
base. A series of controls have been performed as described in section 2.6 to validate the 
method. Chemical modification with PLP can be performed measuring the activity of a 
reduced or of a non-reduced Schiff base (section 2.6). Initially the modified enzyme was 
assayed without prior reduction with NaBH4 - Because in the case of SK a double coupled 
assay is used, the dilution affects the reversibility of the PLP reaction when the Schiff base 
is not reduced, as is evident from the comparison of the results reported in Fig. A3.1a and 
Fig. A3.1b of non-reduced and reduced samples respectively. In both cases there is only a 
partial loss of activity. A control is also reported which shows the effect of the incubation at 
room temperature and stirring on the SK activity. For this reason it was decided to measure 
the activity only of the reduced samples.
From site directed mutagenesis studies it was demonstrated (Kreil et al., 2001) that K15 is 
an essential residue for catalysis; indeed the K15M mutant did not possess detectable 
activity (Krell et al., 2001). The residual activity found in the protection experiments even at 
high concentrations of PLP could be due to the existence of a non-covalent complex 
enzyme-PLP that is not modified by reduction with NaBH4 . For glutamate dehydrogenase it 
has been found that modification by PLP leads to only partial loss of activity (Chen and 
Engel, 1974). The failure to achieve complete inactivation after prolonged incubation could 
be due both to the fact that the covalently modified enzyme is still active, though to a lesser 
extent than the native one, or that the enzyme is not all covalently modified. To check 
between these two possibilities studies on the K^ of the modified enzyme should be 
performed: if the Km of the modified enzyme is the same as that of the unmodified one, the 
decrease in activity is entirely attributable to a decrease in Vmax, that is to say the amount of 
the active enzyme has decreased and so the partial inactivation hypothesis is excluded. 
(Chen and Engel, 1974).
From a pseudo-first order analysis of the results (Fig. A3.2) it is evident that there is a 
deviation from linearity after the first minute. It is not possible to obtain reliable values of kobs 
even when the fitting is restricted to the first part of the curve: in fact the values of kobs do 
not give a linear dependence on PLP concentration. It is difficult to draw any conclusions 
from this non-linear behaviour, because of the numerous difficulties inherent in this kind of 
assay (section 2.6). Although the results are not completely satisfactory, and cannot be 
quantified in terms of inactivation constants they nonetheless gives some useful qualitative 
indications, and could be the basis for protection experiments.
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These protection experiments were carried out using the different substrates (shikimate, 
ATP and ADP) and combination of substrates (ADP and shikimate). Because from studies 
of the myosin-ADP-MgFn ternary complex it was suggested that the overall conformation of 
the complex was quite similar to that in the presence of ATP (Park et a/., 1999), a 
preliminary protection experiment has been attemped in the presence of ADP and NaF (the 
Mg^ "^  ion is present as a buffer constituent). The following experiments were used as 
controls for protection experiments: a) the inactivation curves obtained in the absence of 
ligand using PLP at 1.4mM, and b) the curve obtained in the absence of PLP (effect of the 
incubation at room temperature and of stirring on activity).
The presence of shikimate, either alone or with ADP, does not seem to give any protection 
against chemical modification (Fig. A3.3). The failure of shikimate to protect the enzyme is 
consistent with the fact that Lys15 is not involved in shikimate binding.
While ATP gives substantial protection, with the inactivation curve practically coincident with 
the SK control, ADP seems to give no protection (Fig. A3.5). The differences in the 
protection achieved in the presence of ADP and ATP confirm the role of K15 in the 
coordination of the y-phosphate and that this kind of interaction is necessary to achieve the 
conformational change required for catalysis, as demonstrated by the lack of protection 
even in the presence of shikimate and ADP. The fact that shikimate does not give any 
appreciable protection against PLP inactivation in the presence of ADP could support the 
hypothesis that the observed synergism in Tris-HCI is an artefact due to the presence of 
chloride ions. Probably the presence of the y-phosphate is a key factor in determining the 
conformational change in the presence of ATP plus shikimate.
The results, reported in Fig. A3.6, seem to indicate an increased protection by ADP in the 
presence of NaF. Because this experiment was performed only once it could be reproduced 
before making any conclusion. Moreover it would be necessary to perform a control with 
NaF and NaCI alone to check if the protection observed is due to an ionic strength effect.
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Figure A3.1; Time-courses of inactivation of SK by PLP.
SK (0.046mg/ml) was incubated at room temperature (20°C) while stirring in test tubes as 
described in section 2.6. Reactions were carried out in assay buffer containing the stated 
concentrations of PLP. Zero time activity was determined by sampling prior to PLP addition. 
At chosen time intervals, samples (10pl) were added to 30pl of a) water (non reduced 
samples) or b) to a solution of 5mg/ml of NaBH4 in water (reduced samples), mixed, and 
immediately assayed.
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Figure A3.2; Pseudo-first-order plots of inactivation of SK at various PLP concentrations. 
The data were analysed as described in section 2.6.
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Figure A3.3: PLP inactivation:effect of shikimate, alone and with ADP.
The effect of shikimate on inactivation of SK by PLP was investigated by incubating the 
enzyme with PLP (1.4mM) in the absence (black) and in the presence of 2mM shikimate 
(red) or 2mM shikimate -»- 2mM ADP (blue). The zero-time activity was measured on the 
sample, containing the ligand, before the addition of PLP.
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Figure A3.4: PLP inactivation: effect of nucleotide substrates.
The effect of nucleotide substrates on inactivation of SK by PLP was investigated by 
incubating the enzyme with PLP (1.4mM) in the absence (blue) or presence of 2mM ADP 
(red) and 2mM ATP (green). The inactivation due to sample stirring and incubation is 
reported as well (black). The zero-time activity was measured on the sample, containing the 
ligand, before the addition of PLP.
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Figure A3.5: Effect of NaF and ADP on the time-course of inactivation of SK by PLP
The effect of NaF in the presence of ADP on inactivation of SK by PLP was investigated by 
incubating the enzyme with PLP (1.4mM) in the presence of 0.1 M NaF+ 2mM ADP(green).
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Chapter 4: Effects of salts on the function, conformational stability 
and refolding kinetics of shikimate kinase
4.1 Abstract
Comparison of the effects of urea on the enzyme with those of guanidinium chloride and 
NaCI indicated that both chemicals significantly weakened the binding of shikimate (section
3.3.4). To check if the observed effect was due to a general ionic strength effect or was 
dependent on the ionic species in solution, the effects of different salts (KCl, CaCL, MgCla, 
NaF, NaBr, NaNOg) on the structure, activity, binding, and stability of SK have been 
investigated (sections 4.3 to 4.9).
The chosen salts have only small effects on the secondary structure as judged by far-UV 
CD. Though no effects are observed on the fluorescence spectra, NaCI and NazS0 4  give a 
tightening of the structure as shown by the effect on the near-UV CD (section 4.3).
All the salts studied have an effect on catalytic activity that seems to depend on the ionic 
strength and not on the particular salt used, with the exception of NaF which gives a higher 
degree of inactivation at lower concentration when compared with other salts (section 4.4). 
Moreover inclusion of salts leads to a marked stabilisation against unfolding of the enzyme 
by urea (section 4.8).
Differences between the salts are revealed by binding studies: by contrast with NaCI, 
Na2S0 4  affects the binding of shikimate to only a small degree. Using other chloride salts 
and other halide salts it seems that the shikimate binding is primarily affected by the 
presence of chloride ions, as previously suggested by the results obtained using the chloride- 
free buffer MOPS (section 3.3.1.2). NaCI, Na2 S0 4  and NaF were tested for their effects on 
nucleotide binding, the last one chosen for its different behaviour in the activity 
measurements.
Both NaCI and Na2 S0 4  do not have a major effect on the binding of nucleotides leading to a 
decrease of the Qmax (limiting quenching) and an increase in the Kd. NaF, on the other side, 
at low concentrations (0.1 M) gives a decrease of the Kd for ADP and, at higher 
concentrations to an increase of this parameter with no effect on the Qmax (section 4.6.1).
The same trend is observed for the ATP binding with fluoride again having a different effect. 
NaF at low concentrations determine a marked decrease of the Kd for ATP (section 4.6.2). 
On the basis of their effects on the catalytic activity, binding of substrates, and 
conformational stability of SK, NaCI and Na2 S0 4  were selected as representative salts for a 
more detailed study.
When the enzyme is unfolded by incubation in 4M urea, addition of 1M NaCI or 0.33M 
Na2 S0 4  leads to a relatively slow refolding of the enzyme as judged by the regain of native­
like CD and fluorescence (section 4.10.1). In addition the refolded enzyme can bind
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shikimate weakly while no binding of nucleotide could be directly observed (sections 4.5 and 
4.6). Some evidence for synergism in substrate binding has been observed that leads to the 
hypothesis that nucleotide binds at least to some extent. The degree of fluorescence 
quenching by I suggests that the single Trp has partially regained the positively charged 
environment provided by neighbouring Arg side chains in the native enzyme (section
4.10.1.4). However, the refolded enzyme does not possess detectable catalytic activity. The 
refolding process brought about by addition of salt in the presence of 4M urea is not 
associated with any change in the fluorescence of the probe ANS (section 4.10.1.3), 
indicating that either an intermediate formed by hydrophobic collapse is unlikely to be 
significantly populated or that the concentration of the chaotropic agent used for dénaturation 
displaces the dye by sheer competition (Kumar et al., 1996). The results point to both 
specific and general effects of salts on SK. These are discussed in the light of the structural 
information available on the enzyme (sections 4.10.3 and 4.10.4).
From the refolding experiments using GdmCI as dénaturant (Boam, 1999 - section 3.4.1) it 
seems that the refolding reaction was taking place faster than when urea was used to unfold 
the protein. To check for an effect of the residual ionic strength on the refolding of SK 
different concentrations of salts were included in the refolding buffer (urea was chosen as 
dénaturant in these experiments because of the non-ionic nature of this chemical). In general 
the presence of NaCI and Na2 S0 4  lead to an increase in the refolding rate, while NaF seems 
to impair the efficiency of refolding (Appendix 4.1).
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4.2 Introduction
Saits can affect a wide range of properties of proteins, as described in section 1.1.3.2, and 
for this reason they are widely used both for practical applications, and for research 
purposes. For most proteins, solubility at first increases with ionic strength (salting in), but 
then decreases at high ionic strength (salting out). The first studies on the effect of ionic 
strength on the stability and solubility proteins were performed by Hofmeister (1888). He 
ranked the effectiveness of anions and cations in precipitating proteins in a series now called 
the Hofmeister series, in which the most stabilising ions are those that promote hydrophobic 
associations. In this case the folded protein is stabilised with respect to the unfolded form 
largely by the unfavourable free energy of transfer of the non-polar side chains from the 
interior of the folded protein to the surrounding water (Jelesarov et a i, 1998).
Salts affect the stability of proteins depending on the ways they interact with them. Their 
effect is defined by the balance between their preferential interactions with the native and 
unfolded states (Arakawa et a i, 1990). At high concentrations they can cause preferential 
hydration or preferential binding to the protein depending on the type of salt and solvent 
conditions (Arakawa and Timasheff, 1982) or, at low concentrations, the stabilisation could 
be due to a Debye-Hückel charge screening effect (Moore, 1962; Giancota et a i, 1997). If 
protein solvation is the predominant factor, the effectiveness of anions and cations in 
stabilizing proteins can be ranked in the Hofmeister series (von Hippel and Schleich, 1969; 
Goto et a i, 1990; Baldwin, 1996).
sulphate > phosphate > fluoride > chloride > bromide > iodide > perchlorate > thiocyanate
If discrete ion binding plays a role in the stabilization, the effect should follow the 
electroselectivity series of anion binding to ion-exchange resins (Washabaugh and Collins, 
1986; Muzammil et a i, 2000). The electroselectivity series of anions towards anion 
exchange resins, which assumes that the net charge of anions is more important that their 
hydration, is as follows;
perchlorate > iodide > trichloroacetate > thiocyanate > nitrate > bromide >trifluoroacetate
>chloride > acetate > fluoride
Finally, salts can weaken electrostatic interactions through Debye-Hückel screening. If this 
is the predominant factor for the stabilisation, this should roughly follow the ionic strength, 
should be observed at low concentration of salts (below 0.1M) and should be primarily 
associated with the cation (KOI stabilizes more than an equimolar concentration of 
NaCI)(Arakawa et al., 1990).
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The anions to the left of chloride in the Hofmeister series are called “kosmotropic” anions 
(water structure makers). They are small ions of high charge density that bind water 
molecules tightly and increase the surface tension of aqueous solutions. They are believed 
to stabilize the native structure of the protein molecule by causing preferential hydration of 
the protein, i.e. preferential exclusion of kosmotropes from the protein surface. 
Kosmotropes stabilise proteins and decrease their solubility (salting-out); the only change in 
the system during precipitation is a reduction of the protein surface exposed to the solvent 
due to the formation of protein-protein contacts (Timasheff and Arakawa, 1997).
The chaotropic anions (anions on the right of chloride in the Hofmeister series) are large 
ions of low charge density that do not bind water tightly, but rather increase the mobility of 
nearby water molecules. They generally destabilize the protein structure by preferentially 
interacting with the protein and increase their solubility (salting-in). The binding is 
dependent on the chemical nature of the surface of the protein in contact with the solvent 
and can vary strongly with the state of the system, such as pH, co-solvent concentration, 
and state of folding of the protein (Pace and Grimsley, 1988). The preferential binding will 
led to stabilization if the binding with the native state is more favourable than the binding to 
the unfolded state (Arakawa, 1989; Arakawa et al., 1990). Hence every system needs to be 
studied individually in detail.
In section 1.1.3.2 the importance of the ionic strength of the solution on enzyme activity has 
been discussed. In the case of SK, hinge-bending motions are determinants in the enzyme 
activity. Since hinge-bending motions have low energy barrier height, the populations of the 
closed versus the open conformations are function of their relative stabilities. A shift in the 
equilibrium between the closed and open conformations may be observed in response to 
external factors, such as pH, temperature or ionic strength (Sinha et al., 2001).
The salts can be used for studying the role that electrostatic interactions and ion binding play 
in the refolding of proteins, as has been discussed in section 1.1.3.2. and using different salts 
it can be determined which factor plays a predominant role. Some kinetic data indicate that 
co-solvents can influence the refolding rates by increasing the stability of the intermediates 
that lead to the native form. These intermediates may go undetected but can be induced to 
accumulate transiently at sufficiently high salt concentrations (Eder et al., 1993; Ferguson et 
al., 1999; Krantz and Sosnick, 2000). On the role of these intermediates in the refolding 
pathway there are contrasting opinions (Bieri et al., 1999; Otzen and Oliveberg, 1999). It is 
still a matter of debate whether these states represent key stepping stones in the folding 
process, or are circumstantial pitfalls in the energy landscape. In some cases it has been 
demonstrated that these kinds of intermediates are off pathway: they cause a prematurely 
collapsed state and slow down folding by several orders of magnitude (Otzen and Oliveberg,
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1999). In other cases the presence of salts has increased the rate of folding by enhancing 
the population of productive intermediates (Low et al., 2000).
Clearly a better understanding of the ways in which salts can interact with proteins could 
have important applications (section 1.1.2.2) and could give valuable insights into designing 
experiments and to understanding phenomena such as adsorption, aggregation and 
stabilization which underlie many biological events (section 1.1.1.3). In this study was chosen 
the range of concentrations where the Hofmeister effects become important (0.1-1M): under 
these conditions anions play the major role (Cacace et al., 1997).
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4.3 Fluorescence and CD spectra: the effect of salts
4.3.1 UV and Fluorescence Spectra
Before using NaCI in the experiments described in sections 3.3 3-3.3.5 some preliminary 
controls were performed. In these UV, fluorescence and of CD spectra (near- and far-UV) 
were acquired to verify if the presence of salts had any effect on the overall enzyme 
conformation. The presence of NaCI in a SK solution (0.1 mg/ml) increases the contribution 
to the light scattering at 280nm by 20.6% (calculated with the linear regression on the graph 
log X vs log A) indicating an increase in the aggregation in the presence of this salt (Figure 
4.1). Light scattering experiments (as described in section 2.4) in the presence of NaCI 
were performed during the refolding studies and as well.
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Figure 4.1: Calculation of the light scattering contribution at 280nm.
The absorption spectra of protein solutions 0.1 mg/ml SK in buffer (circles) and in the 
presence of 1M NaCI (squares) were recorded in the range 240-400nm. The contribution of 
the light scattering to the absorbance at 280nm was calculated plotting the logarithm of 
absorbance vs logarithm of wavelength between 320nm and 360nm and making a linear 
extrapolation to the 276-282 region (Pace and Schmid, 1997).
Fluorescence spectra of protein solutions (0.15mg/ml) in the presence of NaCI were 
prepared by dilution from stock solutions (section 2.7) and the fluorescence spectra were 
recorded as described in section 2.4. The spectra were acquired immediately after 
preparation and after 30 minutes and 1 hour incubations at 20°C. This was done to check if 
the increase in aggregation observed in the presence of NaCI was accelerating the 
decrease of fluorescence intensity observed for SK in buffer after incubation at room 
temperature (section 3.3.1.3). In figure 4.2 the data are reported for NaCI: it seems that
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NaCI has no effect on the time course, and the observed decrease in fluorescence seems 
to be due only to the incubation time.
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Figure 4.2: Effect of added NaCI on the decrease in fluorescence intensity at 20°C.
Fluorescence spectra were acquired after excitation at 295nm in the range 300-400nm. The 
protein solutions (0.15mg/ml) were incubated at room temperature (20°C) and the spectra 
acquired again after different incubation times. The data shows the time courses of the 
fluorescence intensity at 350nm: SK (black); SK + 0.25M NaCI (red); SK + 0.5M NaCI 
(green); SK + 1M NaCI (blue).
All the comparisons that follow are made between fluorescence spectra acquired 
immediately after preparation. NaCI seems to have a small effect on the intensity of the 
fluorescence (Figure 4.3a), and no effect on the emission maximum. A control experiment 
performed with the model compound NATA has demonstrated that the observed small 
increase was due to a non-specific effect on the Trp fluorescence (Fig. 4.3b). The 
fluorescence spectra in the presence of other salts were also measured. The concentrations 
of salts were chosen to have the same ionic strength of a 1M NaCI solution, calculated as 
follows:
p = 14 l i  C*^
where p is the ionic strength of the solution, Cj is the concentration of the ion, Zj is the 
charge of this ion, and the sum is extended to all the ions present in solution. The salts 
chosen were: Na2S0 4  (0.33M and 0.17M) because sulphate is a known stabiliser; KCl (1M), 
CaCl2 and MgCl2 (0.33M) to change the cation respect to NaCI; NaF (1M) and NaBr (1M) to 
check the other halide salts. These salts do not give any change in the fluorescence 
emission maximum, indicating that the polarity of the Trp environment is unchanged (Fig. 
4.4a and 4.5), and they have only a small effect on the intensity of the fluorescence spectra, 
with the exception of NaBr. Control experiments performed using NATA, in the presence of 
those salts which had a bigger effect on the SK spectra (Fig. 4.4b), demonstrated that the
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effect on Trp fluorescence was due to a non-specific effect of salts, as in the case of NaCI. 
It should be noted that in other studies the effects of salts on NATA fluorescence were 
found to be opposite (a decrease in fluorescence) but in this study higher concentrations of 
salts were tested than those used in this study (Nishimura et al., 2001).
NaBr leads to a decrease of the intrinsic Trp fluorescence both for the proteins and for 
NATA. An UV-spectrum of a 1M NaBr solution was acquired to assess if the observed 
decrease of intensity was due to inner filter effect or to the quenching of the Trp 
fluorescence. Because this salt absorbs around 200nm, the inner filter effect hypothesis can 
be excluded.
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Figure 4.3: Effect of NaCI on Trp fluorescence.
Fluorescence spectra were acquired in the 300-400nm range after excitation at 295nm, T= 
20“C. The data shows: a) SK 0.15mg /ml in the presence of different concentrations of NaCI.
b) NATA lOpM in the presence of different concentrations of NaCI.
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Figure 4.4: Effect of KCl, CaCl2 , NaF and NaBr on Trp fluorescence.
Fluorescence spectra were acquired in the SOCMOOnm range after excitation at 295nm, T= 
20°C. The data shows: a) SK 0.15mg /ml in the presence of different concentrations of salts, 
b) NATA lOpM in the presence of different concentrations of salts
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Figure 4.5; Effect of Na2S0 4  on intrinsic Trp fluorescence.
Fluorescence spectra were acquired in the 300-400nm range after excitation at 295nm, T= 
20°C. The data s h ^ s : SK 0.15mg /ml in the presence of different concentration of Na2S0 4
4.3.2 Circular dichroism spectra
The far-UV CD spectrum in the presence of different salts was analysed to check if the 
presence of salt had an effect on the secondary structure of the protein (section 1 .3 .1 .2 ). 
The solutions were prepared at the same protein concentration (0.15mg/ml) and in the 
same way as the solutions for the fluorescence experiments. In Fig. 4.6 are reported the far- 
UV CD spectra at different NaCI concentration. At these concentrations of salt there is a 
slight increase in the intensity of the CD spectrum, the biggest effect being observed at 1M 
NaCI. The observed effect does not seem to be due to the nature of the cation, as shown by 
the fact that the CD spectrum in the presence of 1M KCl is very similar to that in 1M NaCI 
(Fig. 4.7a). NaF has the same effect, on the far-UV CD, as NaCI at a similar concentration 
(0.5M) (Fig. 4.7b). In general while salts as NaCI, Na2S0 4  (Fig. 4.8) and, to a lesser extent 
NaF, lead to an increase of the secondary structure content of SK, salts such as MgCb and 
CaCl2 lead to a decrease in the CD signal in the far-UV region. It is possible that the Mg^  ^
and Ca^* cations have an effect on the protein secondary structure because these two 
cations are known to bind to proteins (Arakawa and Timasheff, 1984) and, in this particular 
case, Mg^* is essential for catalysis by SK.
The near-UV CD spectrum was acquired for protein solutions in the presence of 1M NaCI
and 0.33M Na2S0 4 - These two salts have a limited but significant effect on the near-UV CD
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spectrum with a 20-25% increase in ellipticity at 288nm (Figure 4.9). Although the strength 
of near-UV CD signals of proteins can arise from a number of causes (Kelly and Price, 
1997), it is likely that this enhancement of the ellipticity observed for SK in the presence of 
these two salts reflects decreased mobility of the aromatic amino acid side chains.
This tightening of the enzyme structure probably reflects a salt-induced increase in 
hydrophobic interactions. A slight tightening of a protein structure may not result in any 
change in solvent accessibility to aromatic residues and therefore will not change the 
maximum fluorescence of Trp side chain. This seems to be the case of SK because, as 
have reported in the previous section, the presence of salts does not cause any change in 
the fluorescence emission maximum.
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Figure 4.6; Circular dichroism spectra of SK in the presence of NaCI.
Far-UV CD spectra were recorded at 20°C using samples dissolved in buffer D (35mM Tris- 
HCI, pH 7.6, containing 5mM KCl, 2.5mM MgCl2 and 0.4mM dithiothreitol), protein 
concentration 0.15mg/ml and cell pathlength 0.05cm. The data shows the spectra of SK in 
buffer (black), and in the presence of 0.25M NaCI (red), 0.5M NaCI (green) and 1M NaCI 
(blue).
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Figure 4.7: Circular dichroism spectra of SK in the presence of NaCI, KCl and NaF.
Far-UV CD spectra were recorded at 20°C using samples dissolved in buffer D (35mM Tris- 
HCI, pH 7.6, containing 5mM KCl, 2.5mM MgCb and 0.4mM dithiothreitol), protein 
concentration 0.15mg/ml and cell pathlength 0.05cm. The data shows:
a) SK in buffer (black), in the presence of 1M NaCI (red) and 1M KCl (green).
b) SK in buffer (black), in the presence of 0.5M NaCI (red) and 0.5M NaF (green).
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Figure 4.8: Effects of other salts on the CD spectra of shikimate kinase.
Far-UV CD spectra were recorded at 20°C using samples dissolved In buffer D (35mM Tris- 
HCI, pH 7.6, containing 5mM KCI, 2.5mM MgCl2 and 0.4mM dithiothreitol), protein 
concentration 0.15mg/ml and cell pathlength 0.05cm. The data shows: SK in buffer (baick) 
and in the presence of 1M NaCI (red), 0.33M NagSO^ (green), 0.33M CaCl2  (blue) and 0.33M 
MgCb (cyan).
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Figure 4.9: Near-UV CD spectra of SK in the presence of 1M NaCI and 0.33M Na2S0 4  .
Near-UV spectra were recorded at a protein concentration of 0.5mg/ml in buffer D in a cell of 
pathlength 0.5cm. The solid, dashed and dotted lines refer to enzyme in the absence of salts, 
in the presence of 1M NaCI and in the presence of 0.33M Na2S0 4  respectively.
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4.4 Effect of salts on the activity and the kinetic parameters
As previously reported, incubation of SK with urea leads to a loss of activity, with 85% and 
40% activity retained in the presence of 1M and 2M urea respectively. The incubation of SK 
with low concentrations of GdmCI leads to more marked losses of activity; thus in the 
presence of 0.5M and 1M GdmCI 75% and 95% activity is lost respectively. A significant part 
of the effect of GdmCI appears to be due to the ionic strength of the solution, since 
incubation in the presence of 0.5M and 1M NaCI leads to losses of 45% and 65% activity 
respectively (section 3.3.5).
The quenched assay procedure (section 2.2) was used to assess the effects of a number of 
salts (NaCI, KCI, NaBr, NaNOs, MgCb, MgS0 4  and N8 2 8 0 4 ) on the activity of SK.
Controls were performed to check the feasibility of this assay in order to check that the salts 
(even after dilution into the "capture system") had no significant effect on the efficiency of 
the coupling enzymes (pyruvate kinase and lactate dehydrogenase): known concentrations 
of ADP were added to the capture system and the rapid decrease in the concentration of 
NADH was found to correspond to the concentration of ADP added, confirming that the 
quenched assay method was valid. The obtained theoretical and experimental values are 
reported in table 4.1. From these data it seems that calcium ions and nitrate ions have an 
effect on the coupling enzymes, this effect being more pronounced for the former kind of 
ions. Because calcium ions are reported as inhibitors of pyruvate kinase, one of the 
coupling enzymes used in the SK assay (Mildvan and Cohn, 1965; Betts and Evans, 1968), 
it was not possible to further study the effects of calcium ions on the SK activity.
The results (shown in Table 4.2) indicate that for these salts the activity declines in a 
manner that is approximately related to the ionic strength of the solution (Fig. 4.10).
The exceptions are NaF and NaNOg; however for NaNOs the effect on the coupling 
enzymes has to be taken into account (Table 4.1). From the data of Table 4.1 and 4.2 it 
seems that NaNOs has an effect on both SK and the coupling enzymes, giving 78% of 
residual activity in the control experiment but 5% of residual activity under the same 
conditions in the assay.
NaF has the biggest effect on the enzyme activity, and no effect on the coupling enzymes. 
Fluoride is a known inhibitor of some proteins, among them enolase (Nowak and Maurer, 
1981; Bunick and Kashket, 1982; Lebioda et al., 1993), urease (Todd and Hausinger, 2000) 
and the ATPase activity and transport. In this last case, usually fluoride ion has been 
reported to be an inhibitor of proteins like myosin (Maruta ef a/. 1993; Park et a i, 1999) and 
G-proteins (Bigay at a!., 1987) in the presence of traces of AIF3 or BF3 . There is evidence 
that fluoride ion can form a ternary complex with Mg^  ^and ADP in the absence of AP"^  that 
mimics the transition state of the ATPase reaction (Antonny at a i, 1990; 1993; Maruta at a i,
2000). In the case of shikimate kinase the inhibition is observed at higher concentrations of
143
NaF than those reported in the above mentioned studies so, if binding exists, it is very 
weak. It has to be pointed out that the protection experiments performed on the PLP 
inactivation of SK (appendix 3.2) lead to the suggestion that fluoride ions have some effect 
on SK but this should be further investigated before drawing any firm conclusions.
NaCI and Na2S0 4  were selected as representative salts for more detailed study on the 
effect on the kinetic parameters. Using the continuous (double-coupled assay) the effects of 
NaCI and Na2 S0 4  on the kinetic parameters of SK were determined with the results shown 
in Table 4.3. Although the results show that salts have multiple effects on the kinetic 
parameters, some trends emerge. The inclusion of 0.5M NaCI leads to an approximately 2- 
fold increase in the apparent Km values for both substrates; in addition there is a decrease 
of about 40% in the value of Vmax- The inclusion of 0.17M Na2 S0 4  (which has the same ionic 
strength as 0.5M NaCI) causes a substantial (8-fold) increase in the apparent Km for ATP 
and a small (1.3-fold) increase in the apparent Km for shikimate. These changes are 
accompanied by a 50-60% decrease in Vmax- The effect of salts on enzyme activity can be 
due to different factors; the salts can bind to particular sites on the protein, they can 
increase the hydration of protein surface, or salts can increase the hydrophobic interaction 
giving an increase in the rigidity of the enzyme with the elimination of the dynamic motion 
that is required for efficient catalysis.
In order to gain further insights into the origins of the changes in kinetic parameters, the 
effects of salts, in particular NaCI and Na2 S0 4  on the binding of substrates have been 
explored.
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Figure 4.10: Effects of salts on the activity of shikimate kinase.
Quenched assay procedure.The reaction was carried out as described in section 2.2. The 
data are shown in terms of the added ionic strength for NaCI (filled squares), KCI (filled 
circles), MgCb (filled triangles), Na2 S0 4  (open squares) and MgS0 4  (open circles).
Conditions 
in SK assay
Conditions in assay 
after quenching
[ADP] (nM) 
Theoretical
[ADP] (nM) 
Experimental
0.33M NazSO^ 0.016M Na2S04 30.7 33.1
0.5M NaF 0.024M NaF 30.7 31.7
1M NaBr 0.048M NaBr 30.7 31.8
0.33M MgClz 0.016M MgCl2 30.7 31.7
0.33M CaCl2 0.016M CaCl2 30.7 0
0.33M Ca(N03)2 0.016M Ca(NOs)2 30.7 0
1M NaNOs 0.048M NaNOs 30.7 24.08
4M Urea 0.2M Urea 58.6 56.2
4M Urea + 1M NaCI 0.2M Urea + 0.048M NaCI 29.2 29.2
Table 4.1: Controls of the quenched assay procedure
The concentration of an ADP stock solution was determined as described in section 2.3 This 
stock solution was diluted in the appropriate conditions in an “incubation solution” and then 
assayed as described in section 2.2.
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Salt added [Salt] (M) % Activity
NaCI 0.1M 94.2
0.25M 88.8
0.5M 57.4
1M 32.8
Na2S04 0.085M 84.5
0.17M 50.7
0.33M 31.3
NaF D IM 82.8
0.25M 6.1
0.5M 0
NaBr 0.1M 116.1
0.25M 85.6
0.5M 71.5
1M 14.74
Nal 0.1M 85.3
0.25M 61.5
0.5M 6.1
KCI 0.1M 94.5
0.25M 94.5
0.5M 72.2
MgCb 0.085M 84.7
0.17M 71.1
0.33M 35.1
MgS04 0.085M 64.9
0.17M 39.0
0.33M 23.7
NaNOs 0.1M 100.9
0.25M 61.0
0.5M 35.1
1M 4.8
Table 4.2: Effects of salts on the activity of shikimate kinase
The activities were determined using the quenched assay method as described in the text. 
The values are referred to the activity in buffer D as 100%.
Solution Km (ATP) 
(mM)
Vmax (ATP) 
(pnnol/min/mg)
Km (shikimate) 
(mM)
Vmax (shikimate) 
(nmol/min/mg)
SK 0.27 ± 0.02 348 ± 10 0.13 ±0 .02 301 ±11
SK + 0.25M NaCI 0.59 ± 0.07 367 ± 15 0.20 ± 0.01 220 ± 4
SK + 0.5M NaCI 0.67 ±0.11 211 ± 13 0.25 ± 0.04 175 ± 6
SK + 0.083M Na2S04 1.95 ±0 .27 262 ± 15 0.11 ±0 .02 198 ± 7
SK + 0.17M Na2S04 2.13 ±0 .52 177 ± 18 0.18 ±0 .04 124 ± 6
Table 4.3: Effects of salts on the kinetic parameters of SK
The kinetic parameters were determined by using the double-coupled assay as described in
section 2.2.
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4.5 Effects of salts on binding of shikimate
Addition of low concentrations (up to 1M) of GdmCI to the enzyme-shikimate complex led to 
an increase in fluorescence indicating that binding of the substrate had been weakened 
causing a relief of substrate-induced quenching (section 3.3.3). The weakening of shikimate 
binding (as demonstrated by an increase in protein fluorescence) was also observed in the 
presence of NaCI at concentrations up to 1M, indicating that the decrease in affinity for the 
substrate largely arose from the effect of increased ionic strength (section 3.3.4). To check 
the effect of salts on shikimate binding two different kinds of experiments have been 
performed as described in section 2.3; in one set of experiments a protein solution containing 
stated concentration of salts was titrated with shikimate, while in another set of experiments 
a solution of protein and substrate (2mM shikimate) was titrated with a stock solution of salt.
By performing titrations of the enzyme with shikimate in the presence of various 
concentrations of salts, it has been possible to demonstrate that all the salts tested have an 
effect on shikimate binding leading to an increase of the Kd . At comparable ionic strengths, 
chloride ions have a much greater effect on the stability of the enzyme-substrate complex 
than the other anions tested (Table 4.4). This effect is markedly concentration-dependent for 
chloride ions and does not depend on the cation as demonstrated by the values obtained for 
0.33M CaCb and 0.33M MgCl2 (0.66M chloride concentration) being similar to the NaCI 
solution closest in chloride ion concentration (0.5M). Fluoride ions (0.5M) seem to have no 
major effect on the shikimate binding.
The second set of titrations was performed by titrating a solution of SK and shikimate with 
stock solutions of salts prepared as described in section 2.7. The interesting feature of these 
kinds of experiments is that it is possible to examine the effects on the binding of shikimate at 
low concentrations of salts. Table 4.5 reports the values of the Kd calculated when plotting 
the titration curves as a function of the anion concentration. NaCI and CaC^ give very similar 
values of K,, while KCI gives a slightly higher value though the titration curve seems to be 
similar to the one obtained with NaCI (Fig. 4.11). Because also KCI has a different effect on 
the activity, it is not possible to say, with the available data, if the observed difference is due 
to an artefact in the fitting process or to a real effect. NaF does not have any effect on 
shikimate binding, results that confirm the previous results obtained with the shikimate 
titration. In the case of NaCI the effects on the Kd (Table 4.4) indicated that the salt competed 
with the shikimate, with a Kj value estimated as 0.12M (Table 4.5).
These results point to the possibility that there is a specific effect of the chloride ion on the 
shikimate-binding site of SK. As previously reported (section 3.3.1.2) the binding of 
shikimate, In Tris-HCI buffer, is strengthened in the presence of ADP, indicating that a 
degree of synergism occurs in substrate binding. This synergism is also observed in the
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presence of NaCI or Na2S0 4 , that were chosen as representative salts, but is considerably 
more pronounced in the former case (Table 4.6 and Fig. 4.12).
Solution Q m a x Kd (mM)
SKI! (TRIS) 0.89 ± 0.008 0.60 ±0.017
+ 0.25M NaCI 0.84 ±0 .015 2.12 ±0.075
+ 0.5M NaCI 0.79 ± 0.025 2.81 ±0 .172
+ 1M NaCI 0.88 ± 0.036 4.73 ± 0.30
+ 0.085M NazSOA 0.88 ±0 .018 1.07 ±0 .05
+ 0.17M Na2S04 0.87 ±0 .016 1.36 ±0 .053
+ 0.33M Na2S04 0.89 ± 0.014 1.39 ± 0.046
+ 0.5M NaF 0.99 ± 0.03 1.08 ±0 .07
+ 0.33M MgCl2 0.77 ±  0.045 2.8 ± 0.263
+ 0.33M CaCl2 0.67 ± 0.046 1.96 ±0 .24
Table 4.4: Binding of shikimate in the presence of different salts.
The titration was performed as described in section 2.3 The protein concentration used was 
in the range 0.04-0.06mg/ml, the volume of the S K  solution was 1ml. The results were 
expressed as K d  (dissociation constant) and Qmax (limiting quenching of fluorescence).
Salt Q m a x Ki (mM)
NaCI 0.80 ± 0.032 0.12 ±0.016
KCI 0.95 ± 0.044 0.24 ± 0.025
CaCl2 0.97 ±  0.038 0.11 ±0 .014
Na2S04 0.41 ± 0.057 0.096 ± 0.035
Table 4.5: Titration with salts in the presence of shikimate.
Aliquots of salts stock solution were added (llx lO p I) and the fluorescence intensity at 
350nm was recorded (excitation wavelength 295nm; T= 20°C). The protein concentration 
used was in the range 0.04-0.06mg/ml; the volume of the SK solution was 1ml, the shikimate 
concentration 2mM. The results were expressed as Kj and Qr(max
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Solution Kd (mM) Kd (mM)
(+ 2mM ADP)
SKI! (Tris) 0.60 ± 0.02 0.38 ± 0.02
SKII + 1M NaCI 4.73 ± 0.30 1.74 ±0 .07
SKII + 0.33M N82S04 1.39 ±0 .05 1.25 ±0 .06
Table 4.6: Binding of shikimate in the absence and presence of ADP.
The titrations were performed as described in section 2.3 in buffer Tris-HCI and and in buffer 
Tris-HCI containing 2mM ADP.
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Figure 4.11; Titration with salts; effect on the shikimate binding.
A protein solution (0.04-0.06mg/ml) in the presence of shikimate (2mM) was titrated with 
stock solutions of salts and the fluorescence change recorded. The data were fitted by 
hyperbolic function to give an estimation of the Kj as reported in Table 4.5.
149
Q7n
Q6-
Q5-
Q4-Q
4r Q3- .  o
. O '
02- . O '
O
01-
.  o
201.5 2505 1.0 ao
[shikimate] (mM)
Figure 4.12: Binding of shikimate in the presence of salts; effect of the presence of ADP.
The titration was performed as described in section 2.3. The protein concentration used was 
in the range 0.04-0.06mg/ml, the ADP concentration was 2mM; the volume of the SK solution 
was 1ml. The data were analysed by fitting to a hyperbolic curve to give the values of Kd 
reported in Table 4.6. The data show the shikimate titration curves in the presence of 
shikimate and respectively: 1M NaCI (open diamonds), 1M NaCI+2mM ADP (open triangles), 
0.33M Na2 S0 4  (squares), 0.33M Na2 S0 4 + 2 mM ADP (circles).
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4.6 Effects of salts on the binding of nucleotides
NaCI, Na2 S0 4  and NaF were chosen to study the effects of salts on the binding of 
nucleotides because of their different effects on activity and shikimate binding.
The fluorescence quenching curves were corrected for the inner filter effect as described in 
section 2.3 (for each condition a corresponding titration was performed in duplicate with 
NATA). In some cases the low value of Qmax made detailed analysis of the data difficult.
4.6.1 ADP binding
The binding of ADP was tightened to a moderate extent in the presence of NaCI and Na2 S0 4  
(Fig. 4.13a, b and Table 4.7). The effect, in general, does not seems to be salt concentration- 
dependent; from data obtained at lower concentrations of these salts it was not possible to 
discern any obvious trend in terms of the effect of ionic strength on binding of ADP. NaF, at 
low concentrations (0.1M), gives an increase in the Qmax and a decrease of K<j though to a 
smaller extent when compared with the other two salts tested. Moreover it leads to an 
increase of Kd at higher concentrations with no effect on the Qmax (Fig. 4.13c).
Solution Q m a x Kd (mM)
SKII (TRIS) 0.6 ±0 .017 1.71 ±0.1
+ 0.25M NaCI 
+ 0.5 M NaCI 
+ 1 M NaCI
0.38 ±0 .013  
0.38 ±0.011  
0.35 ±0 .014
0.92 ± 0.08 
0.97 ± 0.07 
1.07 ±0 .10
+ 0.085M Na2S04 
+ 0.17 MNa2S04 
+ 0.33 MNa2S04
0.37 ±0 .013  
0.39 ± 0.02 
0.38 ± 0.021
0.96 ± 0.09 
1.75 ±0 .18  
0.78 ±0.11
+ 0.1 M NaF 
+ 0.25 M NaF 
+ 0.5 M N aF
0.69 ± 0.024 
0.62 ± 0.020 
0.63 ± 0.045
1.38 ±0 .10  
1.94 ±0 .12  
2.49 ±0.31
Table 4.7; ADP binding
Aliquots of ADP stock solution were added (lOxlOpI of the lOmM stock solution followed by 
5x1 OpI of the 50mM stock solution) and the fluorescence intensity at 350nm was recorded 
(excitation wavelength 295nm - T= 20°C). The protein concentration used was in the range 
0.04-0.06mg/ml, the volume of the SK solution was 1ml. The data were analysed by fitting to 
a hyperbolic curve to give the values of Kd (dissociation constant) and Qmax (limiting 
quenching of fluorescence).
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Figure 4.13: ADP binding in the presence of salts
The titrations were performed as described previously and in section 2.3.
a) Squares: SK; open circles: 0.25M NaCI; open triangles: 0.5M NaCI; crosses: 1M NaCI
b) Squares: SK; open circles: 0.085M Na2 S0 4 ; open triangles: 0.17M Na2S0 4 ; crosses: 
0.33M Na2S04
c) Squares: SK; open circles: 0.1 M NaF; open triangles: 0.25M NaF; crosses: 0.5M NaF
4.6.2 ATP binding and comparison with ADP titration curves
As reported previously (Krell et al., 2001), when the ATP binding constant was measured by 
fluorescence quenching, ATP was found to bind rather weakly to the enzyme with a K  ^ (2.6 
mM) some 10-fold higher than the apparent Km for this substrate. Changing the buffer Tris- 
HCI to MOPS has an effect only on the binding of ATP while no effect was detected for ADP 
binding (section 3.3.1.2). The titration curves obtained for ATP in Tris-HCI and MOPS are 
reported in figure 4.14. Though the given values of Kd reported in Table 3.1 are obtained 
with a hyperbolic fitting, it seems that the best fitting is obtained with the Hill equation (y= A* 
XV K-fX*’) (Fig. 4.14). This had been noted previously (Boam, 1999) but the origins of this 
behaviour remain unclear. ATP titrations were performed in the presence of NaCI, Na2 S0 4  
and NaF as for ADP. The binding parameters were determined by monitoring the quenching 
of protein fluorescence as described for ADP and in section 2.3. The presence of salts 
“removes” the sigmoidal trend and the best fitting is obtained with a hyperbolic function. 
Moreover the presence of salts leads to a modest increase in the affinity for this substrate, 
with the Kd values reduced by approximately 2-fold (Fig. 4.15 a, b, c and table 4.8), with NaF
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having the biggest effect (Fig. 4.15 c), though at a lower concentration when compared with 
other salts.
Solution Kd (mM)
SK (Tris-HCI) 2.58 ±0 .51*
SK 0.25M NaCI 1.19±0.11
SK + 0.5M NaCI 1.02 ±0 .06
SK + 0.085M NazSO^ 1.14 ±0.08
SK + 0.17IVI NazSO# 1.38 ±0.12
SK -1-0.1 M NaF 0.98 ± 0.08
Table 4.8: ATP binding in the presence of salts.
*Value obtained by fitting to a hyperbolic function.The titration was performed as described in 
section 2.3
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Figure 4.14: Titration curves for ATP obtained in buffers Tris and MOPS.
Red fitting: hyperbolic function fitting (data: table 3.1); Black fitting: Hill equation: 
MOPS: K= 0.89mM; h= 1.47; Qmax= 0.32;Tris-HCI: K= 1.1 OmM; h= 1.76; Qmax = 0.22.
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Figure 4.15: ATP titrations in the presence of salts.
The data show titrations performed in the presence of different concentrations respectively of 
a) NaCI; b) Na2 S0 4 ; c) NaF 0.1M
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4.7 Effects of salts on the quenching of fluorescence by Nal
Quenching of the fluorescence of SK by Nal can be used as an index to check the integrity of 
the electrostatic environment of the single Trp (Trp54) in the enzyme (section 1.3.2.4). 
Enzyme solutions containing salts were titrated with Nal and the data were analysed 
according to the general form of the Stern-Volmer equation (section 2.4).
Control experiments were performed to correct for any small effects of these salts on the 
quenching of the fluorescence of N-acetyltryptophan amide (NATA). The data (summarised 
in Table 4.9) show that the effects are correlated principally with the ionic strength of the 
solution and the nature of the anion added: the observed decrease in Ksv probably reflects a 
screening of the charge of the Arg side chains in the proximity of the side chain of Trp54. In 
fact an ion like fluoride, which is highly hydrated in solution due to its high charge density, 
has the lower screening effect (Collins, 1995). The NaBr has a larger effect but probably this 
is due to the fact that the bromide ion can act as a quencher of the Trp fluorescence (section 
4.3.1).
Conditions Ksv
(NT)
Ksv NATA
(M ')
KsvjSK+x) * Ksv (nata)/Ksv(nata+x)
(NT)
Tris-HCI 20.0 10.1 2 0 0
+1MKCI 14.5 10.2 14.4
+0.5M NaF 22.2 11.2 2 0 . 0
+1M NaB r(*) 6.12 6.64 9.31
+0.33M CaCl2 17.1 10.5 16.5
0.33M Na2S04 17.2 11.7 14.9
Table 4.9: Stern-Volmer constants for the quenching of Trp54 fluorescence by Nal
The Stern-Volmer constants were determined from plots of F/Fq v s  [I ] as described in section
2.4.
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4.8 Equilibrium unfolding in the presence of different salts
The order of effectiveness by which different salts stabilise protein molecules generally 
follows the Hofmeister series, which is believed to occur through the modification of water 
structure. If anion-binding plays a role, the order of stabilisation will follows the 
electroselectivity series (section 4.2).
The effect of salts on the stability of SK was studied using a range of different salts and at 
different concentrations for NaCI and Na2S 0 4 . The salts were chosen to test both the effects 
of cations and anions on the stability of the enzyme. Among the cations tested were: K"^ , Na^, 
Ca^^ and Mg^ "^  which have a decreasing order of stabilisation according to the Hofmeister 
series for cations. Among the anions were chosen, in order of effectiveness: S O 4 F\ Cl', 
Br where chloride is neither a typical kosmotrope nor a chaotrope. The unfolding curves 
obtained in the presence of three different concentration of NaCI are shown in Fig. 4.16.
The presence of NaCI gives a marked stabilisation against dénaturation by urea, and this 
stabilisation is concentration dependent. The stabilising effect does not depend on the cation 
used, as demonstrated by the unfolding curve obtained in the presence of KCI which shows 
a similar stabilisation to that obtained in 1M NaCI (Figure 4.16).
Na2 S0 4  is a well-known stabiliser and salting out agent and has the biggest effect at the 
same ionic strength, as it is shown in figure 4.17. Finally the effects of NaBr, MgCb, CaCb 
and NaF were investigated, though a limited number of points were acquired (Figure 4.18).
Estimated values for [Urea]i/2  (concentration of urea required to give 60% unfolding) are 
shown in Table 4.10, though it should be noted that in some cases only a rough estimate 
was possible due to the small number of data-points. In all cases, the salts stabilised the 
enzyme against unfolding by urea. For example, the addition of 1M NaCI increased the 
[urea]i/2  from 2.1M to 4.6M. From the data it appears that the anion dominates, as 
demonstrated by the equivalence of the unfolding curves obtained using KCI and NaCI, and 
by the fact that 0.33M MgC^ give a stabilisation similar to 0.5M NaCI. The larger degree of 
stabilisation observed with MgCl2 compared with CaCb probably reflects specific coordination 
of Mg^ "^  with protein side chains (Thr16 and Asp32). Instead the higher degree of stabilisation 
given by anions such as sulphate or fluoride can be explained with their position in the 
Hofmeister series.
The strong stabilising effect of the chloride ion does not correlate with its position in the 
Hofmeister series but, as suggested by the shikimate binding data (section 4.5) and 
demonstrated by crystallographic evidence (section 4.10.3 and 4.10.4), ion binding can play 
a role. This effect could reflect general effects of the ionic strength as well as specific binding 
to, and hence stabilisation of, the folded state.
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In summary, the effects of the salts reflect a stabilisation of the folded conformation either by 
favourable screening interactions with surface charges on the enzyme (as is likely to be the 
case with sulphate ions) or by binding to specific sites (as is likely to be the case with 
chloride ions) (section 4.2). The net effect of these mechanisms is rather similar so that 
0.33M NagSO# has a similar but slightly larger effect on [urea]i/2  compared with that of 1M 
NaCI.
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Figure 4.16: Urea-induced unfolding in the presence of NaCI and KCI.
To study the unfolding process, SK (0.15mg/ml) was incubated in the appropriate buffer, in 
the stated concentration of urea and the chosen concentration of salt for 1h at 20°C before 
fluorescence data were recorded (section 2.5). The data shown are the changes in the 
fluorescence intensity at 350nm in the presence, respectively of: Tris-HCI (Black); SK + 
0.25M NaCI (red); SK + 0.5M NaCI (green); SK + 1M NaCI (blue); SK + 1M KCI (magenta).
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Figure 4.17: Urea-induœd unfolding in the presence of Na2S0 4
SK (0.15mg/ml) was incubated previously descnbed before fluorescence data were recorded 
(section 2.5). The data shown are the changes in the fluorescence intensity at 350nm in the 
presence, respectively of: buffer (Black); 0.17M Na2S0 4  (red) and 0.33M Na2S0 4  (green).
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Figure 4.18: Urea-induced unfolding in the presence of NaBr, MgCl2 CaCl2, and NaF
SK (0.15mg/ml) was incubated previously described before fluorescence data were recorded 
(section 2.5). The data shown are the changes in the fluorescence intensity at 350nm in the 
presence, respectively of: buffer (Black); 1M NaBr (red) and 0.33M MgClz (green), 0.33M 
CaCl2 (blue), 0.5M NaF (magenta).
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Solution [Urea]i/2 (M)
S K ( Tris-HCI) 2.1
SK (MOPS) 2.4
SK + 0.25M NaCI 3.0
SK + 0.5M NaCI 3.4
S K + 1M NaCI 4.6
SK + 0.17M Na2S04 4.0
SK + 0.33M NazSO, 5.3
S K + 1M KCI 4.6
S K + 1M  NaBr 4.8
SK + 0.33M CaCl2 2.8
SK + 0.33M MgCl2 3.3
Table 4.10: Values of [Urea] 1 /2  for unfolding of SK
The unfolding of SK by urea was monitored by changes in protein fluorescence at 350nm as 
described in section 3.3.2.
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4.9 Conclusions
Salts are known to have a variety of effects on the structure and function of proteins 
(sections 1.1.2.2 and 4.2). Anions and cations can be ranked in the Hofmeister series 
(Scopes 1994) which was originally drawn up on the basis of their ability to precipitate 
mixtures of proteins. The order of ions in the series can be understood in terms of the degree 
of hydration of the ions; this will alter the stability of a protein by influencing the extent of its 
hydration. Strongly hydrated anions such as sulphate and weakly hydrated cations such as 
ammonium provide the greatest degrees of stabilisation. In addition to these general effects, 
specific effects can arise if there are appropriate ion binding sites in proteins (Pace et al., 
1998) as for example calcium binding sites in ribonuclease Ti (Deswarte et a/., 2001) and 
zinc binding sites in alcohol dehydrogenase (Plapp et al., 1978).
The studies on SK reported show that both general and specific effects of ions can be 
observed. When the effects of salts on the substrate binding and catalytic properties of the 
enzyme are analysed, a complex pattern emerges. In terms of shikimate binding, it is clear 
that chloride ions markedly weaken the interactions (Table 4.4) and this can be described in 
terms of a competitive binding model. The X-ray data (to be discussed in section 4.11.3; Fig. 
4.32) show that chloride ions bind at sites (C3, C4 and C5) which are thought to play a role In 
the binding of shikimate. In the earlier X-ray studies of SK, residual electron density in this 
region was interpreted as bound shikimate. In re-analysed X-ray data this electron density is 
still seen, but it can be concluded that if indeed shikimate is bound it is not in a catalytically 
meaningful orientation. Due to the competitive nature of chloride binding it is therefore more 
likely that the chloride ions give a better indication of the correct position of the shikimate.
It is of interest that the X-ray structure of SK from Mycobacterium tuberculosis in complex 
with ADP shows a total of 6 chloride ions in the molecule (Gu et ai., 2002). The only one of 
these bound in the active site cavity, namely to the P-loop lysine, has no equivalent in the E. 
chrysanthemi SK structure. The chloride C3 found in E  chrysanthemi SK and the K15M 
mutant SK is not present in the M  tuberculosis SK structure, due to the replacement of 
Argi 1 by a Pro in the latter enzyme, thereby blocking the main chain amide nitrogen.
There is no direct evidence for the location (s) of bound sulphate ion(s) in the E. chrysanthemi 
SK structure; however it is likely that one or more could be bound near Arg58, thereby 
accounting for the smaller effects of sulphate on shikimate binding. Analysis of the effects of 
salts on the kinetic parameters of SK (Table 4.3) indicates that the Km for shikimate is 
increased in the presence of chloride, although to a smaller extent than the K .^ The effects of 
sulphate on the Km for shikimate are less pronounced than those of chloride (Table 4.3).
The effects of salts on the binding of nucleotide substrates are more difficult to relate to the 
kinetic parameters. Both chloride and sulphate lead to a strengthening of the binding of both
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ADP and ATP, which at first sight would be unexpected in terms of the proposed binding 
sites for these anions. A possible explanation for the effects of salts on Kd for ADP and ATP 
is that the dominant contribution to the relatively low affinity of the substrates for SK and 
other kinases (Price, 1972) is in fact made by the hydrophobic interactions between the 
adenine base and the enzyme; these would be enhanced by increasing ionic strength. The 
polar interactions between the phosphate groups of ADP and ATP and the enzyme may 
contribute relatively little to the energetics of interaction, but are of course crucial for the 
correct alignment of substrates for the phosphotransfer reaction. By contrast, both chloride 
and sulphate lead to an increase in the Km for ATP, which is particularly marked in the case 
of sulphate (Table 4.3). This would be consistent with the proposal that these anions occupy 
sites crucial for the binding of the nucleotide substrate in the correct orientation for catalysis.
Both salts lead to a marked reduction in the catalytic efficiency (as reflected by Vmax) of the 
reaction. The magnitude of Vmax presumably reflects the ability of the domains of the enzyme 
to move so as to ensure the correct alignment of substrates, as well as to undergo 
conformational changes required for product release. In this context, it may be significant 
that, on the basis of the near-UV CD data (Fig. 4.9), both salts appear to bring about a 
decrease in the mobility of the enzyme, and this can be accounted for by the X-ray results. 
However, further work using methods such as NMR would be required to characterise the 
changes in mobility in more detail. The relative movements of the domains would also affect 
the extent of synergism in substrate binding, and it is clear from Table 4.6 that this depends 
on the type of salt being studied. The locations of the binding sites for chloride ions both at 
substrate binding sites but also between the domains of SK (Fig. 4.32) provide an 
explanation for the range of effects of the salts on the kinetic properties of the enzyme (Table 
4.3).
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4.10 Refolding of enzyme in 4M Urea by addition of salts
Since an increase in ionic strength leads to a marked degree of stabilisation against 
unfolding by urea^ it was reasoned that addition o t salt to a previously unfoldeçl solution of 
enzyme (in 4M urea) might promote refolding of the denatured enzyme. By carrying out this 
ionic strength jump (with the urea concentration maintained at 4M )^s outlined in sectipn 2.6, 
it was found that this was indeed the case. It should be noted that when refolding was carried 
out in this fashion, there was no evidence for formation qf aggregates as determined by light 
scattering experiments. Ttie refojding process and the properties of the product formed were 
investigated as outlined below.
4.10.1 Spectroscopic studies
4.10.1.1 Regain of secondary structure
In the presence of 4M urea, the far UV CD spectrum of shikimate kinase indicates that the 
secondary structurp has been essentially completely lost. After the ionic strength jump, the 
enzyme was found to regain native-like secondary structure as judged by the far-UV CD 
spectrum. Fig. 4.19 shows the spectra of the native and denatured enzyme and the enzyme 
refolded in 4M Urea plus 1M NaCI or in 4M Urea plus 0.33M NazSO,.
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Figure 4.19: Refolding of denatured $K by addition of salts monitored by Cp.
Far-UV CD spectra of SK in buffer D (solid line), SK in buffer D plus 4M urea (dashed and 
dotted line), SK denatured in 4M urea and refolded by addition of 1M NaCI (dashed line), SK 
denatured in 4M urea and refolded by addition of 0.33M Na2 S0 4  (dotted line). The 
concentration of SK was 0.072mg/ml and the cell pathlength was 0.05cm.
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The kinetics of the regain of secondary structure in this process are markedly diff^ent from 
those previously observed in dénaturant jump experiments, i.e. dilution from 4M urea to 
0.36M urea (section 3.4.2). In thp latter e)^)eriment, three kinetic phases could be discerned 
using a combination of manual mixing and stopped flow mixing to initiate refolding with rate 
constants 8s \  O.Q8s’  ^ and 0.009s \  75% of the signal was regained within the dead time of 
manual mixing (2Qs). In the ionic strength jump experiments, using a final concentration of 
1M NaCI, however, the changes in the CD signal at 225nm wpre much slower. Only 20% of 
the totaLehange was observed in the, dead time of manual mixing and the remaining signal 
was regained wjth a rate constant of 0.0024s'^ (Fig. 4.20). In the presence of 0.33M Na2 S0 4 , 
the changes in CD were somewhat more rapid than in the presence of NaCI, with 35% of the 
total change observed in the dead time of the manual mixing and the remaining signal 
regained with a rate constantol0.0083s'^ (Fig. 4.21).
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Figure 4.20: Kinetics of changes in ellipticity at 225nm on addition of 1M NaCI to SK.
Protein denatured by incubation in 4M urea. Curves A, B and C represent SK plus 4M urea, 
SK during refolding on addition of salt, and refolded SK respectively. The SK concentration 
was 0.072mg/ml and the cell pathlength was 0.05cm. The lower panel shows the pattern of 
residuals from the fit to a single exponential process.
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Figure 4.21: Kinetics of changes in ellipticity at 225nm on addition of 0.33M NagSO^
Protein denatured by incubation in 4M urea. Curves A, B and 0  represent SK plus 4M urea, 
SK during refolding on addition of salt, and refolded SK respectively. The SK concentration 
was 0.072mg/ml and the cell pathlength was 0.05cm. The lower panel shows the pattern of 
residuals from the fit to a single exponential process.
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4.10.1.2 Regain of fluorescence intensity
In the presence of 4M urea, the emission maximum of shikimate kinase is 356nm, 
characteristic of a Trp side chain fully exposed to solvent. After an ionic strength jump, the 
fluorescence spectrum becomes native-like with an emission maximum at 348nm (Fig. 4.22). 
The kinetics of the changes in fluorescence at 350nm after initiating refolding by an ionic 
strength jump are shown in figure 4.23. After addition of NaCI to a final concentration of 1M, 
very little change (<5% of the total) occurs within the dead time of manual mixing (20s); the 
observed change occurs in two phases with rate constants O.OOSs’  ^ (14% amplitude) and 
0.002s'^ (78% amplitude). Using 0.33M N32S04 to initiate refolding, the changes are more 
rapid; the kinetic parameters for the two phases are 0.019s‘  ^ (43% amplitude) and O.OOSs'^  
(50% amplitude) (Fig. 4.23). In both cases the rate of the slower phase of the change in 
fluorescence corresponds approximately with the rate of the change monitored by CD.
The fluorescence results contrast with those obtained when refolding is initiated by a 
dénaturant jump (also shown in Fig. 4.23) where two phases are observed with rate 
constants 0.08s'^ (42% of total change and largely complete in the dead time of manual 
mixing) and 0.009s  ^ (45% of the total change) (section 3.4.2).
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Figure 4.22; Refolding of denatured SK by addition of salts monitored by fluorescence.
Fluorescence spectra of unfolded SK (dotted line) and SK refolded by addition of 1M NaCI 
(solid line) or 0.33M Na2 S0 4  (dashed line).
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Figure 4.23: Refolding of denatured SK by addition of salts monitored by fluorescence.
Kinetics of changes in fluorescence at 350nm. Curves A and B represent refolding of SK 
brought about by addition of 1M NaCI and 0.33M Na2S0 4  respectively. Curve C represents 
refolding of SK brought about by a dénaturant jump.
4.10.1.3 Refolding in the presence of ANS
When refolding of shikimate kinase is initiated by a dénaturant jump using urea, there is a 
marked and rapid increase in the fluorescence of ANS, followed by a slow release of the 
probe. These results indicate that the refolding process may proceed via rapid formation of a 
“compact intermediate” structure, though unlike a classical molten globule this intermediate 
would appear to contain relatively little of the secondary structure of native enzyme (section 
3.4.2.8). By contrast, when the ionic strength jump was used to initiate refolding, no changes 
in ANS fluorescence could be detected during the refolding process although the Trp 
fluorescence of the refolded protein indicates a native-like structure had been formed (Fig. 
4.24). While these results may indicate that the ionic strength jump-induced refolding does 
not involve a rapid collapse to a compact intermediate, it is possible that the presence of 4M 
urea may inhibit the binding of ANS to hydrophobic sites, as has been demonstrated in the 
case of cardiotoxin III (Kumar et a/., 1996) and by previous ANS spectra recorded under 
different conditions (section 4.10.5.1).
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Figure 4.24: Tryptophan emission spectra of SK refolded in 4M Urea and salts.
Refolding in the presence of ANS. The data show: a) line: SKI I + 1M NaCI + ANS; dash:
SKII + 4M Urea +1M NaCI + ANS (End); dots: SKII + 4M Urea + 1M NaCI + ANS (refolded); 
dash and dots: SKII + 4M Urea + ANS . b) Line: SKII + 4M Urea + 0.33M Na2 S0 4  + ANS 
(end); Dash: SKII + 4M Urea +0.33M Na2 S 0 4  + ANS (refolded); Dots: SKII + 4M Urea + ANS
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4.10.1.4 Refolding in the presence of Nai
In the presence of 4M urea the Ksv for quenching of the protein fluorescence by Nai is 4M'^ 
(Table 4.11). The dramatic reduction of the value for native enzyme (20M‘ )^ reflects the loss 
of the positively charged environment of the Trp provided by neighbouring Arg side chains. 
When refolding is initiated by an ionic strength jump this value is increased to lO.IM'^ and 
10.8M'^ in the presence of 1M NaCI or 0.33M NazSO^ respectively. While it is evident that 
refolding has led to a re-establishment of a positively charged environment around the Trp, 
the lower values of Ksv compared with those for native enzyme in the presence of 1M NaCI or 
0.33M Na2 S0 4  (15.2M'^ or 14.9M‘  ^ respectively) show that the process is not complete 
(Table 4.11).
When the refolding initiated by an ionic strength jump was performed in the presence of 0.1 M 
Nai, the changes in protein fluorescence were found to fit two successive first order 
processes (Fig. 4.25). The spectra acquired Immediately after the refolding (Fig. 4.26) 
confirm the Stern-Volmer values: the refolded enzyme in 4M urea does not give the same 
degree of quenching as the native enzyme reflecting the disruption of the Trp charged 
environment. When refolding is initiated by 0.33M NagSO/) the kinetic parameters (0.016s'^ 
(amplitude 32%) and 0.004s‘  ^ (amplitude 41%)) are similar to those observed for the 
changes in protein fluorescence in the absence of Nai (Fig. 4.27). However, when refolding 
is initiated by 1M NaCI, the changes are faster in the presence of Nai (0.043s'^ (7% 
amplitude) and 0.005s’  ^ (85% amplitude)) (Fig. 4.28). These data point to the possibility that 
chloride ions play a role in enhancing the rate of formation of the positively charged 
environment of the Trp side chain.
Solution Ksv(M ')
SK (Tris-HCI) 20.0
SK + 4M Urea 4.0
SK + 4M Urea + 1M NaCI (refolded) 10.1
SK + 4M Urea + 0.33M Na2S0 4  (refolded) 10.8
Table 4.11 : Stern-Volmer constants for the quenching of Trp54 fluorescence by Nai
The Stern-Volmer constants were determined from plots of F/Fo vs. [1] as described in 
section 2.4.
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Figure 4.25: Refolding of denatured SK by addition of salts monitored by fluorescence.
Refolding in the presence of Nai 0.1M. Kinetics of changes in fluorescence at 350nm. 
Curves A and B represent refolding of SK brought about by addition of 1M NaCI and 0.33M 
Na2S0 4  respectively in the presence of 0.1M Nai.
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Figure 4.26:Fluorescence emission spectra of refolded SK solution in the presence of Nai
The spectra represent: SK in the presence of 0.36M Urea (line); SK + 4M Urea (dots); SK + 
4M Urea + 1M NaCI (dashes); SK+ 4M Urea + 0.33M Na2 S0 4  (dashes and dots)
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Figure 4.27: Comparison between salt-induced refolding in the absence and presence of Nai.
Kinetics of changes in fluorescence at 350nm following an ionic strength jump in Na2S0 4  
The curves represent: SK refolded in 0.33M Na2S0 4  and 4M urea in the absence (black) 
and in the presence (light gray) of Nai.
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Figure 4.28: Comparison between salt-induced refolding in the absence and presence of Nai.
Kinetics of changes in fluorescence at 350nm following an ionic strength jump in NaCI. The 
curves represent: SK refolded in 1M NaCI and 4M Urea in the absence (A) and in the 
presence (B) of Nai.
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4.10.1.5 Comparison between the refolding traces obtained by different techniques
From the comparison of different traces obtained monitoring different parameters different 
patterns emerge for the two salts used. In the case of NaCI (Fig. 4.29a) in the dead time of 
the manual mixing experiment a state is formed with 22% of secondary structure (see 
Appendix 4.2 for fitting data) but with no tertiary interactions as far as the Trp environment is 
concerned. But when the trace obtained following the regain in fluorescence in the presence 
of Nai (a quencher sensitive to the charged Trp environment due to the presence of three 
arginines) is considered, 10.5% of the signal is regained in the dead time of the manual 
mixing mode (20s).
Chloride ions were found to interact with SK (section 4.11.3) and there are usually arginines 
between the residues with which they interact. In SK, from the crystallographic structure, it 
appears that these interactions Involve Arg11, 139 and 58 which are clustered around the 
single Trp (Trp54) of SK. In particular one of the chloride ions (section 4.11.3) interacts, in 
some SK structures, with both A rg il and 139. This could indicate that the charged arginine 
cluster plays a role in the NaCl-induced folding.
For example the binding of salts to a specific site could be considered as a possible 
"nucleating” point that could lead to the subsequent folding of the entire protein molecule. 
This “template” effect is known to have an influence in the synthesis of macrocyclic 
molecules where the ion acts as a conformational template (Consoli et a!., 2001).
When the refolding induced by Na2 S0 4  is considered the regain in fluorescence in the 
presence and absence of Nai gives the same trace with the same rate constants (ki=0.015s'^ 
and kz= 0.0043s"^) indicating that the regain of the charged Trp environment and the regain 
of the tertiary environment are formed in the same type of process (Fig. 4.29b). These 
considerations lead to the idea that the induced refolding by the two salts may follow different 
mechanisms.
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Figure 4.29: Comparison of different traces obtained after the salt-induced refolding.
Kinetics of changes in CD at 225nm (black), in fluorescence at 350nm (red), in the presence 
of Nai (green) when SK is refolded in 4M urea and in 1M NaCI (a) and in 0.33M Na2S0 4  (b) 
respectively.
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4.10.2 Substrate binding and activity studies
In the presence of 4M urea, there is no detectable binding of shikimate to the enzyme as 
indicated by the lack of effect of the substrate on the fluorescence of the protein (Fig. 4.30). 
After refolding by an ionic strength jump, binding of shikimate could be demonstrated by 
fluorescence quenching. In the presence of 4M urea plus either 1M NaCI or 0.33M Na2 S0 4 , 
the Kd values for shikimate were found to be S.OmM or 3.8mM respectively (Table 4.12 and 
Fig. 4.30). When the titrations were performed in the presence of 2mM ADP, the binding of 
shikimate was tighter with the Kd values 1.4mM or 2.4mM in urea plus 1M NaCI or 0.33M 
NazS0 4  respectively (Table 4.12 and Fig. 4.31). It should be noted that for the refolded 
enzyme there was a significantly lower extent of fluorescence quenching on binding 
shikimate (25-45%) compared with native enzyme (90-95%), indicating that the refolded 
enzyme is capable of undergoing more limited conformational changes on binding the 
substrate. In separate experiments it was shown that addition of ADP to either the unfolded 
or the refolded enzyme led to no significant quenching of the fluorescence; a similar result 
was found for ATP. These results indicate that the binding site for the nucleotide substrate 
had not been correctly formed on refolding. It has to be pointed out that, when ADP titrations 
in the presence of urea were undertaken, urea was shown to have a drastic influence on the 
nucleotide binding, in fact, at a concentration of 1M urea, where no significant conformational 
changes were observed as judged by CD and fluorescence spectra, the effect on the Kd is 
quite marked (from 1.77 to 2.34mM - section 3.3.4). Using the quenched assay system it 
was not possible to demonstrate any significant regain in activity after refolding the enzyme 
in 4M urea by addition of 1M NaCI or 0.33M Na2 S0 4 ; the activity observed is less than 0.5 % 
of the control value. It should be noted that the presence of these salts (in the absence of 
urea) was found to lead to a loss of approximately 65% activity (section 4.4). Hence it can be 
concluded that the refolding induced by the ionic strength jump does not lead to the 
formation of a catalytically competent species. On the basis of the data obtained, this 
appears to be due to the disruption of the nucleotide binding site and the reduced 
conformational response on binding shikimate; thus the correct orientation of bound 
substrates required for catalysis is not achieved.
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Solution Kd (mM) Kd (mM)(+ 2mM ADP)
SK (Tris-HCI) 0.60 ± 0.02 0.38 ± 0.02
SK + 4M Urea + 1M NaCI (refolded) 3.06 ± 0.33 1.36 ±0 .10
SK + 4M Urea + 0.33M NazSOA (refolded) 4.28 ± 0.37 2.40 ± 0.34
Table 4.12: Binding of shikimate to SK in the absence and in the presence of ADP
The binding of shikimate was determined by monitoring the extent of quenching of 
fluorescence at 350nm as described in section 2.3.
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Figure 4.30: Binding of shikimate to refolded SK
Squares: SKII; diamonds: SKII + 4M Urea; Open Triangles: SKII + 4M Urea + 0.33M 
Na2 S0 4 ;0 pen Circles: SKII + 4M Urea + 1M NaCI
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Figure 4.31: Binding of shikimate to refolded SK in the absence and presence of ADP
Filled squares -  0.33M Na2 S0 4  + 4M Urea; Filled circles -  0.33M Na2S04 + 4M Urea + 2mM 
ADP; Open diamonds - 1M NaCI + 4M Urea; Open triangles -  1M NaCI + 4M Urea + 2mM 
ADP
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4.10.3 The location of the chloride ions in shikimate kinase
The X-ray structure of SK was solved at 1.9Â resolution from crystals grown in approximately 
2M NaCI (Krell et al., 1998). A more detailed analysis of these data reveals a total of 21 
chloride ions bound to the two molecules within the asymmetric unit of the crystal. Twelve 
chloride ions are bound to chain A (Fig. 4.32), nine to chain B. Of these ions, seven are 
common to both chains and are labelled in figure 5 and referred to here as C1-C7 
(designated as 601-607 in the PDB file); these will be discussed in detail.
Two chlorides bind in the nucleotide-binding domain of SK, C l is bound in an equivalent 
position to the p-phosphate of the nucleotide, C2 in a position equivalent to the a-phosphate. 
Both chlorides are located in the Walker A motif or P-loop region. C l forming hydrogen 
bonds to the amide backbone of Gly12, Gly14 and C2 to the amide of Thr17.
Chloride C3 is of interest as it binds to the amide backbone of A rg il and is in an equivalent 
position to the chloride found In the K15M SK mutant structure (Krell et a!., 2001), although 
the P-loop is shifted in this structure. The K15M SK structure was crystallised in 0.1M Tris- 
HCI, and only one chloride ion is present, strongly suggesting that this chloride-binding site is 
of higher affinity than the others found in the native high salt SK structure. Additional 
hydrogen bonds formed by this chloride are different between the mutant SK and the two 
chains of the native SK due to differences In protein conformation. In chain A additional 
hydrogen bonds are made with the guanidinium groups of A rg il and Arg 139; however these 
are not essential as the chloride in the K15M structure lacks the Argi 1 interaction and the B 
molecule lacks both these interactions.
As previously described, molecule A and molecule B are non-equivalent in the native SK 
structure (Krell et a/., 1998). In comparison with molecule A, the side chain of A rg i39 in 
molecule B is shifted away from the active site as is the shikimate binding domain (residues 
32-60). As a result the position of the chlorides C4 and C5, although comparable, are in 
different positions in the structure as a result of these conformational changes. Chloride 04 
in molecule A hydrogen bonds to the guanidinium of Arg58, whereas in molecule B it 
hydrogen bonds to the side chain of Argi 39. Chloride C4 in molecule A hydrogen bonds to 
the NE of Arg58, whereas in molecule B the hydrogen bond is to NH2 of Arg58.
Finally, away from the active site, chloride C6 hydrogen bonds to the amide nitrogen of 
Glu85 at the end of an a-helix and chloride C7 (which shows partially occupancy) hydrogen 
bonds to NH2 of Arg88. These two chlorides form the types of interactions seen for the other 
chlorides which are interacting with either the main chain amide at the end of an alpha helix 
(helix dipole) or a positively charged amino acid side chain.
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Figure 4.32: A stereo view of the native shikimate kinase structure.
Molecule A is represented in tubular form coloured according to secondary structure (a-helix 
red, p-sheet green). Chloride ions are shown as green spheres and are labelled C1 - C7; 
these are designated as 601-607 in the PDB file. Key amino acid side chains are 
represented as stick, coloured according to atom type, and labelled in black. The diagram 
was composed in WEBLAB viewer (Accelrys, Inc.)
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4.10.4 Structural basis for effects of salts on shikimate kinase
The presence of discrete chloride ions within in the structure of SK permits a structural 
interpretation of a number of the solution studies. Discrete sulphate binding sites have not 
been observed directly in any crystal structure of SK but their probable positions can be 
deduced from the positions of inorganic phosphate in the K15M mutant of SK (Krell et al., 
2001) and of the phosphate groups of ADP in the SK-ADP complex.
There is compelling evidence that like other NMP kinases, SK can undergo significant 
conformational changes on binding substrates. The observation that chloride ions lead to a 
tightening of the structure of SK can be rationalised by the binding of chlorides C l and C2 in 
the P-loop of the protein, thereby potentially ordering the lid domain of the structure. 
Chlorides C3, C4 and C5 interact directly with residues implicated in shikimate binding, 
namely Arg58 and Arg 139. Both regions are responsible for hinged movements 
characteristic of NMP kinases. Tightening of the structure is a characteristic of substrate 
binding and therefore it is not surprising that both chloride and sulphate inhibit binding of ATP 
and shikimate in the catalytically competent orientation. That inhibition of enzyme activity 
increases in an ionic strength-dependent manner probably represents the screening of 
charges important for shikimate and ATP binding. The structure suggests that this could be 
due in part to the presence of weak binding sites for chloride and sulphate on the surface of 
the protein that are the same sites as the binding sites for shikimate and ATP.
The structure shows a number of chloride ions in the vicinity of Trp54. Chlorides 04 and 05 
could act to screen the quenching of Trp54 by iodide and, due to their proximity to Arg58, it is 
probable that sulphate would bind in similar positions and perform the same function.
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4.11 Conclusions
The presence of salts leads to a marked increase in stability towards unfolding by urea 
(section 4.8). This effect could reflect general effects of the ionic strength as well as specific 
binding to, and hence stabilisation of, the folded state (section 4.2). An interesting feature of 
this work is that it is possible to induce refolding of the enzyme in 4M urea, simply by 
Increasing the ionic strength. This type of behaviour has been observed in a few other 
systems, such as the 63-residue N-terminal domain of the C1 repressor from bacteriophage 
434 (Dotsch et al., 1995) and the peroxidase from Coprinus cinerus (Tams and Welinder, 
1996).
Although the refolded SK has similar secondary and tertiary structure to the native enzyme 
as judged by CD and fluorescence and appears able to bind shikimate, albeit more weakly 
than native enzyme and with a reduced conformational response as judged by the limiting 
extent of fluorescence quenching. However, although there is no direct evidence (from 
fluorescence quenching data) for binding of nucleotide substrates to the refolded enzyme, 
there is indirect evidence for some interaction with nucleotide from the observed tightening of 
shikimate binding in the presence of 2mM ADP (Table 4.12). The failure of the refolded 
enzyme to display catalytic activity is likely to reflect subtle perturbations both of the 
nucleotide binding site itself and of the ability of the enzyme to bring the substrates into the 
correct alignment for the phosphotransfer reaction. It remains a task for future work to 
characterise this "partially folded" form of SK in more detail and to examine whether 
conditions can be found under which it can be readily converted to an active form.
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Appendix 4.1 Refolding of SK in the presence of salts
The refolding of SK in the presence of different concentrations of salts was carried out to 
examine the effect of residual ionic strength on the refolding reaction and to check for any 
specific effect. For this purpose NaCI, Na2S0 4  and, to some extent, NaF were used.
A4.1.1 Regain of Activity
The presence of NaCI or Na2S0 4  in solution leads to inhibition of SK as reported in section
4.5. The residual activities at concentrations of 0.25M NaCI and 0.085M Na2S0 4  are 88.8%  
and 84.5% respectively. Because at higher concentrations there is a more pronounced 
inhibition, these two concentrations were chosen to follow the regain of activity and, as a 
control, a protein solution at the same salt concentration was tested. From the results 
obtained (Fig. A4.1) it was not possible to fit satisfactorily the data because the process is 
faster than in the absence of salts and the initial amplitude is higher, indicating that a large 
amount of activity has been regained before the first data point could be collected.
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Figure A4.1; The kinetics of regain of activity, effect of added NaCI and Na2S0 4
The data show the regain in activity in Tris buffer and in Tris buffer in the presence of salts. 
Activity values are expressed relative to a control sample incubated in the presence of the 
final concentration of urea, and salt i.e. 0.36M urea + 0.25M NaCI or 0.085M Na2S0 4 .
182
A4.1.2 Regain of secondary structure
The regain of CD signal at 225nm was followed when NaCI, Na2S0 4  and NaF were present 
in the refolding buffer. All the controls were prepared in the presence of 0.36M urea and salt. 
The concentrations of salt used in the refolding buffer were: 0.25M and 1M for NaCI (Fig. 
A4.2a); 0.085M and 0.17M for Na2S0 4 (Fig. A4.2b) and 0.5M for NaF (Fig. A4.2c). In general 
the presence of these salts seems to accelerate the rate of regain of secondary structure, 
though no fitting was possible because the regain was nearly complete in the dead time of 
the manual mixing experiment (20s). Addiction of NaF leads to the regain of only the 46% of 
the signal of the control solution; hence it probably interferes with the refolding process.
It has to be noted that, performing the refolding with GdmCI (2.8M 0.25M) the regain of the
CD signal was complete within the dead time of the manual mixing experiment (Boam, 
1999). While NaCI leads to a complete regain of the control signal at both concentrations, 
Na2S0 4  at 0.33M does not (67% of the control signal is regained), even though this salt Is a 
better stabiliser. These data suggest that the ionic strength could play an important role in 
the refolding of SK. Because the process is faster than in the absence of salts it is not 
possible to check eventual differences in stabilising refolding intermediates between the two 
salts used. For this reason it would be interesting to check the regain of secondary structure 
using the stopped flow apparatus. Only a preliminary stopped-flow experiment with 1M NaCI 
in the refolding buffer was carried out (Fig. A4.3), but more experimental work would be 
necessary using other NaCI concentrations and Na2S0 4  to draw any valid conclusions.
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Figure A4.2: Kinetics of changes in ellipticity in the presence of salts (manual mixing).
Protein denatured by incubation in 4M Urea. The SK concentration was in the range 0.08 -  
0.09mg/ml and the cell pathlength was 0.05cm. A and B refers to the start (4M Urea) and 
end (0.36M Urea + salt) solutions.The refolding was started by dilution, lowering the urea 
concentration to 0.36M following the change of signal at 225nm, in buffer containing different 
concentration of salts: a) 0.25M and 1M NaCI; b) 0.085M and 0.33M Na2S0 4  c) 0.5M NaF.
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Figure A4.3: Kinetics of changes in ellipticity in the presence of 1M NaCI (stopped flow)
Refolding of SK after dénaturation in 4M urea.The refolding was initiated by stopped flow 
mixing and monitored at 225nm; the inset shows data in the first 2s of the reaction. Curves A, 
B and C refer to enzyme in the presence of 0.36M urea + 1M NaCI, enzyme in the presence 
of 0.36M urea, and enzyme in the presence of 4M urea. Curves E and D are the refolding 
curves in buffer and in buffer +1M NaCI respectively.
A4.1.3 Regain of fluorescence intensity
A4.1.3.1 Preliminary Light scattering experiments
During the refolding in the presence of GdmCI the light scattering signal was greater than 
the upper experiment detection limit (1000 units) for both the refolded and the equilibrium 
solution (0.25M GdmCI). An ionic strength jump was performed (2.8M -> 0.25M NaCI) to 
assess if the aggregate formation was influencing the fluorescence signal during the 
refolding (section 3.4.1.5). This experiment led to the conclusion that the observed 
aggregation at 0.25M GdmCI derived both from the ionic strength jump and from the 
induced aggregation of partially exposed hydrophobic surfaces.
Light scattering experiments were performed, as described in section 2.4, to check for 
formation of aggregate in the presence of higher concentrations of salts. Solutions at two 
different protein concentration (0.1 mg/ml and 0.15mg/ml) and salt concentration (0.25M, 
0.5M and 1M) were prepared and the light scattering was measured (A,ex= ^ em =320nm). 
Only for the solution at 1M NaCI was the light scattering signal greater than 1000 units.
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A4.1.3.2 Regain of fluorescence intensity in the presence of chloride 
When NaCI was included in the refolding buffer a different pattern of refolding was observed 
(Fig. A4.4). In general the presence of NaCI leads to an increase of the refolding rate, with 
the lowest concentrations of NaCI being more effective than the higher one. No important 
difference is observed between 0.25M and 0.5M, both giving traces that could be fitted with 
a double exponential function indicating the existence of at leasts two phases with rate 
constants, for the refolding in 0.25M NaCI, of 0.12s‘  ^ (no salt: O.OSs'^ ) and 0.012s"^  (no salt: 
0.009s’ )^. The rate constants and relative amplitude of the phases are reported in appendix 
4.2. During the refolding in the presence of 1M NaCI some aggregate formation may occur: 
in fact the refolded solution in the presence of 1M NaCI gives light scattering signal at 
320nm greater than 1000 units.
The effect of protein concentration was checked for the refolding in the presence of 0.25M 
NaCI where the biggest effect on the refolding rate had been observed. The refolding 
traces, after normalisation, for protein concentrations of 0.1 mg/ml and 0.5mg/ml are 
coincident (Fig. A4.5). Moreover the nature of the cation had no effect on the refolding rate 
as demonstrated by refolding experiments performed including 0.25M KCI in the refolding 
buffer (Fig. A4.6). It would be interesting to perform these experiments using the stopped 
flow instrument because the most significant difference that is observed in the manual 
mixing mode is in terms of the initial amplitude from 32% in the absence of salt (considering 
the manual mixing trace) to 45% (value referred to the refolding trace obtained in 0.25M 
NaCI). Only one trial experiment was carried out with stopped flow mixing, at 1M NaCI (Fig. 
A4.7). The rate constants obtained fitting the curve with a double exponential function are: 
0.094s'\no salt: 0.08s‘ )^ and 0.017s"\no salt: 0.009s )^ so it seems that the most significant 
effect of the NaCI, at this concentration, is on the rate constant of the slower phase.
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Figure A4.4: Kinetics of changes in protein fluorescence in the presence of NaCI.
Refolding of SK, initiated by manual mixing, after dénaturation in 4M urea and followed at 
SSOnm. Curves A, B and C refer to refolding of the enzyme in the refolding buffer (A) and in 
the presence of: 0.25M NaCI (B), 0.5M NaCI (C) and 1M NaCI (D).
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Figure A4.5: Protein concentration dependence of the kinetics of refolding.
Kinetics of changes at 350nm. Protein denatured in 4M Urea at two different concentrations 
and refolded by 11-fold dilution in buffer containig 0.25M NaCI
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Figure A4.6; Kinetics of changes in protein fluorescence in the presence of NaCI and KCI
Refolding of SK, initiated by manual mixing, after dénaturation in 4M urea and followed at 
350nm. The data shows the refolding of the enzyme in the presence of; 0.25M NaCI (green) 
and in the presence of 0.25M KCI (black). The end (A) and start (B) point are reported.
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Figure A4.7: Kinetics of changes in protein fluorescence in the presence of 1M NaCI.
Refolding of SK after dénaturation in 4M urea. Refolding was initiated by stopped flow mixing 
and followed at 350nm. The fluoresœnce signals have been corrected for the buffer signal. 
Curves A, B refer to enzyme in the presenœ of 0.36M urea and enzyme in the presenœ of 
4M urea. The black curve is referred to the enzyme during refolding in buffer and the blue 
curve to the enzyme during refolding in buffer +1M NaCI.
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A4.1.3.3 Regain of fluorescence intensity in the presence of sulphate 
The effect of sulphate on the refolding of SK is different from that observed in the presence 
of NaCI at the same ionic strength (Fig. A4.8). At low concentration of Na2S0 4  only a small 
increase of the refolding rate is observed; the ki is raised from 0.08s'^ in the absence of salts 
(manual mixing trace) to 0.1 s‘  ^ in the presence of 0.85M Na2S0 4 , while the k2 increases from 
0.009s  ^ to 0.01 Os'\ But at higher ionic strength, the rate decreases respect to the rate of 
refolding in the absence of salt (ki= 0.03s^ and k2 = O.OOSs^  in 0.33M Na2S0 4  - see appendix 
4.2 for the rate constants and phase amplitude values). With Na2S0 4  the light scattering was 
<1000 units after a jump to 0.085M but there is aggregation for the jumps to 0.17M and 
0.33M. There is an increase of the starting amplitude in the presence of Na2S0 4  (32% in the 
absence of salt, referred to the manual mixing trace, and 38%, 48% and 49% in the presence 
of 0.085M, 0.17M and 0.33M Na2S0 4  respectively), but a concomitant decrease of the 
refolding yield, i.e. 94%, 83% and 71% for Na2 S0 4  concentrations of 0.085M, 0.17M and 
0.33M respectively.
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Figure A4.8: The kinetics of changes in protein fluorescence in the presence of Na2S0 4 .
Refolding of SK, initiated by manual mixing, after dénaturation in 4M urea and followed at 
350nm. Curves A, B and 0  refer to refolding of the enzyme in the refolding buffer (A) and in 
the presence of: 0.085M Na2 S0 4  (B), 0.17M Na2 S0 4  (C) and 0.33M Na2 S0 4  (D).
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A4.1.3.4 Refolding in ttie presence of fluoride
The fluoride ion is another strong stabiliser of SK (section 4.8) and has no major effect on the 
secondary structure or fluorescence intensity of SK (section 4.3); however it inhibits the SK 
activity at lower concentrations when compared with the other salts tested (section 4.4). It 
has no effect on the shikimate binding (section 4.5) but it has an effect on the nucleotide 
binding leading to a decrease of the Kd for ATP at low concentration (0.1M) (section 4.6). 
When the refolding was carried out in the presence of 0.5M NaF there is a regain of 50% of 
the native fluorescence relative to the end point of the protein solution in the presence of 
fluoride (Fig. A4.9). The fluorescence spectrum of the refolded solution is native-like in terms 
of the emission maximum wavelength (Fig. A4.10).
This effect on the refolding is not common, for example it has been found that fluoride ion 
induced an acceleration of the oxidative folding of reduced pancreatic ribonuclease A (Low et 
al., 2000). Further investigations would be necessary to check the reason for the observed 
effect.
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Figure A4.9: Kinetics of changes in protein fluorescence in the presence of NaF
Refolding of SK, initiated by manual mixing, after dénaturation in 4M urea and followed at 
350nm. Protein concentration was 0.084mg/ml.
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Figure A4.10: Normalised fluorescence spectra (refolded solution) in the presence of NaF
Spectra were recorded at 20°C in the 300-400nm range after excitation at 295nm, T= 20°C 
and normalised dividing for the intensity at 350nm (Fn/Faso).
A4.1.4 Refolding with salts in the presence of sodium iodide
The refolding in the presence of 0.1 M Nai was performed only in the presence of 1M NaCI, 
(Fig. A4.11) but t)ecause of the ionic nature of the quencher, further experiments in the 
presence of salts were not undertaken t>ecause of difficulties of interpretation of the 
experiments due to the multiple effects present.
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Figure A4.11: Refolding of denatured SK in the presence of 1M NaCI (Nai 0.1M)
Kinetics of changes in fluorescence at 350nm. The curves represent refolding of SK brought 
about by dilution in buffer (black) and buffer +1M NaCI (red) in the presence of 0.1M Nai.
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A4.1.5 Refolding in the presence of ANS
A4.1.5.1 ANS spectra in the presence of N a d
The effects of different conditions on both ANS florescence and on the fluorescence of the 
ANS bound to SK was investigated. Fluorescence spectra of an ANS solution (40 pM) in 
buffer, in the presence of 1M NaCI and 4M urea plus 1M NaCI, both in the absence than in 
the presence of protein were acquired. The free-ANS spectra, the SK bound ANS spectra 
and the difference spectra (SK.ANS) (cond x) -  (ANS) (cond.x) are reported (Fig. A4.12 (a,b,c)). 
The presence of NaCI leads to an increase in the fluorescence of ANS in solution (free 
ANS) (Fig. A4.12a), but a decrease in the fluorescence when protein is present (Fig. 
A4.12b). From the difference spectra (Fig. A4.12c) it seems that the presence of urea does 
not allow ANS to bind to the protein. This is also observed in the presence of 1M NaCI, 
conditions under which SK has a native-like conformation.These results are useful to 
interpret the kinetics of ANS fluorescence change during refolding in the presence of salts 
(section 4.10.5.2) and of the refolding in 4M urea induced by salt (section 4.11). In fact, 
because the presence of NaCI in solution leads to a decrease of ANS fluorescence the 
initial increase observed in the refolding experiment when salt is present in the refolding 
buffer cannot be due to an artefact. Moreover, the competition of urea for ANS binding sites 
could explain the absence of ANS binding observed during the refolding in 4M urea induced 
by salts.
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Figure A4.12: ANS spectra (40 pM) in buffer and in the presence of NaCI and Urea 
The emission spectra were acquired after excitation at 380nm. Solid line : ANS and buffer 
dotted line: ANS in the presence of 1M NaCI + 4M Urea; dashed line: ANS in the presence of 
1M NaCI respectively and in the absence (a) and in the presence of protein (b) (c) 
difference spectra: (SK.ANS) (cond. x) -  (ANS) (cond x)
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A4.1.5.2 Refolding in the presence of ANS
The refolding experiment in the presence of ANS was carried out at only one concentration 
of NaCI (1M). Figure A4.13 shows a comparison between the traces obtained in the absence 
and presence of salt. It seems that the presence of salt increased the initial jump observed.
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Figure A4.13; Changes in ANS fluorescence in the presence of 1M NaCI.
Refolding of SK (manual mixing) after dénaturation in 4M urea. Change in ANS fluorescence 
during refolding in buffer Tris (black), buffer Tris+IM NaCI (red). The protein concentration 
was 0.1 mg/ml and the ANS concentration 40pM.
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A4.1.6 Conclusions
From the refolding experiments in the presence of salts after dilution of urea from 4M to 
0.36M it appears that both the ionic strength and the chloride ions have an influence on the 
refolding process of SK . The presence of salts in the refolding buffer seems to accelerate, at 
low concentrations of NaCI or Na2 S0 4 , the rate of regain of both structure and activity, while 
fluoride ion seems to impair this process. Further studies on the effect of fluoride on SK 
would be interesting because of the effects this salt has on binding, stability and refolding. 
The results obtained with NaCI or Na2 S0 4  could explain the faster refolding observed when 
GdmCl was used as dénaturant (Boam, 1999) and underline the importance of taking into 
accont the residual ionic strnegth of the solution. From the observed differences between 
NaCI and Na2 S0 4  it seems possible that the two salts exert their effects by different 
mechanisms. Stopped flow experiments using these two salts would be useful to distinguish 
between different mechanisms because, for example in the manual mixing CD experiment, 
all the changes happened before the dead time of this experiment. The increase observed in 
ANS fluorescence in presence of salt could be an indication of the formation of a more 
compact intermediate, but again stopped flow experiments could be useful to investigate this 
In more detail.
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Appendix 4.2: Refolding in the presence of salts: fitting values
SK + 0.25M NaCI SK + 0.5M NaCI SK+1M NaCI
Fluorescence 
(Manual Mixing)
Ai = 19.35 ±0.12  
ki =0.12 ±0.0015 
Aa =33.5 ±0.08  
ka =0.012 ±0.00004 
B = 97.87 ±0.017
Ai =22.61 ±0.18 
ki =0.11 ±0.0019 
Aa = 35.67 ±0.12  
ka =0.011 ±0.00008 
B = 100.64 ±0.053
Ai = 10.75 ±0.18  
ki =0.068 ±0.0019 
Aa = 26.74±0.14 
ka =0.098 ±0.00012 
B = 83.41 ± 0.07
SK + 0.085M NazSO# SK + 0.17M NaaS04 SK + 0.33M NaaSO#
Fluorescence 
(Manual Mixing)
Ai = 16.70 ±0.13  
ki = 0.099± 0.0016 
Aa =38.5 ±0.09  
ka =0.010 ±0.00005 
B = 93.66 ±0.038
Ai =7.2  ±0.16  
ki = 0.084± 0.0037 
Aa = 27.85 ±0.12 
ka = 0.0098 ± 0.0001 
B =83.1 ±0.062
Ai = 6.51 ± 0.57 
ki =0.032± 0.003 
Aa = 15.61 ±0.31 
ka = 0.0054 ± 0.0004 
B =70.8 ±0.37
Table A4.1: Values of the fitting of refolding in the presence of salt (dénaturant dilution)
Conditions Fluorescence Fluorescence +Nal CD
SK + 4M Urea + 1M NaCI Ai = 13.9 ± 1.43 
ki = 0.0046 ± 0.0002 
Aa =78.12 ±1.42  
ka = 0.0022 ± 0.00002
B = 95.3 ±0.034
Ai = 7.24 ±0.14  
ki =0.042 ±0.0017 
Aa = 84.85 ±0.12  
ka =0.0054 ±8.56 10“® 
B =102.6 ±0.014
A = 73.7 ± 0.27 
k = 0.002 ± 0.00002 
8 = 21.9 ±0.27
SK + 4M Urea + 0.33M NaaSO^
Ai = 42.93 ± 0.45 
ki =0.019 ±0.0002  
Aa = 49.66 ± 0.44 
ka = 0.0047 ± 0.00004 
B = 100.01 ±0.0458
Ai = 31.62 ±0.71 
ki =0.016 ±0.0003 
Aa = 40.61 V 0.695 
ka = 0.0043 ± 0.00007 
B =98.42 ±0.072
A = 55.1 ±1.39  
k = 0.0083 ± 0.00046 
B = 35.8 ±1.48
Table A4.2: Values of the fitting of the refolding traces (ionic strength jump experiments)
Ai, ki. As, ks are respectively the amplitude and the rate constants of the first and second 
phases of the process. B is the total amplitude regained during the process. The amplitude at 
the beginning of the process is given by difference: B minus the amplitude of the two phases. 
In the last column (CD) of table 4.14: A is the amplitude of the phase with k being the rate 
constant, while B is the starting amplitude. The total amplitude regained during the process is 
given summing 8 and A.
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Chapter 5: General Discussion 
5.1 Activity and ligand binding studies
To be catalytically active an enzyme such as SK must bind the substrates in the correct 
position to allow the movements that lead to productive catalysis. For SK, as for other NMP 
kinases, during catalysis there is the closure of the active site around the bound substrates 
(hinge-bending motions). These motions have low energy barrier heights between the well 
minima so the relative equilibrium between populations of the closed and the open 
conformations can be shifted by external factors, such as pH, T or ionic strength (Sinha et 
ai, 2001). The comparison between the effect of different salts and dénaturants on SK has 
highlighted differences between the effects of anions on substrate binding and catalysis.
In fact it has been found that non-ionic species, such as urea, lead to a loss of activity, with 
85% and 40% activity retained in the presence of 1M and 2M urea respectively, while the 
incubation of SK with low concentrations of GdmCI or salts leads to more marked losses of 
activity. It should be pointed out that only minor differences have been observed in the far- 
UV CD and fluorescence spectra of SK in the presence of salts; this rules out the possibility 
of a major structural alteration as a possible explanation of the observed decrease in 
activity.
The decrease in activity has been found to be related to the ionic strength of the solution 
with the exceptions of NaF and NaNOs, which lead to higher degrees of inactivation at the 
same concentration as the other salts used. Under these conditions different factors, such 
as specific binding to particular residues or preferential hydration of protein surfaces 
(leading to an increase the hydrophobic interactions) can affect enzyme activity. The two 
effects will lead to a decrease in activity by different mechanisms: the ions can bind to a site 
close to the substrate binding site establishing Interactions with residues which normally 
interact with the substrate or, in the second case, the increase in the rigidity of the enzyme 
could lead to the elimination of the dynamic motion that is required for efficient catalysis.
That an increase in ionic strength leads to an increase in structural rigidity has been 
suggested by the increased intensity of the CD signal in the near-UV region. The study of 
the effects of salts and dénaturants on the binding and kinetic parameters has given further 
insights allowing some distinction between these two mechanisms to be made. In fact it was 
expected that, if the first mechanism was predominant, there would be a bigger effect on the 
binding constant while, if the rigidity of the protein was responsible for the observed 
decrease of activity, there would be still binding though not productive, leading to a 
decrease in Vmax-
The quenching of the fluorescence of the single Trp residue of SK (Trp54) as consequence 
of the binding of shikimate, and to a lesser extent of nucleotides, (Idziak et a i, 1997) has
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been extensively used to study the effects of the solvent conditions on the binding of 
substrates, in particular it seem that while the change in ionic strength has the largest effect 
on shikimate binding and a smaller effect on nucleotide binding, the effects of urea (non­
ionic) appear to be more marked in the case of the ADP binding than for the shikimate. This 
could indicate that different kind of interactions are predominant for the binding of these two 
substrates: in the case of shikimate binding electrostatic interactions play a major role, 
whereas in the binding of nucleotides the main factor is hydrophobic interactions, which 
would explain the larger effect of urea on the binding of ADP. It would be of interest to study 
the effects of other non-ionic co-solvents on the binding of nucleotides.
When titration experiments with shikimate were carried out in the presence of ADP the effect 
of medium composition on the hinge-bending movements was demonstrated. The decrease 
of the Kd for shikimate in the presence of ADP has been considered to be a consequence of 
the hinge-bending movements typical of NMP kinases. This degree of synergism has been 
found to be very markedly dependent on the type of salt present in the buffer system. From 
this it follows that it is important to consider the effects of different medium conditions on 
parameters such as binding and activity. In the case of SK, use of a different buffer system 
(MOPS) instead of the Tris normally used gave different results as far as the binding of 
shikimate and the substrate synergism were concerned.
Analysis of the effects of salts on the kinetic parameters of SK indicates that while the Km for 
shikimate is increased in the presence of chloride, although to a smaller extent that the Kd, 
the effects of sulphate on the Km for shikimate are less pronounced than those of chloride. 
Both salts lead to a marked reduction in the catalytic efficiency (as reflected by Vmax) of the 
reaction. The magnitude of Vmax presumably reflects the ability of the domains of the enzyme 
to move so as to ensure the correct alignment of substrates, as well as to undergo 
conformational changes required for product release.
These data were confirmed by the re-analysis of the crystallographic data using the recently 
refined structural model (1SHK) with the identification of specific chloride binding sites on the 
enzyme. The binding sites are mainly arginine side chains and, in particular, chloride ions 
establish interactions with two residues involved in the binding of the carboxylate group of 
shikimate, Arg139 and Arg58. Probably the binding of ADP affects in some way the binding 
of these chloride ions increasing the Kd for shikimate: this could explain the higher degree of 
synergism observed when chloride was present in the buffer system.
Further work using methods such as NMR or fluorescence energy transfer would be required 
to characterise further the changes in mobility. Moreover it would be interesting to study in 
more detail the effects of NaF on activity and binding by determining the Km and Vmax In the 
presence of this salt.
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5.2 Stability studies: Chemical dénaturation
The stability and activity of an enzyme are two parameters which do not always go in the 
same direction. This is especially true for enzymes, such as SK, where flexibility plays a 
determining role in catalysis. A flexible molecule can be depicted as having an energy funnel 
with a rugged bottom with low energy barriers separating the conformers. A change in 
solvent composition will result in a change in the height of these barriers. So a 
thermodynamic stabilization, influencing the distribution of conformers, could lead to a higher 
kinetic barrier between the stabilized conformer and the one catalytically competent (Kumar 
et al., 2000). This seems to be the case for SK which has been found to be strongly 
stabilised under conditions leading to a marked degree of inactivation.
Chemical dénaturation studies employed both urea and GdmCI because it has been 
demonstrated that the comparison of the effects of these two dénaturants can give valuable 
insights into the understanding of the mechanism of unfolding. Differences were found 
between the two dénaturants used, especially when comparing the changes in activity or the 
Kd for substrates with the degree of unfolding measured by CD and fluorescence as functions 
of the dénaturant concentration. Unfolding by urea was used for the investigation of salt 
effects on the protein (Pace and Scholtz. 1997; Pace and Grimsley, 1988); for this purpose a 
range of different salts and different concentrations of NaCI and N8 2 6 0 4  have been explored. 
The salts at high concentrations stabilise the protein conformation mainly by two 
mechanisms: preferential hydration, ranked in the Hofmeister series, and preferential 
binding. The stabilising effect observed in the case of SK depends from the anion and the 
degree of stabilisation can be explained with their position in the Hofmeister series, with the 
exception of NaCI. Specific effects can arise if there are appropriate ion binding sites in 
proteins (Pace et al., 1998) as for example calcium binding sites in ribonuclease Ti 
(Deswarte et al., 2001) and zinc binding sites in alcohol dehydrogenase (Plapp et a i, 1978). 
The strong stabilising effect of the chloride ion on SK can be explained by ion binding, as 
suggested by the shikimate binding data and confirmed by crystallographic evidence. In fact 
the X-ray data show that chloride ions bind at sites which are thought to play a role in the 
binding of shikimate. The net effect of these mechanisms is rather similar so that 0.33M 
N8 2 8 0 4  has a similar but slightly larger effect on [urea] 1 /2 compared with that of 1M NaCI.
It would be interesting to study the effect of nucleotides, especially ATP, on chemical 
dénaturation (ATP has been reported to stabilise the SK against thermal dénaturation; Boam, 
1999) using GdmCI as dénaturant, because of the marked effect of urea on the binding of 
nucleotide.
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5.3 Refolding after dénaturation
When SK is refolded from the urea-denatured state the results of spectroscopic and activity 
studies indicated that refolding occurs in at least 4 kinetic phases: the average rate 
constants for these phases are >100s’  ^ (half life <7ms), lOs'^ (half life 70 ms), 0.08s  ^ (half 
life 9s) and 0.009s'^ (half life 80s). The slowest phase (k = 0.009s'^) corresponds to the 
regain of shikimate binding and of enzyme activity and the two most rapid phases are 
associated with a substantial increase in the binding of 8-anilino-1-naphthalenesulphonate 
with only modest changes in the far-UV CD. This indicates that a collapsed intermediate 
with only partial native secondary structure was formed rapidly, as have been found for the 
refolding of other proteins such as the 89 amino acid protein barstar (Agashe et al., 1995) 
and the small all p-sheet protein CTX(ill) (Sivaraman et ai., 1998). The refolding process is 
slower than for many proteins of a similar size (Jaenlcke, 1987; Grantcharova et al., 2001; 
Gunasekaran et al., 2001): this might be a feature of a number of a/p domain proteins, 
where the formation of the p-sheet is expected to be a slower process than the formation of 
a-helices (Houry et al., 1999; Plaxco et al., 1998; Sivaraman et al., 1998). The outline 
model proposed involves 3 intermediates (h, I2  and I3 ) between the unfolded state (U) and 
the native state (N). The results indicate that the pathway described for SK should act as a 
model for many other members of this subclass of a/p proteins.
A more complete understanding of the folding mechanism will be derived from further 
experimental investigations to explore the nature of the early formed intermediate(s) by using 
CD over a wider range of wavelengths in the far-UV or using a range of selected mutants. 
These could be used in conjunction with theoretical studies such as those reported in the 
case of AK, where molecular dynamics calculations were used to demonstrate the 
importance of the N-terminai 36 residue block of adenylate kinase from Saccharomyces 
cerevisiae in directing the folding of the protein (Kumar et al., 2001). Indirect evidence 
suggesting that this may also be the case for the folding of SK comes from our observations 
that the native structure of the shikimate-binding domain is only formed at the later stages of 
the process. Moreover further detailed studies of the refolding of mutants of SK in which the 
proline residues had been systematically substituted and of the refolding after very short 
periods of unfolding (the "double jump" technique (Nall, 1994)) would help to establish the 
role (if any) played by isomérisation of Xaa-Pro bonds in the refolding of the enzyme.
The residual ionic strength in solution seems to have an effect on the outcome and the rate 
of the refolding process. This effect seems to depend on the ionic species present in 
solution. In fact it has been found that the presence of NaCI or Na2 S0 4  in the refolding buffer 
leads to an increase in the refolding rate of both structure and activity. These results can 
account for the faster refolding observed when GdmCI was used as dénaturant (Boam, 1999)
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and underline the importance of taking into account the residual ionic strength of the solution 
during the refolding studies. Differences have been observed between the effects of NaCI 
and Na2 S0 4  on the refolding of SK suggesting that these two salts may exert their effect by 
different mechanisms. A more detailed study using stopped flow mixing would be useful to 
check this hypothesis. Finally further studies on the effect of fluoride on SK, which seem to 
impair the refolding process, would be interesting because of the particular effects of this salt 
on binding, stability and refolding.
SK can be refolded in 4M urea simply by increasing the ionic strength: this has been 
observed in a few other systems, such as the 63-residue N-terminal domain of the C1 
repressor from bacteriophage 434 (Dotsch et a i, 1995) and the peroxidase from Coprinus 
cinerus (Tams et a i, 1996). The refolded SK in these conditions has similar secondary and 
tertiary structure to the native enzyme. It appears to be able to bind shikimate weakly but 
with a reduced conformational response as judged by the limiting extent of fluorescence 
quenching. Though there is no direct evidence (from fluorescence quenching data) for 
binding of nucleotide substrates to the refolded enzyme, there is indirect evidence for some 
interaction with nucleotide from the observed tightening of shikimate binding in the presence 
of 2mM ADP. The refolded enzyme does not display catalytic activity: this is likely to reflect 
subtle perturbations both of the nucleotide binding site itself and of the ability of the enzyme 
to bring the substrates into the correct alignment for the phosphotransfer reaction. From the 
analysis of different traces obtained monitoring different parameters, characteristic patterns 
emerge for the two salts used. In the case of refolding induced by Na2 S0 4 , the charged Trp 
environment and the tertiary environment are formed in the same type of process; this does 
not appear to be the case when NaCI is used to start the refolding. It seems that the charged 
arginine cluster in SK could play a role in the case of the refolding induced by chloride ions. 
From the re-analysis of the crystallographic structure it appears that chloride ions are 
involved in interactions with Arg11, 139 and 58 which are clustered around the single Trp 
(Trp54) of SK. In particular one of the chloride ions interacts, in some of SK structures, with 
both A rg il and 139. So the binding of chloride to a specific site could be considered as a 
“nucleating” point that could lead to the subsequent folding of the entire protein molecule. 
These considerations lead to the idea that the refolding induced by the two salts may follow 
different mechanisms.
It would be interesting in future work to characterise this "partially folded" form of SK in more 
detail and to examine whether conditions can be found under which it can be readily 
converted to an active form. Moreover a study of the interactions present in the 4M unfolded 
enzyme (e.g. by NMR), in the absence and in presence of salts, would give insights into the 
cluster of interactions that are likely to be involved in this kind of folding process.
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5.4 Future work
It would be interesting to use the SRS facility to study the early events in the folding of this 
protein and to undertake a more detailed study, using the SF-instruments available in the lab, 
of the effects of different salts on the refolding, thus extending the manual mixing data 
already available. Therefore, it would be possible to check for general effects (eg: ionic 
strength) or specific effects due to ion binding.
The role of the N-terminal segment in the refolding could be studied in more detail, both with 
dynamic simulations (like those already performed with adenylate kinase) and with studies of 
mutants (eg: studying the refolding of the K15M mutant).
Because mobility plays an important role in enzyme activity, it would be interesting to perform 
studies using methods such as NMR to characterise the changes in mobility, in different 
medium conditions, in more detail.
More protection experiments could be carried out in the prescence of different salts and 
particularly in the prescence of NaF because some of the results obtained in this work seem 
to indicate an increased protection by ADP in the prescence of NaF. Moreover the effects of 
this particular salts on the refolding, activity and binding of substrates could be studied in 
more detail.
Finally it would be interesting to further characterise the "partially folded” form of SK obtained 
in 4M urea and to examine whether conditions can be found under which it can be^readily 
converted to an active form.
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